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Glucose transporter 4 (GLUT4) in skeletal muscle plays a vital role in the maintenance of 
glucose homeostasis. Chapter 2 of this thesis develops an immunofluorescence microscopy 
method to generate novel information in human skeletal muscle on the effect of physiological 
stimuli on GLUT4 localisation, translocation to the plasma membrane and total protein 
content. Chapter 3 shows that training-induced increases in total GLUT4 protein content are 
driven by increases in the number of large and size of smaller intracellular GLUT4 storage 
clusters in human skeletal muscle. In chapter 4 the method successfully demonstrates GLUT4 
translocation 30 min following glucose ingestion and 30 min after the start of moderate 
intensity cycling exercise in humans. GLUT4 translocation after glucose ingestion is transient 
and modest in comparison to the exercise response. Chapters 5 and 6 report no changes in 
GLUT4 translocation following an 80 min hyperinsulinaemic-isoglycaemic clamp in rats and 
a 2 h hyperglycaemic clamp in humans despite elevated rates of whole body glucose disposal 
in both experiments. This immunofluorescence method will be a valuable analytical tool in 
future studies investigating the mechanisms behind changes in muscle glucose uptake in 
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1.1. Glucose homeostasis 
Blood glucose concentration must be maintained within a tight range (70 – 90 mg.dL
-1
 ~ 3.9 – 
5.0 mM) in order to meet the physiological demands of the human body (Abdul-Ghani et al., 
2006, Wasserman, 2009). Glucose is a major fuel used in humans and is the sole fuel source 
for the brain in the fed, post-absorptive and overnight fasted state (Abdul-Ghani et al., 2006). 
In the post-absorptive state the brain accounts for 50 % of glucose disposal (Defronzo, 2009). 
Severe reductions in blood glucose to concentrations as low as 2 mM (hypoglycemia) are 
deleterious to brain function (Wasserman, 2009). Conversely prolonged recurrent increases in 
blood glucose concentration (hyperglycaemia) as occurs in type 2 diabetes lead to function 
loss and damage in all tissues (Manley, 2003). Therefore, tight control mechanisms exist in 
healthy individuals to prevent substantial perturbations in blood glucose concentration 
(Abdul-Ghani et al., 2006). The main control mechanisms are outlined below. 
1.1.1. Mechanisms to ensure tight control of blood glucose concentration 
Feeding and exercise challenge the glucose homeostasis mechanisms. In the postprandial 
state, elevations in blood glucose concentrations are sensed by the beta cells of the pancreas, 
resulting in insulin secretion (Fridlyand and Phillipson, 2011). In order to counter the rise in 
glucose appearance in the circulation, increased insulin production by the beta cells of the 
pancreas leads to an increase in plasma insulin concentration and suppression of the hepatic 
glucose production (Abdul-Ghani et al., 2006). Postprandial increases in plasma insulin 
concentration also stimulate glucose uptake into insulin-sensitive peripheral tissues such as 
muscle (Katz et al., 1983) and adipose tissue (Coppack et al., 1990) and also the liver 
(Ferrannini et al., 1980). The rise in plasma insulin also stimulates glycogen synthesis in liver 
and muscle (Wasserman, 2009). Conversely, in the post-absorptive state decreases in blood 
glucose concentration are sensed by the alpha cells of the pancreas which secrete the hormone 
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glucagon (Abdul-Ghani et al., 2006). Glucagon stimulates endogenous glucose output from 
the liver and to a lesser extent the kidneys in order to maintain blood glucose concentration 
sufficient for normal brain function (Gerich et al., 2001). Liver glucose output occurs via 
increased rates of glycogenolysis (glycogen breakdown) and gluconeogenesis (glucose 
synthesis) (Wasserman, 2009). During the initial stages of moderate to high intensity exercise 
(> 50 % VO2max), increased rates of muscle glycogen breakdown and glucose uptake from the 
circulation provide the glucose moieties that are required to generate the ATP that is needed 
to support continued muscle contraction, while an acute increase in liver glycogen breakdown 
generates the glucose that is required to prevent reductions in plasma glucose concentration 
(Coggan, 1991). In the case of longer duration exercise (3-4 h), gradual increases in whole 
body lipolysis generates glycerol (Coggan, 1991), while acceleration of the glucose-alanine 
cycle increases net alanine release from the muscle (Felig et al., 1970, Van Hall et al., 1999). 
Glycerol and alanine, in addition to lactate, are substrates that can be used for hepatic 
gluconeogenesis (Felig et al., 1970, Bergman et al., 2000, Emhoff et al., 2013). As a result 
hepatic gluconeogenesis becomes the more dominant source of glucose production compared 
to liver glycogen breakdown and serves to prevent decreases in plasma glucose concentration 
during prolonged exercise. 
1.1.2. Impaired glucose homeostasis 
Insulin resistance is a phenomenon whereby normally insulin sensitive tissues do not respond 
adequately to insulin (Shulman, 2000). The development of insulin resistance can be 
associated with obesity and is an early step in the pathogenesis of type 2 diabetes (T2D), 
occurring many years before the onset of the disease. It is important to note that metabolic 
abnormalities such as insulin resistance and a predisposition to T2D can also be present in 
normal weight individuals, driven, for example, by inflammation (Ruderman et al., 1998, 
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Karelis et al., 2004). Blood glucose concentration is not as tightly regulated and large 
excursions in blood glucose can occur following glucose ingestion due to a reduction in 
insulin-mediated glucose uptake in peripheral tissues (primarily skeletal muscle) and a failure 
in insulin-mediated suppression of hepatic glucose production (Abdul-Ghani et al., 2006). 
Initially, insulin secretion is elevated in the postprandial state to compensate for the reduction 
in insulin-mediated glucose disposal (Abdul-Ghani et al., 2006). However over time the 
increased demand exerted on the pancreatic beta cells leads to beta cell apoptosis (Costes et 
al., 2013). As a result insulin secretion in response to excursions in plasma glucose is reduced 
and can no longer compensate for reduced insulin-mediated glucose disposal. Therefore 
plasma glucose concentration becomes chronically elevated (Abdul-Ghani et al., 2006) and 
overt T2D has developed. Chronically high plasma glucose concentrations (hyperglycaemia) 
can lead to the secondary complications of T2D such as cardiovascular disease, microvascular 
damage, retinopathy and neuropathy (Crawford et al., 2009, Stirban and Tschoepe, 2008, Park 
et al., 2004, Khan and Chakrabarti, 2006). 
The oral glucose tolerance test (OGTT) is a method used to assess whole body glucose 
tolerance, at the start of which glucose is ingested and blood samples are taken every 30 min 
to measure blood glucose and insulin concentrations (Matsuda and DeFronzo, 1999). It 
reflects the efficiency of the body to return plasma glucose concentration to baseline 
following an oral glucose load. The OGTT is not a direct measure of whole body insulin 
sensitivity as many factors apart from sensitivity to insulin affect the removal of glucose from 
the blood (Muniyappa et al., 2008). For example, individuals with a higher body mass, and in 
particular a higher muscle mass, will have a higher capacity to dispose of an oral glucose 
load. However the OGTT is a simple and practical, low cost tool to use in the lab and 
importantly, the Matsuda insulin sensitivity index derived from OGTT plasma insulin and 
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glucose concentrations has been shown to have a high correlation (r = 0.73, P < 0.0001) with 
the rate of whole body glucose disposal during the gold standard assessment of insulin 
sensitivity, the hyperinsulinaemic-euglycaemic clamp (Matsuda and Defronzo, 1999). In 
some of the studies in this PhD thesis the aim will be to relate skeletal muscle insulin 
sensitivity to GLUT4 translocation from intracellular stores to the muscle plasma membrane. 
It should be noted that both the OGTT and the hyperinsulinaemic-euglycaemic clamp have 
the limitation that multiple tissues (liver, adipose tissue and skeletal muscle) contribute to 
whole body glucose uptake. 
According to the clinical definitions an individual is regarded to have normal glucose 
tolerance (NGT) if the fasting plasma glucose remains between 3.9 – 5.0 mM (Gagliardino, 
2005) and if plasma glucose concentrations return to baseline by 2 h after the start of an 
OGTT (Matsuda and DeFronzo, 1999, Zhou et al., 2006). T2D is diagnosed if fasting plasma 
glucose is greater than 7 mM or if plasma glucose 2 h after glucose ingestion is greater than 
11.1 mM (Genuth et al., 2003). T2D develops over time and intermediate states of insulin 
resistance have been diagnosed before overt T2D (Abdul-Ghani et al., 2006). Fasting plasma 
glucose concentration of 5.6 – 6.9 mM has been suggested to point at hepatic insulin 
resistance, while 2 h plasma glucose of 7.8 – 11 mM has been suggested to point at impaired 
glucose tolerance (IGT) and reduced peripheral tissue insulin sensitivity (Genuth et al., 2003). 
1.1.3. Epidemiology of obesity and type 2 diabetes 
Increases in the availability of food and changing eating habits towards convenience food 
with low nutritional value and often a high fat content combined with reduced physical 
activity has caused alarming increases in the prevalence of obesity throughout the globe 
(Kelly et al., 2008). According to the World Health Organisation (WHO) fact sheet No 311 in 





and this figure is predicted to further increase to 1.12 billion by 2030 (Kelly et al., 2008). In 
addition to the increasing prevalence of obesity, in 2008 347 million adults worldwide were 
classed as T2D (Danaei et al., 2011). Importantly T2D has a significant impact on mortality. 
In 2004, 3.4 million deaths were attributed to the consequences of high fasting blood glucose 
(World Health Organisation, 2009). The cost to the NHS in Great Britain in 2010-2011 of 
treatment of the secondary complications of T2D has been estimated at £8.8 billion (Hex et 
al., 2012) and approximately 10 % of the total NHS budget (Department for Health, 2006). 
This is estimated to rise to £15.1 billion by 2035-2036 (Hex et al., 2012). These figures 
highlight the need for research into the mechanisms behind the development of T2D to guide 
strategies for the prevention and treatment of T2D. 
1.1.4. Central role of skeletal muscle in glucose homeostasis 
Skeletal muscle is the primary site of postprandial glucose uptake (Katz et al., 1983, 
Ferrannini et al., 1985). Leg glucose uptake was elevated four-fold 30 min after oral glucose 
ingestion in healthy young individuals and remained significantly elevated above baseline for 
4 h with maximal leg glucose uptake occurring between 30 min and 120 min (Katz et al., 
1983). Furthermore peripheral tissues such as skeletal muscle have been shown to be the most 
significant site of insulin resistance with leg glucose uptake being reduced by 45 % in patients 
with T2D compared to healthy control (DeFronzo et al., 1985). In addition, the contribution of 
plasma glucose to ATP production in the working muscle during endurance exercise 
demonstrates the importance of glucose uptake into skeletal muscle during exercise (Katz et 
al., 1991, Kjaer et al., 1991, van Loon et al., 2001). Skeletal muscle glucose uptake is central 
to the maintenance of glucose homeostasis both following feeding and during exercise and is 
also a major site of insulin resistance. Therefore this thesis will concentrate solely on glucose 
uptake mechanisms in skeletal muscle. Skeletal muscle glucose uptake requires three distinct 
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stages; delivery of glucose to the muscle fibre, glucose transport across the plasma membrane 
(PM) and phosphorylation of glucose by hexokinase to make the process irreversible and trap 
glucose inside the muscle fibre (Wasserman and Ayala, 2005). Glucose transport is believed 
to be the main barrier to skeletal muscle glucose uptake (Wasserman and Ayala, 2005). As 
glucose transporter 4 (GLUT4) is the main glucose transporter protein isoform expressed in 
skeletal muscle (Mueckler, 1994, Bell et al., 1993) this thesis investigates the role of GLUT4 
in insulin- and contraction-mediated glucose uptake in human skeletal muscle. Substrate 
delivery to muscle cells will be discussed in section 1.2 and glucose phosphorylation will be 
returned to in the general discussion in section 7.4. 
 
1.2. Substrate delivery to muscle cells 
Insulin delivery to the skeletal muscle is proposed to be a rate-limiting step in insulin-
stimulated skeletal muscle glucose uptake (Barrett et al., 2009). Insulin acts on the 
microvasculature to increase its own delivery and the delivery of glucose to the skeletal 
muscle. This occurs through two key mechanisms which will be outlined in subsequent 
sections; firstly the dilatation of skeletal muscle terminal arterioles to increase blood delivery 
to capillaries supplying muscle fibres and secondly by increasing the trans-endothelial 
transport of insulin from the blood into the muscle interstitium (Barrett et al., 2009). Insulin-
mediated increases in total limb blood flow start to occur after about 90 min and do not 
correspond temporally to the insulin-mediated increases in skeletal muscle glucose uptake 
which start to occur after 15-30 min (Barrett et al., 2009). Rather it is insulin action on the 
microvasculature that is key to increasing insulin and glucose delivery to the skeletal muscle 




1.2.1 Microvascular recruitment 
Insulin has been shown to increase microvascular blood volume (MBV, for review see Barrett 
et al. 2009). The mechanism involves insulin-induced dilation of terminal arterioles, which 
leads to recruitment of previously unperfused skeletal muscle capillaries, thereby increasing 
the endothelial surface area available for insulin and glucose transport and, therefore, 
increasing glucose and insulin delivery to the skeletal muscle fibres. Microvascular 
recruitment occurs before insulin-mediated increases in total limb blood flow (Barrett et al., 
2009). In rats increases in microvascular blood volume are seen as early as 5-10 min into a 
hyperinsulinaemic-euglycaemic clamp and these increases precede the activation of the 
insulin signalling cascade and increases in glucose uptake in skeletal muscle fibres (Vincent 
and Barrett, 2002, Vincent et al., 2004). Gudbjornsdottir et al. (2003) have shown that there is 
a marked increase in the capillary permeability surface area (PSA) product for glucose in 
humans, which is proportional to the increase in glucose uptake during an OGTT and also 
proportional to the larger increase seen during a hyperinsulinaemic-euglycaemic clamp 
leading to physiological increases in insulin concentrations (Gudbjornsdottir et al., 2003). 
Insulin has been shown to act on vascular endothelial cells via the insulin receptor resulting in 
the activation of phosphatidylinositol 3-kinase (PI3K), Akt and ultimately, via serine
1177
 
phosphorylation, activation of endothelial nitric oxide synthase (eNOS) (Liu et al., 2009b). 
The active form of eNOS synthesises nitric oxide (NO) and it is NO that causes relaxation of 
the surrounding vascular smooth muscle and is responsible for the dilatation of the terminal 
arterioles (Steinberg et al., 1994, Vincent et al., 2003, Barrett et al., 2009). Treatment of rats 
with the NOS inhibitor L-NAME prevented both the insulin-mediated increases in MBV and 
skeletal muscle glucose uptake, demonstrating that MBV increases are vital for insulin-
mediated glucose uptake (Vincent et al., 2003). 
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Increases in microvascular recruitment have been shown to occur following insulin 
stimulation (Rattigan et al., 1997, Coggins et al., 2001, Vincent et al., 2004, Zhang et al., 
2004), feeding (Vincent et al., 2006) and exercise (Honig et al., 1982, Dawson et al., 2002, 
Wheatley et al., 2004, Vincent et al., 2006). 
1.2.2. Trans-endothelial insulin transport 
Insulin concentration in the muscle interstitium is 40-60 % of that in the plasma indicating 
that there is a barrier to movement of insulin across the endothelial cell layer of the capillaries 
(Barrett et al., 2009). The mechanism by which insulin traverses the endothelial cell barrier is 
somewhat controversial (Barrett et al., 2009), however studies in human forearm using 
increasing physiological insulin concentrations suggest the movement of insulin out of the 
capillaries relies on a saturable transport process and points to a mechanism whereby 
endothelial cell insulin receptors mediate a transport mechanism in which insulin is 
transported through the endothelial cells from the luminal to the interstitial side, thus allowing 
insulin entry into the muscle interstitium (Eggleston et al., 2007). 
It is important to state at this point that the microvascular effects of insulin are vital for insulin 
and glucose to be transported into the interstitial fluid of skeletal muscle fibres and activate 
the insulin signalling cascade. However, the focus of this thesis is on the regulation of glucose 
uptake in the skeletal muscle fibres and particularly the role played by increases and decreases 
in GLUT4 translocation in mediating skeletal muscle glucose uptake and as a cause of 
skeletal muscle insulin resistance, respectively. It is however acknowledged that insulin must 
first exert its effects on the microvasculature before skeletal muscle insulin signalling and 
GLUT4 translocation can occur. It is recognised that impairments in the microvascular effect 
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of insulin most likely also contribute to skeletal muscle insulin resistance in T2D and pre-
diabetic states. 
 
1.3. Glucose transporters in skeletal muscle 
Glucose is lipophobic and also too large to traverse muscle cell membranes via diffusion, 
therefore transmembrane transporter proteins are required to facilitate glucose movement into 
the cell (Stuart et al., 2006). Glucose transporters (GLUTs) are passive carriers that do not 
require energy as they transport their substrate down a concentration gradient (Mueckler, 
1994). All tissues in the human body express a GLUT isoform to allow glucose uptake into 
the cell (Uldry and Thorens, 2004). There are 14 members of the SLC2A/GLUT family of 
facilitative hexose transporters, of which the mRNAs for GLUT4, GLUT5, GLUT12, 
GLUT8, GLUT11, GLUT3 and GLUT1 have all been detected in human skeletal muscle, 
listed in the order of greatest abundance (Stuart et al., 2006). In the same study Western 
blotting and immunohistochemistry demonstrated strong expression of GLUT4, GLUT5 and 
GLUT12 in skeletal muscle. Furthermore despite its low mRNA expression, GLUT1 
demonstrated a strong immunohistochemical signal in the endothelial cells of capillaries 
between muscle fibres (Stuart et al., 2006). All GLUT isoforms are composed of 12 
transmembrane domains, with the amino- and carboxyl-termini on the cytoplasmic side of the 
membrane (Uldry and Thorens, 2004). GLUT4 is the primary glucose transporter isoform 
expressed in skeletal muscle and is largely responsible for insulin- and contraction mediated 
glucose uptake (Mueckler, 1994). GLUT1 is widely believed to be responsible for basal 
glucose uptake (Mueckler, 1994, Bell et al., 1993). In the coming paragraphs the expression 





GLUT4 is predominantly expressed in the insulin responsive tissues skeletal and cardiac 
muscle and adipose tissue (Mueckler, 1994) and is commonly reported to have a higher 
expression in type I oxidative skeletal muscle fibres compared to type II muscle fibres 
(Houmard et al., 1991, Gaster et al., 2000, Daugaard et al., 2000, Daugaard and Richter, 2004, 
Stuart et al., 2006). However other groups have shown no relationship between GLUT4 
content and fibre type (Hughes et al., 1993, Andersen et al., 1993, Hardin et al., 1995), while 
one group has observed higher GLUT4 expression in type II muscle fibres (Borghouts et al., 
2000). 
Transgenic mice that express high levels of GLUT4 exhibit increased insulin- and 
contraction-mediated glucose disposal (Marshall and Mueckler, 1994, Hansen et al., 1995, 
Ren et al., 1995), increased basal glucose disposal (Liu et al., 1993, Hansen et al., 1995) and 
reduced basal plasma glucose concentrations (Liu et al., 1993, Ren et al., 1995). GLUT4 
overexpression has a greater effect on insulin- and contraction-mediated glucose uptake 
compared to basal glucose uptake which is consistent with GLUT4 being responsible for 
insulin and contraction stimulated glucose uptake, though suggests a minor role for GLUT4 in 
basal glucose uptake (Hansen et al., 1995). Basal glucose uptake is primarily mediated by a 
different glucose transporter, thought to be GLUT1 (Mueckler, 1994, Bell et al., 1993). 
Further detail is given on GLUT1 in section 1.3.2 below. 
Male GLUT4 knockout mice display elevated fed state plasma glucose concentration 
compared to wild type (Katz et al., 1995) and exhibit a reduced glucose uptake response to 
insulin (Stenbit et al., 1996). Interestingly, basal glucose uptake into the soleus muscle of 
male GLUT4 knockout mice was increased (Stenbit et al., 1996). In female GLUT4 knockout 
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mice there was no change in fed state glycaemia (Katz et al., 1995) or in insulin induced 
increases in glucose disposal compared to wild type (Stenbit et al., 1996). Therefore it seems 
that alternative glucose transporters are able to compensate for the lack of GLUT4 in GLUT4 
knockout mice to increase basal glucose uptake in male mice and to maintain insulin-
stimulated glucose uptake in female mice; these glucose transporters are proposed as GLUT1 
and GLUT12, respectively (Stuart et al., 2009, Stenbit et al., 1996).  
GLUT4 translocation in human skeletal muscle has been demonstrated through increased 
GLUT4 in PM cellular subfractions 60 min following glucose ingestion (Goodyear et al., 
1996), following 30 – 40 min hyperinsulinaemic-euglycaemic clamp (Guma et al., 1995) and 
following 45 – 60 min exercise (Kennedy et al., 1999). In addition membrane fractionation 
studies using human skeletal muscle have demonstrated the effects of insulin and exercise on 
GLUT4 PM content are additive (Thorell et al., 1999).  Additionally studies in rodents have 
shown GLUT4 translocation to the PM and T tubule membranes following insulin injection 
(Ploug et al., 1998, Lauritzen et al., 2006) and electrical stimulation of muscle (Ploug et al., 
1998, Lauritzen et al., 2010) using confocal IF microscopy techniques. 
As skeletal muscle is responsible for the majority of postprandial glucose uptake (Katz et al., 
1983, Ferrannini et al., 1985) and takes up plasma glucose during endurance exercise for ATP 
production in the working muscle (Katz et al., 1991, Kjaer et al., 1991, van Loon et al., 2001) 
the role of GLUT4 in skeletal muscle is vital for the maintenance of glucose homeostasis; 
therefore supporting the attention of this thesis on the role of GLUT4 in insulin- and 
contraction-mediated skeletal muscle glucose uptake. Previously published literature in 
human skeletal muscle which measured the GLUT4 content of muscle PM fractions assumes 
a driving role for GLUT4 translocation in insulin and contraction-mediated increases in 
glucose uptake (Goodyear et al., 1996, Kennedy et al., 1999). This thesis will further 
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investigate the role of GLUT4 translocation in insulin and contraction mediated increases in 
glucose uptake using immunofluorescence microscopy methods in human skeletal muscle. 
The importance of using immunofluorescence microscopy methods to make estimates of 
GLUT4 localisation in the PM is discussed in section 1.4.1. 
1.3.2. GLUT1 
Glucose transporter 1 (GLUT1) is widely expressed and found in almost every tissue (Uldry 
and Thorens, 2004, Mueckler, 1994). GLUT1 overexpression studies have shown decreased 
fasting and fed plasma glucose concentrations and increased rates of basal glucose disposal 
(Ren et al., 1993, Marshall et al., 1993, Gulve et al., 1994, Hansen et al., 1998b) supporting its 
role as the primary glucose transporter isoform responsible for glucose uptake in the basal 
state. Consistent with its role in basal state glucose uptake, GLUT1 is constitutively localised 
at the PM (Gulve et al., 1994, Wang et al., 1996, Hansen et al., 1998b). Immunohistochemical 
studies of GLUT1 localisation in human skeletal muscle have shown high GLUT1 expression 
in the endothelial cells of capillaries between muscle fibres. Low intracellular GLUT1 signal 
was observed in type I muscle fibres (Stuart et al., 2006). In transgenic mice overexpressing 
GLUT1, the transporter was observed at the PM in the basal state and to a lesser extent the T 
tubule membranes (Wang et al., 1996). Intraperitoneal injection of insulin did not alter the 
localisation of GLUT1 in these mice (Wang et al., 1996). 
1.3.3. GLUT12 
Glucose transporter 12 (GLUT12) was first characterised in 2002 in MCF7 cells and the 50 
kDa protein was subsequently shown to be expressed in skeletal muscle, adipose tissue cells 
and small intestine tissues with a substrate selectivity for ᴅ-glucose (Rogers et al., 2002, 
Rogers et al., 2003). Importantly the proportion of muscle cell GLUT12 localised to the PM 
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increased following 3 h hyperinsulinaemic-euglycaemic infusion in non-obese healthy 
individuals (Stuart et al., 2009). In L6 myoblasts inhibition of insulin signalling at the level of 
PI3K inhibits the insulin-mediated increase in GLUT12 at the PM (Stuart et al., 2009). 
Transgenic mice that overexpress GLUT12 exhibit improved glucose tolerance and insulin 
sensitivity and increased insulin stimulated glucose disposal into peripheral tissues, with no 
change in basal glucose disposal (Purcell et al., 2011). As stated previously, GLUT4 knockout 
mice do not lose their ability to increase glucose uptake in response to insulin (Katz et al., 
1995, Stenbit et al., 1996). GLUT12 is therefore a good candidate for a second insulin 
regulatable glucose transporter that compensates for the lack of GLUT4 in GLUT4 null mice. 
In support of this, immunohistochemical staining has shown higher GLUT12 signal in type I 
compared to type II fibres (Stuart et al., 2006), consistent with its potential role in 
compensating for reduced GLUT4 expression in red muscle type (Stenbit et al., 1996). 
GLUT12 protein content has been shown to account for 12% of insulin-responsive glucose 
transporter (GLUT4 and GLUT12) protein content in human vastus lateralis muscle (Stuart et 
al., 2009). 
1.3.4. GLUT5 
Glucose transporter 5 (GLUT5) mRNA and protein have been shown to be present in human 
skeletal muscle at relatively high levels (Hundal et al., 1998, Stuart et al., 2006). However 
GLUT5 does not transport glucose; it is solely a fructose transporter and as such is expressed 
at much higher levels in the small intestine (Douard and Ferraris, 2008). GLUT5 expression 
appears to be higher in type IIb muscle fibres and its intracellular localisation is unaffected by 





1.4. GLUT4 in skeletal muscle cells 
GLUT4 is predominantly located in intracellular storage clusters with a small amount 
contained within the PM of muscle cells in the basal state. These intracellular storage clusters 
are mainly located at the fibre periphery, with some areas of intense intracellular staining 
(Ploug et al., 1998, Lauritzen et al., 2006). Large and smaller clusters of GLUT4 staining have 
been observed with a particularly high density in the perinuclear region (Ploug et al., 1998, 
Lauritzen et al., 2008). Studies combining confocal immunofluorescence microscopy 
techniques with immunogold labelling electron microscopy (EM) applied to whole single 
fibres of rat soleus muscle demonstrate a high concentration of GLUT4 in membranes 
associated with the trans-Golgi network (TGN) region as well as in smaller endosomal 
membrane stores. Tubulovesicular storage structures, which are still smaller, were also seen 
and were assumed to be the GLUT4 storage vesicles (GSVs) (Ploug et al., 1998). GSVs are 
formed by budding away from endosomal and TGN-associated membranes (Bogan and 
Kandror, 2010, Bogan, 2012) and following insulin and contraction stimulation GSVs 
translocate and dock and fuse with the PM and T-tubule membranes to allow increased 
glucose uptake (Foley et al., 2011). Fig.1.1 outlines the spatial distribution of these GLUT4 




Fig. 1.1. Representation of GLUT4 storage and trafficking in skeletal muscle cells in basal 
and stimulated states. During resting conditions and with low interstitial glucose and insulin 
concentrations GLUT4 is stored intracellularly associated with the membranes of the trans-
Golgi complex and in endosomes and GSVs which are predominantly located at the fibre 
periphery, but also in deeper regions. A small amount of GLUT4 is located in the PM and T-
tubule membranes. Following contraction or increasing interstitial insulin concentrations 
GSVs fuse with the outer membrane and GLUT4 becomes inserted into the PM and T-tubule 
membranes to enable increased rates of glucose uptake. TGN stores (large GLUT4 clusters) 
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of GLUT4 reduce in size while endosomal stores reduce in number. The information in this 
figure is based on information provided by the following references all obtained from 
information generated in rat and mouse skeletal muscle (Ploug et al., 1998, Lauritzen et al., 
2006, Lauritzen et al., 2008, Lauritzen et al., 2010). 
 
1.4.1. Methods to investigate GLUT4 localisation and trafficking 
The structure of skeletal muscle is complex with the contractile proteins actin and myosin 
comprising approximately 80 % of muscle protein (Jones, 1990) and the T-tubule membrane 
network of PM invaginations running deep into the fibre interior (Peachey and Eisenberg, 
1978). The primary role of the T-tubule membranes is to rapidly conduct action potentials 
from the cell surface to the fibre interior, thereby inducing calcium release from the 
sarcoplasmic reticulum and subsequently activating myofibril contraction (Peachey and 
Eisenberg, 1978). T-tubule membranes run around the myofibrils either side of the Z line at 
the A-I band junctions of the sarcomere and adjacent to the sarcoplasmic reticulum (Jones, 
1990). In immunofluorescence images of longitudinally-oriented skeletal muscle fibres T-
tubule membranes are visualised as cross striations that run perpendicular to the fibre axis 
(Wilson et al., 2012, Murphy et al., 2009). As well as their role in action potential conduction, 
T-tubule membranes are well characterised as a site of insulin signalling and insulin- and 
contraction-mediated GLUT4 translocation (Ploug et al., 1998, Lauritzen et al., 2006, 
Lauritzen et al., 2010). T-tubule membrane surface area is proposed to be two- to three-fold 
higher than that of the sarcolemma (Lauritzen et al., 2006), with suggestions it may even be 




The complex structure of a muscle fibre and the importance of the T-tubule membranes in 
insulin- and contraction-mediated glucose uptake elicit specific methodological requirements 
in the analysis of GLUT4 localisation and translocation. Contributing to these requirements 
are the heterogeneous intracellular GLUT4 storage pools which, to date, have undergone 
limited characterisation in skeletal muscle. 
A wide range of techniques have been employed in the study of GLUT4 localisation and 
trafficking; each with their own advantages and disadvantages. In earlier studies GLUT4 
translocation was primarily investigated using subcellular fractionation techniques in both 
rodent (Klip et al., 1987, Douen et al., 1990a, Marette et al., 1992) and human skeletal muscle 
(Goodyear et al., 1996, Kennedy et al., 1999) through quantitation of GLUT4 content in PM 
fractions. Firstly subcellular fractionation requires large muscle samples. For example 
previous studies investigating GLUT4 localisation through subcellular fractionation collected 
approximately 1g of muscle using an open biopsy method (Goodyear et al., 1996, Kennedy et 
al., 1999). While subcellular fractionation can be completed on smaller muscle samples 
(~100mg), this is the higher end of the yields obtainable with the Bergstrom percutaneous 
needle biopsy technique (Bergstrom, 1975) and is significantly more than what is needed to 
carry out immunofluorescence microscopy analysis which can be performed on as little as 20-
30mg muscle, provided the sample is not damaged. Additional limitations include 
contamination of the isolated PM fractions with myofibrillar proteins and with other 
intracellular membrane fractions with a high GLUT4 content (Fazakerley et al., 2009b). A 
further limitation is the inability to discriminate between GLUT4 just adjacent to the PM and 
GLUT4 fully incorporated into the PM after docking and fusion of GSV's and, therefore, able 
to transport glucose (Schertzer et al., 2009). Therefore, repeated suggestions have been made 
in the literature that data generated with the PM fractionation method do not provide reliable 
19 
 
estimates of the amount of GLUT4 present in the PM (Fazakerley et al., 2009b, Schertzer et 
al., 2009, Lauritzen and Schertzer, 2010). 
Immunofluorescence studies in rodent skeletal muscle have clearly shown translocation of 
GLUT4 to PM and T tubule membrane regions (Ploug et al., 1998, Wang et al., 1996). 
However as no PM marker was used in these studies GLUT4 was assessed in a region 
assumed to represent the PM rather than know to be the PM. The same is true for GLUT4 
translocation to the T-tubule membranes. 
Temporal information regarding GLUT4 translocation in response to insulin and contraction 
in rodent skeletal muscle in vivo has been generated using highly elegant experiments utilising 
GFP-tagged GLUT4 (Lauritzen et al., 2006, Lauritzen et al., 2010), however this is still 
limited by the aforementioned lack of PM marker therefore leaving uncertainty about the 
exact location of GLUT4 docking in PM and T-tubule membranes. In vitro experiments in 
non-permeabilised L6 skeletal muscle cells expressing GLUT4 with HA or myc tags on the 
first exofacial loop resolved this problem as the tag was only detectable when GLUT4 was 
fully inserted into the PM (Fazakerley et al., 2009a). However cultured muscle cells are 
missing key features of mature skeletal muscle such as the T tubule membrane system and, 
therefore, in vivo model systems were developed in which mice express GLUT4-myc or 
GLUT4-HA for confirmation of GLUT4 insertion into the PM in vivo (Schertzer et al., 2009, 
Fazakerley et al., 2009b). However in human skeletal muscle in vivo transient or chronic 
expression of tagged-GLUT4 for experimental purposes is not technologically possible.  
Electron microscopy (EM) methods using immuno-gold labelling of GLUT4 have been 
utilised to generate high resolution images of GLUT4 at the PM, T-tubule membranes and in 
intracellular stores (Ploug et al., 1998). Immuno-gold EM, however, also has limitations. The 
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most important of which is the negative effect tissue dehydration and embedding can have on 
the preservation of GLUT4 antigenicity through GLUT4 denaturation (Hayat, 1989, Hyatt, 
1991). Furthermore dehydration and embedding can also effect the penetration of the antibody 
to the target (Hayat, 1989). Finally the addition of colloidal gold particles to an antibody can 
alter the protein conformation of that antibody, thereby affecting its binding affinity to the 
target (Hayat, 1989). Taken together these limitations could all reduce the sensitivity of 
GLUT4 detection using immuno-gold EM. 
To summarise, there are limitations associated with many of the methods used to investigate 
GLUT4 localisation and trafficking. Therefore, new methods, beyond PM fractionation and 
immuno-EM, must be developed to enable further investigation of GLUT4 localisation and 
trafficking in human skeletal muscle. As expression of tagged GLUT4 is not technologically 
possible in human skeletal muscle, confocal immunofluorescence microscopy, despite its 
resolution limitations, could generate novel information on GLUT4 localisation and 
trafficking in human skeletal muscle. The novel approach chosen in this PhD project will be 
to measure the colocalisation of GLUT4 with the PM marker dystrophin as a measure of 
GLUT4 present in the PM using traditional immunofluorescence microscopy methods. This 
approach has not been used in previous research investigating translocation of GLUT4 to the 
PM. 
1.4.2. GSV components 
GSVs (GLUT4 storage vesicles) are lipid bilayer bound structures that have been shown to 
contain between 1 and 25 GLUT4 molecules (Ploug et al., 1998). GSVs are characterised 
biochemically by the presence of the SNARE protein VAMP2 and insulin-regulated amino 
peptidase (IRAP) (Foley et al., 2011). As a SNARE protein VAMP2, in combination with 
other SNARE proteins, is responsible for the docking and fusion of GSVs at the PM 
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(Kristiansen et al., 1996, Randhawa et al., 2000). IRAP may be involved in GSV intracellular 
retention in the basal state (Foley et al., 2011). Also involved in GSV intracellular retention 
and present in the GSV is a protein called 'tether containing a UBX domain for GLUT4' 
(TUG) (Foley et al., 2011). In the basal state Akt substrate of 160 kDa (AS160) is also 
associated with the GSVs, potentially via interaction with the N terminal of IRAP (Larance et 
al., 2005, Eguez et al., 2005, Thong et al., 2007). Sortillin is another protein identified on the 
GSV and is thought to play a role in GSV biogenesis at the TGN (Foley et al., 2011). GSVs 
contain no endosomal or TGN proteins (Stockli et al., 2011). 
1.4.3. Other intracellular GLUT4 stores 
GLUT4 continually cycles between intracellular membranes and the surface membranes of 
cells (Fazakerley et al., 2009a, Stockli et al., 2011, Foley et al., 2011). Studies on GLUT4 
intracellular trafficking have been carried out predominantly in cultures of rodent adipocyte 
cells and to a lesser degree in cultured L6 skeletal muscle cells (Stockli et al., 2011, Foley et 
al., 2011). While there are specific differences in GLUT4 trafficking between adipose tissue 
cells and skeletal muscle cells the fundamental mechanisms are comparable (Foley et al., 
2011). GLUT4 internalisation from the PM occurs via clathrin-mediated endocytosis and 
cholesterol-dependent endocytosis (Handberg et al., 1990). Following internalisation, 
GLUT4-containing regions of the PM form early endosomes, which in turn accumulate into 
endosomal recycling compartments (ERC) for cycling of GLUT4-containing membranes back 
to the PM (~10 %) or sorting into GSVs or subcompartments of the TGN. In the absence of 
stimulation GLUT4 is retained in this slow cycling state between the ERC and the PM or the 
ERC, GSVs and the TGN (Bryant et al., 2002, Adachi et al., 2007, Foley et al., 2011, Stockli 
et al., 2011). 
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Immunofluorescence analysis of rat skeletal muscle fibres showed GLUT4 staining as large 
and smaller clusters which are located predominantly in perinuclear regions and at the fibre 
periphery (68 % within 3 µm of the PM), though staining was also present in deeper regions 
(Ralston and Ploug, 1996, Ploug et al., 1998). In rodent skeletal muscle TGN GLUT4 stores 
have been estimated as > 1 µm in diameter (Lauritzen et al., 2008). The size of endosomal 
stores and GSVs in skeletal muscle is less conclusively reported. Adipose cell studies have 
revealed that GLUT4 is stored in 50 – 70 nm GSVs (Larance et al., 2008, Bogan and Kandror, 
2010, Stockli et al., 2011, Bogan, 2012) and approximately 200 nm endosomal stores (Bogan, 
2012). Based on EM images and their scale bars endosomes appear to be 200 – 300 nm in 
rodent skeletal muscle with GSVs smaller still (Ploug et al., 1998). TGN markers partially 
overlapped with large clusters of GLUT4 only, while the endosomal marker (transferrin 
receptor) overlapped with both large and smaller clusters of GLUT4, but there were additional 
smaller clusters that did not overlap with the endosomal marker. These are likely to be GSVs 
(Ploug et al., 1998). In vivo studies in mice transiently transfected with green fluorescent 
protein (GFP)-tagged GLUT4 also confirmed the presence of GLUT4 in large and small 
clusters; again the large clusters were located predominantly in perinuclear regions (Lauritzen 
et al., 2006). A limited amount of non-continuous GLUT4 staining was present in the PM 
region in the basal state, while a weak and irregular staining of cross striations was seen, 
which demonstrates limited presence of GLUT4 in T-tubule membranes in the basal 
unstimulated state (Ploug et al., 1998, Lauritzen et al., 2006). In addition studies in transgenic 
mouse muscle fibres using labelling of exofacially myc-tagged GLUT4 demonstrate a 
substantial GLUT4 fusion with the PM in the basal state, with externalised myc labelling 
under basal conditions approximately 50 % of that after insulin stimulation (Schertzer et al., 
2009). In contrast EM immunogold labelling studies suggest that GLUT4 is completely 
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excluded from the PM in the basal state (Ploug et al., 1998). This discrepancy may be due to 
the effects of tissue fixation and embedding on GLUT4 antigenicity which as discussed 
previously may reduce the sensitivity of immuno-gold EM methods (Hayat, 1989, Hyatt, 
1991). Previous attempts of immunohistochemical studies of GLUT4 in human skeletal 
muscle in the basal state have shown a high punctuate staining intensity in the perinuclear 
region, a granular staining pattern in the PM region and a small amount of a diffuse 
intracellular staining with higher intensity in type I muscle fibres (Gaster et al., 2000, Stuart et 
al., 2006). 
1.4.4. GLUT4 trafficking following insulin stimulation and muscle contraction 
Following insulin stimulation and muscle contraction the slow cycling of GLUT4 between the 
PM and intracellular storage membranes is interrupted, which is assumed to lead to increased 
presence of GLUT4 at the PM through increases in the exocytosis of GSVs and reductions in 
the endocytosis of GLUT4 containing PM sections (Foley et al., 2011, Kampmann et al., 
2011). Studies in L6 muscle cells have demonstrated increases in GLUT4 at the surface 
membrane following stimulation with insulin or AMPK agonists (Fazakerley et al., 2009a). In 
these studies the GLUT4 internalisation rate constant was reduced by 50 % following insulin 
or AICAR stimulation. In comparison the externalisation rate constant was increased only 
slightly following insulin stimulation and even decreased slightly following AICAR 
stimulation (Fazakerley et al., 2009a). This study highlights the importance of a decrease in 
GLUT4 endocytosis following insulin stimulation and muscle contraction to increase GLUT4 
availability at the PM (Fazakerley et al., 2009a).  
Insulin injection and electrical muscle stimulation led to a redistribution of GLUT4 from 
intracellular clusters to the PM and T-tubule membranes in in vivo studies of mice transiently 
transfected with GFP-tagged GLUT4 (Lauritzen et al., 2006, Lauritzen et al., 2010). Increased 
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GLUT4 staining in the PM region was observed 10 min after insulin stimulation, reached 
maximum values by 20 min after insulin injection (Lauritzen et al., 2006) and was maintained 
for 150 min (Lauritzen et al., 2008). Following insulin injection a 10 minute delay was 
observed between maximal GLUT4 translocation to the PM and to the T-tubule membranes, 
with T-tubule GLUT4 staining reaching maximum values 30 min after insulin stimulation 
(Lauritzen et al., 2006). The authors suggest that this delay is the result of reductions in 
insulin diffusion rate into the T-tubular lumen (Lauritzen et al., 2006). In contrast contraction-
induced GLUT4 translocation to the PM and T-tubule membranes occurred simultaneously 
and continued to increase throughout three 5 min bouts of high voltage electrical stimulation 
and three 10 min bouts of lower voltage electrical stimulation (Lauritzen et al., 2010). 
Immuno-gold particle electron microscopy studies have demonstrated that the effects of 
insulin and contraction on GLUT4 redistribution to the PM and T-tubule membranes are 
additive in rat skeletal muscle with 14-fold increases in immunogold particle density in the 
PM in comparison to the unstimulated state. Following insulin and exercise alone increases 
were 7-fold and 9-fold, respectively (Ploug et al., 1998). It must be emphasised that the 
insulin boluses given to the animals in the experiments described above were very large and 
elicited very high plasma insulin concentrations (peak 200 000 µIU.mL
-1
 in Lauritzen et al. 
(2008)). In addition contraction was induced through electrical stimulation consisting of two 5 
min periods of tetanic contractions (one 200ms train of 100 Hz pulses each second) with 
electrodes inserted in the feet and through the skin in the posterior hip region close to the 
sciatic nerve (Ploug et al., 1998). This is a stronger stimulus than dynamic exercise. Therefore 
the strong insulin and contraction stimuli described above may explain why the magnitude of 
insulin and contraction induced increases in GLUT4 immunogold labelling at the PM are 
larger in this EM study than those that can be expected in human skeletal muscle under 
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normal physiolological conditions (OGTT and moderate intensity exercise; chapter 4 of this 
thesis). A reduced sensitivity of immunogold labeling of GLUT4 at the PM under basal 
conditions may also exaggerate the increase seen under stimulated conditions using EM 
immunogold labelling (Hayat, 1989, Hyatt, 1991). 
During the 4 h period following glucose feeding leg glucose uptake increased threefold (Katz 
et al., 1983), during a hyperinsulinaemic-euglycaemic clamp leg glucose uptake increased 
fivefold (DeFronzo et al., 1985) and during submaximal exercise leg glucose uptake increased 
approximately fifteen-fold (Katz et al., 1986, Martin et al., 1995). While there are limitations 
associated with subcellular fractionation methods, the increases in GLUT4 content of PM 
fractions in response to physiological increases in plasma insulin concentration (27 % 
increase in PM GLUT4) and cycling exercise (71 % increase in PM GLUT4) (Goodyear et al., 
1996, Kennedy et al., 1999) in human skeletal muscle only partly explain these large increases 
in leg glucose uptake. Therefore, while this thesis focuses on GLUT4 translocation to the PM 
as it has been suggested to be the primary mechanism to increase skeletal muscle glucose 
uptake under stimulated conditions, there seem to be other mechanisms that contribute to the 
insulin- and contraction-mediated increases in skeletal muscle glucose uptake as well. 
Previous research in rats suggested that both exercise and insulin appeared to recruit GLUT4 
from large and small clusters with reductions seen in the size of the large clusters and in the 
number of the small clusters (Ploug et al., 1998). The additive nature of GLUT4 translocation 
in response to insulin and contraction stimulation has led to the suggestion that insulin and 
contraction recruit GLUT4 from different pools. Consistent with this suggestion density 
gradient centrifugation studies using rodent skeletal muscle have shown insulin and 
contraction deplete GLUT4 from different intracellular membrane fractions (Douen et al., 
1990b, Coderre et al., 1995). The endosomal marker, transferrin receptor, was subsequently 
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used to define the insulin- and contraction-responsive intracellular GLUT4 pools using 
subcellular fractionation techniques (Lemieux et al., 2000). Insulin only recruited GLUT4 
from transferrin receptor negative, non-endosomal pools, while contraction recruited GLUT4 
from both transferrin receptor positive and negative pools (Lemieux et al., 2000). Similarly 
Ploug et al. (1998) used immunofluorescence microscopy to show GLUT4 depletion 
primarily from small transferrin receptor negative (non-endosomal) stores in response to 
insulin, while contraction recruited GLUT4 primarily from transferrin receptor positive 
endosomal storage sites (Ploug et al., 1998).  
During the first 30 min of insulin stimulation large (>1 µm) GLUT4 clusters did not move as 
a whole, rather they were stationary in their original position at the PM or T-tubules and were 
locally depleted of GLUT4 by budding off of smaller vesicles (Lauritzen et al., 2008). 
Photobleaching experiments revealed that smaller vesicles (<1 µM) moved from perinuclear 
GLUT4 clusters out along the PM upon insulin stimulation (Lauritzen et al., 2008). 
To summarise the above section insulin-mediated increases in GLUT4 PM content appear to 
occur as a result of reduced endocytosis and increased exocytosis, while contraction-mediated 
increases in GLUT4 PM content occur predominantly through reductions in endocytosis 
(Fazakerley et al., 2009a). Insulin depletes GLUT4 from small, non-endosomal stores which 
are likely to be GSVs, while contraction is reported to deplete GLUT4 predominantly from 
endosomal stores (Ploug et al., 1998).  
1.4.5. The role of the cytoskeleton 
Insulin-mediated cortical actin polymerisation and remodelling has been demonstrated in L6 
skeletal muscle myoblasts and myotubes (He et al., 1995). Furthermore disruption of insulin-
mediated actin remodelling via inhibition of actin polymerisation prevented GLUT4 
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translocation and glucose uptake in L6 myotubes (He et al., 1995, Tsakiridis et al., 1995, 
Khayat et al., 2000) and rat skeletal muscle (Brozinick et al., 2004). The Rho-GTPase Rac1 is 
thought to be responsible for the stimulation of cortical actin remodelling in skeletal muscle in 
response to insulin (Chiu et al., 2011) and contraction (Sylow et al., 2013b). A Rac1-
dependent insulin signalling pathway occurs in parallel to the commonly-described Akt-
dependent pathway (Chiu et al., 2011). Downstream of PI(4,5)P2 conversion to PI(3,4,5)P3 by 
PI3K, Rac1 is GTP-bound and activated leading to p21-activated kinase (PAK) 
autophosphorylation at Thr423 and cortical actin remodelling (Chiu et al., 2011, JeBailey et 
al., 2004). Downstream of Rac1 and PAK, nucleating factors such as N-WASp bind and 
activate the Arp2/3 complex, which then directly binds actin filaments and catalyses the 
formation of branches of actin filaments (Chiu et al., 2011). Silencing of the individual 
subunits of the Arp2/3 complex in L6 muscle cells prevented insulin-mediated cortical actin 
remodelling (Chiu et al., 2010). The functional role of cortical actin remodelling in GLUT4 
translocation and glucose uptake remains unclear. However possible suggestions include; 
tethering of GLUT4 or other insulin signalling molecules to the remodelled actin filaments to 
bring them into close proximity to the PM and the provision of tracks along which GSV 
movement over short distances can occur (Chiu et al., 2011). The myosin motor proteins 
Myo1c and Myo5 have been proposed to mediate this process as they are associated with 
GSVs and the actin filaments (Chiu et al., 2011, Stockli et al., 2011). In particular Myo5 was 
found to associate with actin following insulin stimulation and silencing Myo5 reduced 






1.5. Insulin stimulated GLUT4 translocation 
Insulin stimulates GLUT4 translocation from intracellular stores to the muscle fibre surface 
via a relatively well characterised, though in parts still incomplete, signalling pathway. This 
pathway will be outlined in the subsequent sections and is broken down into proximal 
signalling from the insulin receptor and distal signalling regulating GLUT4 docking and 
fusion at the PM. A representation of insulin and contraction signalling pathways leading to 




Fig. 1.2. Representation of insulin and contraction signalling cascades leading to GLUT4 
translocation in skeletal muscle. Insulin- and contraction-mediated signals converge at 
AS160 and TBC1D1 releasing GSVs for translocation to the PM along actin filaments. At the 
PM SNARE complex formation mediates GSV fusion and GLUT4 insertion into the PM to 
allow insulin- or contraction-mediated increases in glucose uptake. For references see 
sections 1.5 and 1.6. 
 
1.5.1. Proximal insulin signalling 
Many cells in the body express insulin receptor (IR) proteins which are localised in the cell 
PM and insulin elicits a range of responses in different cell types (Saltiel and Kahn, 2001, 
Minokoshi et al., 2003). In skeletal muscle cells, IR is found on the PM and the deep 
membrane invaginations of the T-tubule membranes (Burdett et al., 1987, Lauritzen et al., 
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2006). The IR is a heterotetramer with two extracellular insulin binding α subunits and two 
membrane-spanning β subunits with tyrosine kinase activity. When insulin binds the IR, the 
tyrosine kinase activity of the β subunits is activated and the β subunits are 
transphosphorylated (Watson et al., 2004, Chang et al., 2004). Phosphorylated tyrosine 
residues on the IR β subunits provide docking sites for insulin receptor substrate (IRS) 
proteins with a phosphotyrosine binding (PTB) domain; of which there are 4 isoforms 
(Watson et al., 2004, Chang et al., 2004, Karlsson and Zierath, 2007). IRS1 appears to be the 
main isoform involved in insulin signalling in skeletal muscle (Krook et al., 2004). IRS1 
global knockout mouse models display reduced glucose tolerance and reduced insulin 
stimulated glucose uptake (Tamemoto et al., 1994, Araki et al., 1994). Similarly gene 
silencing of IRS1 in L6 myotubes reduced glucose uptake and GLUT4 translocation (Huang 
et al., 2005). IRS1 is itself tyrosine phosphorylated by IR (Karlsson and Zierath, 2007) to 
provide docking sites for recruitment of downstream signalling proteins containing src-
homology 2 (SH2) domains. Phosphatidylinositol 3-kinase (PI3K) is an important insulin 
signalling intermediate that is recruited to IRS1 (Krook et al., 2004). PI3K is formed of two 
subunits; the p85 regulatory subunit of PI3K contains an SH2 domain which docks at IRS1 
and allosterically activates the p110 catalytic subunit recruiting it to the PM (Watson et al., 
2004). The activated p110 subunit of PI3K phosphorylates the 3’ –OH moiety of the PM 
inositol phospholipid phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) to generate 
phosphatidylinositol-3,4,5-triphosphate (PI(3,4,5)P3) (Karlsson and Zierath, 2007). PI3K is 
necessary for insulin stimulated glucose uptake (Krook et al., 2004, Chang et al., 2004). In L6 
skeletal muscle cells inhibition of PI3K by wortmannin reduced insulin stimulated glucose 
uptake (Tsakiridis et al., 1995). Furthermore overexpression of a dominant negative form of 
PI3K in 3T3-L1 adipocytes that prevents the IRS1/PI3K interaction reduces GLUT4 
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translocation and glucose uptake (Sharma et al., 1998), while overexpression of a 
constitutively active form of PI3K in 3T3-L1 adipocytes results in GLUT4 translocation 
(Martin et al., 1996). PI(3,4,5)P3 binds proteins containing pleckstrin homology (PH) 
domains, such as phosphoinositide-dependent kinase (PDK) and protein kinase B (PKB), 
otherwise known as Akt, to localise these proteins to the PM (Chang et al., 2004). 
Furthermore PI(3,4,5)P3 allosterically activates PDK (Krook et al., 2004). Akt is 
phosphorylated by the mammalian target of rapamycin (mTor) and Rictor protein complex on 
Ser 473 and subsequently by PDK on Thr 308, to achieve full Akt activation (Chang et al., 
2004, Watson et al., 2004). There are three known isoforms of Akt, with Akt2 the main 
isoform in skeletal muscle and adipose (Karlsson and Zierath, 2007). Akt2 is vital for normal 
glucose homeostasis. In global Akt2 knockout mice insulin sensitivity and glucose tolerance 
are reduced (Cho et al., 2001). 
Akt substrate of 160 kDa (AS160, also known as TBC1D4) was identified in 2002 in 3T3-L1 
adipocytes as an Akt substrate (Kane et al., 2002). Following insulin stimulation in adipocytes 
AS160 is phosphorylated on residues Ser318, Ser570, Ser588, Thr642 and Ser751 (Sano et 
al., 2003). As these residues lie within Akt consensus sequences it is likely that Akt is the 
kinase responsible for their phosphorylation (Sano et al., 2003). GLUT4 translocation is 
inhibited in the AS160-4P mutant in which Ser318, Ser588, Thr642 and Ser751 
phosphorylation sites are mutated to alanine residues, demonstrating the need for AS160 
phosphorylation in GLUT4 translocation (Sano et al., 2003). Importantly studies have also 
confirmed AS160 expression in skeletal muscle and insulin-stimulated phosphorylation of 
AS160 by Akt in skeletal muscle (Bruss et al., 2005). AS160 contains a Rab GTPase 
activating protein (GAP) domain which is active in the basal state promoting GTP hydrolysis 
to GDP and maintaining associated Rab proteins in the GDP-loaded inactive form (Kane et 
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al., 2002, Chen et al., 2011). In support of the inhibitory effect of AS160 activity on GLUT4 
translocation, AS160 RNA interference in adipocytes resulted in GLUT4 translocation to the 
cell surface without insulin stimulation (Eguez et al., 2005). Rabs are small G proteins 
required for membrane trafficking (Zerial and McBride, 2001) and in the inactive GDP-bound 
state GSV-associated Rabs retain GSVs inside the cell (Chen et al., 2011). Upon insulin 
stimulation phosphorylation of AS160 inhibits AS160 RabGAP activity and GSV-associated 
Rab proteins remain in a GTP-loaded active form to allow GSV translocation to the PM 
(Chen et al., 2008). Interestingly in the basal state AS160 is found associated with GSVs, but 
upon insulin stimulation this association is reduced (Larance et al., 2005). Interaction of a 
single 14-3-3 protein dimer with phosphorylated residues pT642 and pS341 either side of a 
PTB domain of AS160 has been shown to be important in insulin mediated GLUT4 
translocation and indicates that 14-3-3 binding may regulate the RabGAP activity of AS160 
(Ramm et al., 2006, Geraghty et al., 2007, Chen et al., 2008). 
1.5.2. Distal insulin signalling 
The GSV-associated Rab proteins appear to differ between muscle and adipose cells (Sun et 
al., 2010). In adipose cells the AS160 GAP domain has been shown to be active against Rabs 
2A, 10 and 14 (Larance et al., 2005, Miinea et al., 2005). However, in L6 muscle cells Rab10 
is not activated by insulin (Sun et al., 2010). Instead Rabs 8A and 13 are GTP loaded 
following insulin stimulation in L6 muscle cells (Sun et al., 2010). Furthermore in L6 muscle 
cells Rab8A and Rab13 overexpression rescue the reduced GLUT4 translocation observed in 
AS160-4P mutant cells and siRNA knockdown of either Rab reduces GLUT4 translocation 
(Ishikura et al., 2007, Ishikura and Klip, 2008, Sun et al., 2010). Rab protein signalling is 
thought to impact on the initial docking stages of GSVs at the PM (Krook et al., 2004). 
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For insulin mediated glucose uptake to occur GSVs containing 1 to 25 GLUT4 molecules 
must be inserted into the muscle cell surface membrane following the formation of specific 
SNARE protein complexes (Chen and Scheller, 2001). Vesicle and target membrane fusion 
events are controlled by vesicle (v)- and target (t)-SNARE proteins that interact via coiled-
coil domains to form a 4 helix bundle (Watson et al., 2004) in a SNARE complex which 
brings the two membranes into close proximity and is able to overcome the energy barrier of 
membrane fusion (Weber et al., 1998). t-SNARES are located on target membranes, while v-
SNARES are located in the donor membrane; in the case of insulin mediated GLUT4 
translocation this equates to the PM and the GSV membrane, respectively (Watson et al., 
2004). Studies have identified SNAP23 and syntaxin 4 as the t-SNAREs involved in insulin-
mediated GSV docking and fusion (Kawaguchi et al., 2010). In line with this, SNAP23 and 
syntaxin 4 are localised at the PM (Bostrom et al., 2010, Khan et al., 2001). The identity of 
the v-SNARE responsible for insulin-mediated GLUT4 fusion is less certain (Bryant and 
Gould, 2011). VAMP2, VAMP3, VAMP5 and VAMP7 are enriched in GSVs in mature rat 
skeletal muscle (Rose et al., 2009). Addition of VAMP2, but not VAMP3, to L6 skeletal 
muscle cells in which endogenous VAMP2 and VAMP3 had been proteolytically cleaved by 
tetanus toxin rescued inhibition of GLUT4 translocation (Randhawa et al., 2000). In addition 
siRNA knockdown of VAMP2 and VAMP5 but not VAMP3 or VAMP7 inhibited insulin-
mediated GLUT4 translocation in cultured cardiomyocytes (Schwenk et al., 2010). In the 
basal state syntaxin 4 binds the Sec1/Munc18 (SM) family member Munc18c preventing 
VAMP2 binding to form the SNARE complex (Tellam et al., 1995, Tellam et al., 1997). 
Insulin stimulation reduces the Munc18c-Syntaxin 4 interaction, indicating that GSV docking 
and fusion is inhibited by Munc18c in the basal state and that insulin stimulation removes this 
inhibition (Pessin et al., 1999). In addition overexpression of Munc18c reduces GLUT4 
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translocation, consistent with an inhibitory role for Munc18c (Khan et al., 2001). Tyrosine 
phosphorylation of Munc18c has been demonstrated at Tyr521 in adipocytes prior to 
dissociation from syntaxin 4 (Oh and Thurmond, 2006, Umahara et al., 2008). Furthermore 
Munc18c phosphorylation of Tyr219 and Tyr521 has been shown to be necessary for GSV 
exocytosis (Jewell et al., 2011). Interestingly IR tyrosine kinase activity was found to be 
responsible for the phosphorylation of Munc18c at Tyr521 in both adipocytes and skeletal 
muscle cells linking the insulin proximal insulin signalling pathway with stimulation of GSV 
docking and fusion (Jewell et al., 2011). 
 
1.6. Contraction stimulated GLUT4 translocation 
Glucose uptake into skeletal muscle increases in response to muscle contraction (Katz et al., 
1986, Martin et al., 1995, Rose and Richter, 2005). Whole body or muscle-specific GLUT4 
knockout abolishes contraction-stimulated glucose uptake demonstrating the crucial 
importance of GLUT4 in contraction stimulated glucose uptake (Ryder et al., 1999, Zisman et 
al., 2000). Subcellular fractionation has been used to demonstrate a 71 % increase in GLUT4 
in the PM regions in response to 45-60 min of cycling exercise in human skeletal muscle 
(Kennedy et al., 1999). The mechanisms controlling contraction stimulated GLUT4 
translocation and glucose uptake are distinct from insulin mediated glucose uptake, though 
interplay does occur (Rose and Richter, 2005, Wojtaszewski and Richter, 2006, Richter and 
Hargreaves, 2013). 
1.6.1. Calcium signalling 
Skeletal muscle fibre surface membrane depolarisation leads to Ca
2+
 release from the 
sarcoplasmic reticulum into the cytosol to induce muscle fibre contraction (Jones, 1990). 
Increases in cytosolic Ca
2+
 concentration that occur during muscle contraction are associated 
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with increased glucose transport (Holloszy and Narahara, 1967). Furthermore 
pharmacological methods to increase intracellular Ca
2+
 concentration also induce increases in 
glucose transport (Youn et al., 1991, Terada et al., 2003). Ca
2+
/Calmodulin (CaM) dependent 
protein kinase II (CaMKII) is activated by Ca
2+
-bound CaM during exercise in human skeletal 
muscle (Rose and Hargreaves, 2003, Rose and Richter, 2005). Inhibition of CaMKII reduces 
contraction-stimulated glucose transport in rat muscle demonstrating that CAMKII activation 
plays a role in contraction-mediated glucose transport (Wright et al., 2004, Wright et al., 
2005). Conventional protein kinase C (cPKC) isoforms are activated in response to elevated 
intracellular Ca
2+
 concentration (Nishizuka, 1995), exercise and contraction in rat muscle 
(Richter et al., 1987, Cleland et al., 1989), but not in human muscle (Rose et al., 2004). 
Downregulation or inhibition of novel (nPKC) and cPKC isoforms reduces contraction 
mediated glucose transport (Cleland et al., 1990, Ihlemann et al., 1999). Therefore PKC may 
be involved in contraction signalling leading to increases in muscle glucose uptake, however 
further studies are required for more conclusive evidence (Rose and Richter, 2005).  
1.6.2. Sensing cellular energy status 
AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase that senses the 
energy status of the muscle cell based on the AMP:ATP and creatine:phosphocreatine ratios 
(Hardie et al., 1998). As would therefore be expected muscle AMPK activity has been shown 
consistently to increase during muscle contraction and exercise (Rose and Richter, 2005, 
Jorgensen et al., 2006). Furthermore pharmacological activation of AMPK through the AMP 
analogue AICAR has been shown to increase muscle glucose transport (Jorgensen et al., 
2006). Therefore it seems logical for AMPK to have a role in contraction mediated GLUT4 
translocation. However studies investigating the role of AMPK in contraction-mediated 
glucose uptake via AMPK knockout, inhibition and overexpression of dominant negative 
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forms have proved inconclusive (Rose and Richter, 2005). In incubated mouse muscle, 
knockout, over-expression of a dominant-negative isoform or inhibition of α1 or α2 catalytic 
or γ3 regulatory subunits of AMPK does not reduce contraction-mediated glucose uptake 
following electrical stimulation in comparison to wild-type mice (Barnes et al., 2004, 
Jorgensen et al., 2004, Merry et al., 2010). In addition, in vivo glucose uptake during 
electrically-stimulated contraction in mice expressing inactive α1 and α2 AMPK subunits was 
not different to wild-type mice (Fujii et al., 2004). In contrast Mu et al. (2001) demonstrated a 
30 – 40 % reduction in contraction-mediated glucose transport in fast and slow twitch muscles 
of mice overexpressing a dominant negative form of AMPK (Mu et al., 2001). Subsequently 
however it was suggested that the reduction in glucose transport was attributable to impaired 
force development in these mice (Mu et al., 2003). AMPK may have a different role in 
different fibre types as dissociation between AMPK activity and glucose uptake has been 
observed in slow twitch, but not fast twitch muscle groups (Derave et al., 2000). In summary, 
AMPK is activated during muscle contraction, however a consensus has not been reached on 
the importance of AMPK activation in GLUT4 translocation and glucose uptake. Certainly 
alternative mechanisms appear able to maintain contraction-mediated glucose uptake in the 
absence of AMPK activity. 
1.6.3. Role of ATP 
Skeletal muscle releases ATP during contractile activity (Li et al., 2003). Incubation of 
primary myotubes in ATP resulted in increases in glucose uptake and GLUT4 translocation to 
the cell surface (Osorio-Fuentealba et al., 2013). Data suggest that ATP-induced increases in 
glucose uptake occur through purinergic receptor signalling to Akt, PI3K and ultimately 
AS160 phosphorylation to induce GLUT4 translocation (Osorio-Fuentealba et al., 2013). 
Incubation of primary myotubes in ATP led to Akt and AS160 phosphorylation and 
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furthermore inhibition of PI3K or Akt reduced the ATP-mediated increases in glucose uptake 
(Osorio-Fuentealba et al., 2013). Rab8A is likely to be involved as Rab8A knockdown in 
primary myotubes reduced ATP-mediated GLUT4 translocation (Osorio-Fuentealba et al., 
2013). 
1.6.4. Role of NO 
As well as its role in endothelial cells, NO is produced in muscle fibres by nNOS (McConell 
et al., 2012). nNOS activity increases during exercise in humans (Linden et al., 2011). 
Inhibition of nNOS via infusion of the nNOS inhibitor N
G
-monomethyl-L-arginine (L-NMMA) 
into the femoral artery during exercise in humans reduced the exercise-induced increases in 
glucose uptake by approximately 30% with no effect on blood flow (Bradley et al., 1999). 
This supports a role for NO in the signalling behind contraction-mediated increases in glucose 
uptake. Potential mechanisms include signalling via increased cGMP production and protein 
kinase G (PKG) activation and NO-induced posttranslational modification of signalling 
proteins such as Akt (McConell et al., 2012)  
1.6.5. Intracellular signalling to GLUT4 plasma membrane insertion 
As with insulin-mediated glucose uptake, there must be mechanisms to link intracellular 
contraction signalling pathways with GLUT4 insertion into the PM to allow contraction-
mediated glucose uptake. TBC1D1 is a protein similar to AS160 with a RabGAP domain that 
is inhibited following stimulation to promote GTP loading of Rab proteins and GLUT4 
translocation to the cell surface (Roach et al., 2007). Phosphorylated Ser237 and Thr590 are 
14-3-3 binding sites on TBC1D1, which is confirmed through lack of 14-3-3 binding on the 
TBC1D1 double mutant (Chen et al., 2008). Stimulation of L6 cells with insulin alone 
induced Thr590 phosphorylation, but 14-3-3 binding did not occur. In contrast activation of 
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AMPK with phenformin induced Ser237 phosphorylation and 14-3-3 binding (Chen et al., 
2008). In human skeletal muscle 30 s – 20 min ‘all out’ exercise induced 70 – 230 % 
increases in TBC1D1 Ser237 phosphorylation and concomitant 60 – 250 % increases in 14-3-
3 binding capacity (Frosig et al., 2010). In rat epitrochlearis muscle inhibition of PI3K with 
wortmannin prevented contraction-stimulated phosphorylation of AS160 while TBC1D1 
phosphorylation and glucose uptake were unaffected. In contrast AMPK inhibition reduced 
TBC1D1 phosphorylation and glucose uptake, while AS160 phosphorylation was unaffected 
(Funai and Cartee, 2009). Furthermore mutation of TBC1D1 phosphorylation sites in mouse 
skeletal muscle impairs contraction stimulated glucose transport but does not affect insulin 
stimulated glucose transport (An et al., 2010). These data implicate phosphorylation of 
TBC1D1, potentially by AMPK, in the regulation of contraction-mediated skeletal muscle 
glucose uptake.  
Both insulin- and contraction-mediated glucose uptake into skeletal muscle require GLUT4 
insertion into the PM therefore there may be convergence of the signalling pathways at this 
distal step in GLUT4 translocation. Proximal insulin signalling mechanisms, from IR to PI3K, 
are not involved in contraction mediated glucose uptake (Treadway et al., 1989, Goodyear et 
al., 1995, Wojtaszewski et al., 1999, Rose and Richter, 2005). Most, but not all, studies have 
shown increased Akt activity during contraction (Rose and Richter, 2005). Akt 
phosphorylation of AS160 increases during contraction in rodent skeletal muscle, but this is 
unlikely to be linked directly to contraction-mediated glucose uptake (Bruss et al., 2005). 
Interestingly AMPK has also been shown to phosphorylate AS160 in response to AICAR and 
contraction in mouse skeletal muscle (Kramer et al., 2006a) and more recently a novel AMPK 
phosphorylation site, Serine 711, has been identified on AS160 (Treebak et al., 2010). 
Furthermore in the AS160-4P mutant contraction- as well as insulin-mediated glucose uptake 
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is inhibited (Kramer et al., 2006b). In addition, mutation of the calmodulin binding domain of 
AS160 inhibits contraction- but not insulin-mediated glucose uptake (Kramer et al., 2007). 
Taken together these data suggest that AS160 may act as a point of convergence in both the 
insulin and contraction signalling pathways to glucose uptake (Rockl et al., 2008). 
In 3T3-L1 adipocytes AS160 and TBC1D1 appear to have identical Rab protein specificity 
(Roach et al., 2007), however as stated previously the Rab proteins involved in AS160 
regulation of glucose uptake in adipocytes and skeletal muscle are different (Sun et al., 2010) 
therefore in skeletal muscle it is not known which Rab proteins are targeted by TBC1D1. In 
skeletal muscle AS160 has specificity for RAB8A and Rab13 (Sun et al., 2010) and 
potentially Rab14 (Ishikura et al., 2007, Ishikura and Klip, 2008), therefore TBC1D1 
specificity in skeletal muscle may be the same. 
SNARE proteins are also required for GLUT4 docking and fusion at the PM in contraction-
mediated GLUT4 translocation (Rose et al., 2009). The t SNAREs syntaxin 4 and SNAP23 
located at the PM are likely to be required for contraction-, as well as insulin-mediated 
GLUT4 docking and fusion (Schwenk et al., 2010). There is no consensus regarding which v 
SNARE is responsible for contraction-mediated GSV fusion at the PM (Richter and 
Hargreaves, 2013). VAMP2 is the isoform more commonly reported to be responsible for 
insulin-mediated GSV fusion (Bryant et al., 2002). VAMP2, VAMP5 and VAMP7, but not 
VAMP3, have been shown to translocate to the PM in rat skeletal muscle in response to 
contraction (Rose et al., 2009). In addition VAMP3 null mice display normal contraction-
mediated glucose uptake (Yang et al., 2001). However contrasting evidence suggests VAMP3 
is involved in contraction-mediated GLUT4 translocation based on the observation that 
VAMP3 knockdown abolished glucose uptake increases induced by AMPK activation 
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(Schwenk et al., 2010). Further research is required to confirm the identity of the v-SNARE 
responsible for contraction mediated GLUT4 PM fusion. 
 
1.7. Defects in obesity, insulin resistance and type 2 diabetes 
Skeletal muscle insulin resistance is associated with obesity and precedes the development of 
type 2 diabetes. Using the hyperinsulinaemic-euglycaemic clamp technique it has been shown 
that whole body insulin-stimulated glucose metabolism is reduced by 38 % in T2D patients 
(DeFronzo et al., 1985). Furthermore insulin-stimulated leg glucose uptake was reduced by 45 
% demonstrating that the peripheral tissues, and more specifically skeletal muscle, are the 
main sites of insulin resistance (DeFronzo et al., 1985). Interestingly contraction-mediated 
glucose uptake is unaffected in insulin resistant muscle, with evidence even demonstrating 
higher contraction-mediated leg glucose uptake in T2D patients compared to controls (Minuk 
et al., 1981, Martin et al., 1995). The higher glucose uptake rates may be the result of the 
higher basal plasma glucose levels (DeFronzo et al., 1989).  
Western blot studies have shown that total GLUT4 protein content in skeletal muscle is 
unchanged in obesity and the early stages of T2D (Handberg et al., 1990, Pedersen et al., 
1990), while GLUT4 protein content is reduced in later stages of T2D that require insulin 
treatment (Kampmann et al., 2011). As muscle GLUT4 protein content does not change in the 
early stages of T2D decreases in this variable do not appear to contribute to the initial 
development of insulin resistance. GLUT4 translocation, on the other hand, is reduced 
following hyperinsulinaemic-euglycaemic clamp in skeletal muscle from T2D patients 
compared to normal glucose tolerant controls (Zierath et al., 1996, Garvey et al., 1998). 
Interestingly contraction-mediated GLUT4 translocation, following 45-60 min cycling 
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exercise, measured with the PM fractionation method is preserved in obesity and T2D 
(Kennedy et al., 1999). 
Regular exercise has long been recommended as a method to improve glycaemic control in 
T2D patients (American Diabetes Association, 1990) and the role of exercise in improving 
insulin sensitivity will be discussed in section 1.8 of this chapter. In the current section the 
main molecular mechanisms proposed to contribute to the development of insulin resistance 
and T2D will be considered. A representation of the main mechanisms that contribute to the 





Fig. 1.3. Mechanisms of skeletal muscle insulin resistance. The high abundance of fatty acids 
in skeletal muscle of obese individuals cannot be compensated for by TAG synthesis and or -
oxidation and therefore leads to the accumulation of FA metabolites, such as LCA-CoAs, 
DAGs and ceramides. These FA metabolites have been proposed to inhibit the proximal 
insulin signalling cascade resulting in reduced translocation of GLUT4 to the PM. 
Furthermore accumulation of LDs increases the demand for SNAP23 in LD fusion, therefore 
reducing SNAP23 availability at the PM for GSV fusion. As a result glucose uptake in 
response to insulin is reduced in insulin resistant individuals. This figure is based on the 






1.7.1. Altered lipid handling 
Studies infusing intralipid/heparin into healthy individuals to increase the concentration of 
plasma fatty acids (FA) have demonstrated lipid-induced impairments in glucose uptake and 
insulin resistance in previously insulin sensitive individuals (Boden et al., 1994, Boden et al., 
1991, Roden et al., 1999, Roden et al., 1996). 
Fat is stored in the body as triacylglycerol (TAG) which is composed of a glycerol-3-
phosphate backbone and three esterified long chain fatty acid side chains (Coleman and Lee, 
2004). TAG is stored in lipid droplets (LDs); with the majority of TAG in the human body 
found in subcutaneous or visceral adipose tissue cells. Smaller TAG depots, also contained in 
smaller LDs, are found in most tissues. In muscle fibres these are known as intramuscular 
triacylglycerol (IMTG) (Shaw et al., 2010). Type I muscle fibres have a higher IMTG content 
than type II muscle fibres (Malenfant et al., 2001, van Loon et al., 2003, van Loon, 2004a, 
Shaw et al., 2009, Shepherd et al., 2013). IMTG provides a FA source that can be utilised 
during periods of high energy demand, such as during exercise in physically active 
individuals (Shaw et al., 2009). An increased IMTG content is seen in obese individuals and 
in patients with T2D (Phillips et al., 1996a, Goodpaster et al., 2001). In these groups there is a 
strong inverse association between IMTG content of skeletal muscle and insulin sensitivity 
(Phillips et al., 1996a, Pan et al., 1997). It, therefore, was initially postulated that elevated 
IMTG concentrations were mechanistically linked to the development of insulin resistance. 
However, a paradox has emerged whereby highly trained and highly insulin sensitive athletes 
have at least equal, if not higher IMTG content as obese and T2D individuals (Goodpaster et 
al., 2001, van Loon et al., 2004). This has led to the theory that the high concentration of 
intracellular FA metabolites, such as long-chain fatty acyl-CoAs (LCFA-CoAs), 
diacylglycerols (DAGs) and ceramides, that are seen in muscle fibres of obese and T2D 
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individuals lead to insulin resistance rather than the total IMTG content per se (Shaw et al., 
2010). Increased LCFA-CoAs, DAGs and ceramide have been reported in skeletal muscle of 
obese and T2D humans (Pan et al., 1997, Goodpaster et al., 2001, Bandyopadhyay et al., 
2006). More recent work, however, has shown that a similar paradox also applies to the total 
skeletal muscle DAG content with twofold higher DAG concentrations in endurance trained 
athletes compared to obese sedentary individuals (Amati et al., 2011). Amati et al. (2011) 
further showed that DAG species containing two saturated or only one unsaturated FA had a 
higher content in endurance trained compared to obese sedentary individuals, while DAG 
species that contain two unsaturated FAs had a higher content in the obese individuals (Amati 
et al., 2011). This led to the suggestion that FA composition of DAG is different between 
obese and endurance trained athletes, therefore suggesting that different DAG species impact 
insulin sensitivity differently (Amati et al., 2011). In addition Amati et al. (2011) showed that 
ceramide content was higher in obese individuals compared to endurance trained athletes 
(Amati et al., 2011). 
The balance between IMTG synthesis, lipolysis and fatty acid oxidation determines not only 
the IMTG content, but also the concentration of FA metabolites (Shaw et al., 2010).  
Suggestions have also been made that high turnover rates of the IMTG pool are 
mechanistically linked to reductions in the intracellular concentration of FA metabolites (van 
Loon, 2004b, Moro et al., 2008). In trained individuals up to 70 % reductions in IMTG 
content in type I muscle fibres are observed during an endurance exercise bout of 2 – 3 h 
duration, in order to provide fatty acids for β-oxidation (van Loon et al., 2003, De Bock et al., 
2007, Stellingwerff et al., 2007a, Stellingwerff et al., 2007b). In contrast fatty acid oxidation 
during exercise is low in lean sedentary, obese and obese T2D individuals (Blaak et al., 2000, 
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Schrauwen et al., 2002), therefore leading to increased levels of FA metabolites and insulin 
resistance.  
The balance between the activity and content of the enzymes involved in IMTG breakdown 
and synthesis has a great impact on the intracellular concentration of FA metabolites and 
therefore on insulin sensitivity (Shaw et al., 2010). The initial step in IMTG hydrolysis is the 
liberation of the first FACoA by the enzyme adipose triglyceride lipase (ATGL) and its 
coactivator CGI-58. This generates DAG, which in turn is broken down to monoacylglycerol 
(MAG) and FACoA by the enzyme hormone sensitive lipase (HSL) (Haemmerle et al., 2002).  
Endurance training has been shown to increase ATGL content, but not HSL content therefore 
indicating that there may be differences in ATGL, but not HSL, between trained and 
untrained individuals (Alsted et al., 2009, Shaw et al., 2010). However in the muscle of obese 
insulin resistant individuals, reduced HSL content has been reported (Blaak et al., 2004). 
Therefore reductions in ATGL and HSL may explain the reduced utilisation of fatty acids 
during exercise in T2D (van Loon et al., 2005). Furthermore a high TAG/DAG hydrolysis 
ratio has been observed in obesity which would lead to DAG accumulation, potential 
inhibition of the insulin signalling cascade, and reductions in insulin sensitivity (Moro et al., 
2009).  
Alternatively, incorporation of intracellular fatty acids into inert IMTG stored within LDs 
appears to be a mechanism to protect muscle insulin sensitivity. The sequential addition of 3 
fatty acids to the glycerol backbone is catalysed by 3 distinct enzymes. The addition of the 
first fatty acid to the glycerol-3-phosphate backbone is catalysed by glycerol-3-phosphate 
acyltransferase (GPAT), the second fatty acid is added by the enzyme acylglycerol-3-
phosphate acyltransferase (AGPAT) and the final fatty acid by the enzyme diacylglycerol 
acyltransferase (DGAT) (Takeuchi and Reue, 2009). Overexpression of DGAT1 in rats has 
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been shown to increase TAG synthesis and protects insulin sensitivity even in the presence of 
increased levels of plasma fatty acids (Liu et al., 2009a, Roorda et al., 2005, Timmers et al., 
2011). Schenk and Horowitz (2007) demonstrated the protective effect of a single bout of 
endurance exercise against FA-induced insulin resistance and showed concomitant increases 
in DGAT1 and mitochondrial GPAT expression (Schenk and Horowitz, 2007). Expression of 
the FA transporter (FAT/CD36) is increased in skeletal muscle in obesity and T2D (Bonen et 
al., 2004) and has been shown to be increased in the PM fraction of muscle in obese compared 
to non-obese women (Li et al., 2011). Therefore it has been suggested that increased fatty acid 
uptake into muscle cells in obesity is not compensated for by increased IMTG synthesis, 
therefore leading to accumulation of intracellular lipid metabolites which impact on insulin 
sensitivity (Bonen et al., 2004). This is supported by data showing there are no differences in 
skeletal muscle content of triglyceride synthesis enzymes between lean and obese women 
(Thrush et al., 2009, Li et al., 2011). Furthermore IMTG fractional synthetic rate is reduced in 
pre-diabetic men, compared to those with normal glucose tolerance (Perreault et al., 2010), 
which may also contribute to the accumulation of lipid metabolites, rather than storage as 
IMTG, in skeletal muscle of insulin resistant individuals. 
1.7.2. Proximal insulin signalling defects. 
Intracellular FA metabolites such as LCA-CoAs, DAGs and ceramides have been shown to 
interfere with proximal insulin signalling pathway events (Hulver and Dohm, 2004). IR 
autophorylation, IR tyrosine kinase activity, IRS1 tyrosine phosphorylation and PI3K and Akt 
activation have all been shown to be reduced in human skeletal muscle in obesity and insulin 
resistance (Caro et al., 1987, Itani et al., 2000, Goodyear et al., 1995). Serine or threonine, as 
opposed to tyrosine, phosphorylation is proposed to be responsible for these reductions 
(Hulver and Dohm, 2004). Protein kinase C (PKC) is a serine kinase which is activated by 
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LCFA-CoA and DAG (Shulman, 2000). Lipid/heparin infusion in rats resulted in reduced 
insulin-stimulated IRS1 tyrosine phosphorylation, which was associated with increased PKCθ 
activation (Griffin et al., 1999). PKCθ phosphorylates serine 312, 636 and 1101 on IRS1, 
thereby preventing IRS1 tyrosine phosphorylation and the propagation of downstream insulin 
signalling events, which ultimately reduces GLUT4 translocation and glucose uptake (Schenk 
and Horowitz, 2007). In addition the PKCβ isoform has been shown to phosphorylate and 
inactivate the IR (Bossenmaier et al., 1997). In support of this the IR from insulin resistant 
muscle cells has been shown to exhibit increased serine/threonine phosphorylation compared 
to insulin sensitive muscle cells (Hulver and Dohm, 2004). Ceramides also activate protein 
phosphatase 2A (PP2A) which dephosphorylates Akt, thereby preventing downstream 
signalling events and again reducing GLUT4 translocation and glucose uptake (Hulver and 
Dohm, 2004). AS160 protein content is not altered in T2D (Vind et al., 2011), while insulin-
stimulated phosphorylation of AS160 at S318, S588 and S751 is impaired in T2D patients 
compared to controls (Vind et al., 2011). In contrast lipid infusion does not alter insulin-
mediated AS160 phosphorylation (Hoeg et al., 2011, Storgaard et al., 2004). 
1.7.3. The role of inflammation  
Chronic low levels of inflammation have been associated with the development of skeletal 
muscle insulin resistance (Wei et al., 2008). Increased inflammatory cells and circulating 
levels of inflammatory cytokines such as TNFα, IL-1 and IL-6 are associated with insulin 
resistance in skeletal muscle in patients with T2D (Wei et al., 2008). TNFα activates JNK, 
NFkB and MAPK pathways and reduces insulin signal transduction by reducing IRS1 
tyrosine phosphorylation (del Aguila et al., 1999) and increasing serine phosphorylation 




1.7.4. The role of oxidative stress and mitochondrial function 
Reactive oxygen species (ROS) play important physiological roles, however excess ROS 
production in muscle mitochondria of obese individuals leads to oxidative stress (Samocha-
Bonet et al., 2012). ROS are elevated in obesity and T2D and levels are inversely correlated 
with measures of insulin sensitivity in patients with T2D (Nourooz-Zadeh et al., 1997). 
Furthermore antioxidant treatment of insulin resistant animals improves insulin sensitivity 
(Blendea et al., 2005, Henriksen, 2006). ROS activate intracellular signalling pathways such 
as those involving MAPK, JAK/STAT and JNK activation which may subsequently interfere 
with the insulin signalling pathway (Wei et al., 2008). In addition ROS lead to increased 
expression of inflammatory cytokines such as TNFα which further exacerbates inflammation-
induced insulin resistance (Nathan, 2003). 
Lowell and Shulman (2005) proposed the hypothesis that skeletal muscle insulin resistance 
occurs as a consequence of mitochondrial dysfunction; including a reduction in ATP turnover 
and capacity to oxidise fatty acids (Lowell and Shulman, 2005). This hypothesis was 
supported by two publications from the Shulman group (Petersen et al., 2004 and Petersen et 
al., 2005), which used 
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P-magnetic resonance spectroscopy (MRS) methodology to show that 
both basal and insulin-stimulated ATP turnover rates in human skeletal muscle in vivo were 
lower in the muscle of insulin-resistant offspring of patients with type 2 diabetes compared to 
a control group with parents that did not have type 2 diabetes. It was therefore suggested that 
in individuals with a predisposition to the development of type 2 diabetes a reduction in 
mitochondrial ATP production was an early event in the development of insulin resistance 
(Petersen et al., 2004). This mitochondrial dysfunction was also proposed to reduce the rate of 
β-oxidation, therefore explaining the intramuscular accumulation of fatty acid metabolites 
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(fatty acyl CoA and diacylglyerol) that disrupt insulin signalling (Lowell and Shulman, 2005), 
as described in section 1.7.2 of this thesis. 
However, the existence of mitochondrial dysfunction has since been disputed (Wagenmakers, 
2005, Dela and Helge, 2013). In an editorial comment on the Petersen et al. (2005) 
publication, Wagenmakers (2005) questioned the evidence of a mitochondrial impairment 
based on alternative explanations for the observed reduction in ATP turnover in skeletal 
muscle both in the basal and insulin stimulated state (Wagenmakers, 2005). In addition, later 
studies measuring mitochondrial function concluded that there are no intrinsic defects in 
mitochondria in insulin resistant states (Boushel et al., 2007, Larsen et al., 2009, Rabol et al., 
2009, Gnaiger et al., 2009, Ara et al., 2011). The O2 flux capacity, measured by high-
resolution respirometry in saponin-permeabilised muscle fibres from the quadriceps, was 
lower in T2D patients compared to age-matched controls. However when normalised for 
mitochondrial content or citrate synthase activity there were no differences in oxidative 
phosphorylation or electron transport capacity between the groups (Boushel et al., 2007). This 
suggests that lower ATP production rate is due to a decrease in the content of mitochondria, 
rather than a functional impairment. The reduction in mitochondrial content is likely a result 
of a sedentary lifestyle which is adopted by individuals that can go on to develop insulin 
resistance and type 2 diabetes later in life (Wagenmakers, 2005). Accordingly, as discussed 
by Goodpaster (2013) and Holloszy (2013), there is currently no consensus on whether there 
is simply an association between mitochondrial content and insulin resistance (Hollozsy, 
2013) or whether the relationship is causal (Goodpaster, 2013).  
1.7.5. Distal insulin signalling defects 
As described above there is much evidence that implicates proximal insulin signalling defects 
in the development of insulin resistance. However there are also studies in which 2-6 h of 
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intralipid infusion in rats and lean and obese humans did not affect IRS1 tyrosine 
phorphorylation, PI3K activity, Akt or AS160 phosphorylation (Hoy et al., 2009, Hoy et al., 
2007, Tsintzas et al., 2007, Storgaard et al., 2004, Hoeg et al., 2011). This suggests that 
proximal insulin signalling defects may not be responsible for reduced insulin-mediated 
glucose uptake in insulin resistance and, therefore, the more distal stages of the insulin 
signalling pathway such as in the GLUT4 translocation machinery and GLUT4 docking and 
fusion at the PM should also be considered as sites where insulin resistance may occur. 
A recently suggested distal candidate for defects in the development of insulin resistance is 
Rac1. Rac1 muscle-specific knockout leads to decreased insulin-stimulated glucose transport 
in ex vivo mouse muscles (Sylow et al., 2013a). Mice fed a high fat diet, humans undergoing 
intralipid infusion and obese and T2D human patients display reduced insulin-mediated PAK 
phosphorylation, suggesting an impairment in the Rac1signal to PAK, which was associated 
with reduced insulin-mediated glucose uptake (Sylow et al., 2013a). As the Rac1-PAK 
pathway is thought to lead to cortical actin remodelling (JeBailey et al., 2004), Sylow et al. 
(2013) suggest that impairments in Rac1/PAK signalling in obesity and T2D limit insulin-
mediated glucose uptake through impaired cortical actin remodelling therefore preventing 
GLUT4 translocation (Sylow et al., 2013a). 
SNAP23, one of the t-SNAREs required for GSV fusion with the PM, is also required for 
lipid droplet fusion (Bostrom et al., 2007). One theory, known as the SNARE highjacking 
hypothesis, proposes that in muscle with a high concentration of IMTGs there is an increased 
requirement for SNAP23 in lipid droplet fusion, which may reduce the availability of 
SNAP23 at the PM for GSV fusion (Sollner, 2007). This SNAP23 highjacking hypothesis 
provides an alternative explanation for reduced insulin-mediated GLUT4 translocation and 
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glucose uptake in obesity and T2D. In support of the highjacking hypothesis, treatment of 
cardiomyocytes with oleic acid caused cellular lipid droplet expansion and insulin resistance 
and led to redistribution of SNAP23 from the PM to intracellular regions as well as increased 
SNAP23 association with LD (Bostrom et al., 2007). Furthermore SNAP23 was redistributed 
away from the PM to cytosolic membrane compartments in human skeletal muscle from 
patients with T2D in which lipid accumulation was apparent (Bostrom et al., 2010). In 
addition, the total SNAP23 protein content was shown to be increased in skeletal muscle from 
T2D patients compared to healthy insulin-sensitive controls (Bostrom et al., 2010).  
More research will be required to further investigate the role of Rac1 and SNARE highjacking 
in lipid induced insulin resistance and their relative contribution to insulin resistance in 
comparison to the previously proposed proximal defects in the insulin signalling cascade. 
However, these alternative mechanisms will not be investigated in this thesis. 
1.7.6. Impaired substrate delivery 
Glucose and insulin delivery to skeletal muscle is vital to insulin-mediated glucose uptake but 
is also a key impairment in obesity and type 2 diabetes which may underlie insulin resistance 
in these conditions. Studies in obese Zucker rats (OZR) have shown that increases in skeletal 
muscle microvascular blood volume (MBV), which occur early in a hyperinsulinaemic-
euglycaemic clamp in lean Zucker rats (Steinberg et al., 1994), may be defective. Furthermore 
capillary PSA available for insulin and glucose delivery is reduced in OZR due to reductions 
in insulin-mediated recruitment of the microvasculature (Gudbjornsdottir et al., 2003, 
Gudbjornsdottir et al., 2005). Additionally obesity and T2D have been associated with 
reduced NO production and reduced capillary density, which are suggested to contribute to 
skeletal muscle insulin resistance (Wagenmakers et al., 2006, Barrett et al., 2009, Barrett et 
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al., 2011). Furthermore insulin-mediated skeletal muscle microvascular recruitment has been 
shown to be reduced in obese compared to lean humans (Clerk et al., 2002, Clerk et al., 2006, 
Keske et al., 2009). These impairments in microvascular recruitment are likely to contribute 
to insulin resistance, as the surface area available for insulin and glucose delivery to the 
skeletal muscle will be reduced, thereby reducing insulin-mediated glucose uptake, but are 
beyond the scope of this thesis. 
 
1.8. Exercise as a tool to improve insulin sensitivity 
Exercise has long been recommended as a tool to improve glycaemic control and to prevent or 
delay the onset of T2D and insulin resistance (American Diabetes Association, 1990). 
Broadly speaking there are two aspects to the benefits of exercise on glucose homeostasis; 
firstly the effect of an acute bout of exercise to enhance glucose uptake and improve post 
exercise insulin sensitivity, and secondly the molecular adaptation to include changes in 
enzyme content and activities that is the result of chronic exercise training which coincide 
with a greater muscle insulin sensitivity (Rockl et al., 2008). 
1.8.1. Effect of an acute exercise bout on glucose homeostasis 
As mentioned previously contraction-mediated glucose uptake and GLUT4 translocation are 
maintained in obese and T2D patients with glucose uptake in fact higher in T2D patients 
compared to controls (Minuk et al., 1981, Martin et al., 1995, Kennedy et al., 1999), which 
provides a mechanism to reduce plasma glucose concentrations in such conditions. In support 
of this, 45 min of exercise at 70 % of maximum workload normalised plasma glucose 
concentration in T2D patients (Musi et al., 2001). An acute exercise bout can improve insulin 
sensitivity for up to 48 h, making acute exercise an effective treatment to improve insulin 
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sensitivity in insulin resistant and T2D individuals (Wojtaszewski and Richter, 2006). One 
hour cycling exercise increased insulin-mediated glucose uptake during a hyperinsulinaemic-
euglcyaemic clamp in healthy, untrained humans immediately after and 48 h after exercise 
(Mikines et al., 1988). In addition 1 h one legged knee extensor exercise increased insulin-
mediated glucose uptake during hyperinsulinaemic-euglycaemic clamp 4 h after exercise in 
healthy humans (Richter et al., 1989). GLUT4 mRNA concentration in skeletal muscle 
increases within 3 h after a single exercise bout in human muscle (Neufer and Dohm, 1993, 
Ren et al., 1994) and increases in GLUT4 protein content can be seen in as little as 16-24 h 
(Kraniou et al., 2006, Ren et al., 1994). Improved insulin sensitivity after an acute exercise 
bout has been proposed to be important in the repletion of skeletal muscle glycogen stores 
post exercise with studies showing an association between the amount of glycogen depletion 
and the observed increase in insulin sensitivity (Bogardus et al., 1983). Muscle insulin-
mediated glucose uptake 4 h after an exercise bout is also primarily directed to glycogen 
synthesis (Richter et al., 1989) with a large activation of glycogen synthase occurring in the 
exercised and therefore glycogen depleted leg (Wojtaszewski et al., 2000). Insulin-stimulated 
GLUT4 translocation was shown to be increased 3.5 h after an exercise bout compared to 
after a rest period (Hansen et al., 1998a). The increased GLUT4 translocation does not appear 
to result from increases in proximal insulin signalling from IR-Akt (Wojtaszewski et al., 
1997, Wojtaszewski et al., 2000). Research is currently investigating whether intracellular 
contraction-induced signals converge with the insulin signalling pathway at AS160 to mediate 
post exercise improvements in insulin sensitivity. Studies in rat and human muscle have 
shown increased AS160 phosphorylation post exercise which is maintained for 3-4 h in 
association with post exercise increases in insulin sensitivity (Arias et al., 2007, Howlett et 
al., 2008, Funai and Cartee, 2009, Treebak et al., 2009, Treebak et al., 2010). Furthermore 
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following insulin stimulation with hyperinsulinaemic-euglycaemic clamp AS160 
phosphorylation at residues S318, S341 and S751 has been shown to be higher 3-4 h 
following a prior bout of exercise compared to a resting control (Arias et al., 2007, Treebak et 
al., 2009). This is not thought to be due to increased sensitivity of AS160 to insulin but rather 
a higher AS160 phosphorylation at baseline due to exercise-induced AS160 phosphorylation 
on these sites (Arias et al., 2007). Therefore part of the improved glycaemic control achieved 
through exercise may be due to the cumulative effects of acute exercise bouts which firstly 
reduce plasma glucose concentration through contraction-mediated glucose uptake and 
secondly improve insulin sensitivity of the working muscle up to 48 h after the exercise bout 
(Schneider et al., 1990). 
1.8.2. Exercise training adaptations to improve insulin sensitivity 
Endurance exercise training (ET) is known to increase whole body insulin sensitivity in 
young and old (Hughes et al., 1993, Dela et al., 1996, Cox et al., 1999), trained and sedentary 
(Houmard et al., 1991, Houmard et al., 1993), and obese diabetic and non-diabetic subjects 
(Vind et al., 2011). Similarly sprint interval training (SIT), a time efficient mode of exercise, 
has also been shown to increase whole body insulin sensitivity in young sedentary subjects 
(Babraj et al., 2009, Richards et al., 2010, Shepherd et al., 2013). Furthermore increased 
insulin-stimulated skeletal muscle glucose uptake has been demonstrated following ET in 
healthy, T2D and aging participant groups (Dela et al., 1992, Dela et al., 1995, Dela et al., 
1996, Frosig et al., 2007). 
Exercise can improve the content and fatty acid composition of intramuscular lipids (Bergman 
et al., 2010, Schenk and Horowitz, 2007). A single bout of endurance exercise has been 
shown to prevent FA acid induced insulin resistance during a lipid infusion on the following 
day (Schenk and Horowitz, 2007). This was accompanied by increased IMTG content, 
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increased expression of enzymes involved in triglyceride synthesis and reduced accumulation 
of FA metabolites in comparison to no prior exercise bout (Schenk and Horowitz, 2007). This 
is likely due to the high IMTG breakdown that occurs during exercise in athletes (van Loon et 
al., 2003, De Bock et al., 2007, Stellingwerff et al., 2007a, Stellingwerff et al., 2007b) 
allowing rapid repletion of the IMTG stores in conditions of high FA, therefore keeping the 
concentration of plasma TG and muscle FA metabolites low and insulin sensitivity high. A 
study comparing highly endurance trained athletes to sedentary controls has demonstrated 
endurance trained athletes have a higher IMTG fractional synthetic rate (Bergman et al., 
2010). The increased capacity to store FA as IMTG may serve as a training adaptation in 
athletes (van Loon, 2004a, van Loon and Goodpaster, 2006). As expected the muscle cells of 
athletes contained more IMTG, while perhaps more surprisingly there were no differences in 
DAG content between the two groups (Bergman et al., 2010). Percentage DAG saturation was 
however lower in endurance trained athletes, and furthermore percentage DAG saturation 
correlated significantly with insulin sensitivity (Bergman et al., 2010). However this data 
conflicts with that of Amati et al. (2011) who showed that DAG containing two unsaturated 
FAs was increased in obese sedentary compared to endurance trained athletes (Amati et al., 
2011). Taken together, the above data demonstrate that training status can influence lipid 
synthesis and lipid type and FA-composition in skeletal muscle ultimately providing multiple 
mechanisms to manipulate lipid induced insulin resistance. 
The reported adaptations in the insulin signalling pathway intermediates that result from 
endurance training among others involve increases in Akt protein content but no change in 
protein content of IR, IRS1 or the p85 subunit of PI3K (Frosig et al., 2007). There was also no 
change in syntaxin 4, SNAP23 or Munc18c protein content (Frosig et al., 2007). Insulin-
stimulated Akt phosphorylation and IRS1-associated PI3K activity were not affected by 
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training (Frosig et al., 2007). AS160 phosphorylation by Akt was increased following 
training, both in the basal and insulin-stimulated states (Frosig et al., 2007). Another study 
demonstrated increased AS160 protein content following training in T2D patients (Vind et al., 
2011). Training also increased insulin-stimulated phosphorylation of AS160 at S341 and 
T642 in T2D patients. Before training insulin-stimulated increases in AS160 phosphorylation 
at S318, S588 and S751 were lower in T2D compared to controls. This difference was 
normalised by endurance training (Vind et al., 2011). 
Increased mitochondrial oxidative capacity, in part through increases in mitochondrial protein 
content, is a major training adaptation which improves lipid and glucose fuel handling 
(Holloszy, 1967, Oscai and Holloszy, 1971, Rockl et al., 2008). Six weeks ET in mice 
increases mitochondrial protein content and enzyme activity (Rockl et al., 2008). Both ET and 
SIT increase mitochondrial enzyme content and activity over 2-6 week training periods 
(Gibala et al., 2006, Little et al., 2010, Hood et al., 2011, Shepherd et al., 2013). Increased 
mitochondrial protein content can improve glucose and lipid metabolism and reduce the ROS 
production that occurs as a result of mitochondrial dysfuction in insulin resistance, thereby 
reducing intracellular FA metabolites and improving insulin sensitivity (Kim et al., 2008).  
Increased muscle GLUT4 content is associated with improved insulin action, as demonstrated 
in animal models overexpressing GLUT4 in skeletal muscle (Ren et al., 1995, Hansen et al., 
1995, Leturque et al., 1996). Western blot analysis has also shown that GLUT4 protein 
content of muscle cells is increased robustly following both traditional ET (Houmard et al., 
1991, Houmard et al., 1993, Hughes et al., 1993, Houmard et al., 1995, Dela et al., 1996, 
Phillips et al., 1996b, Cox et al., 1999, Daugaard et al., 2000, Vind et al., 2011) and SIT 
(Burgomaster et al., 2007, Little et al., 2010, Hood et al., 2011). Daugaard et al. (2000) 
reported that increases in total GLUT4 protein content following endurance exercise were 
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driven by increased GLUT4 content in type I muscle (Daugaard et al., 2000), whereas 
following more strength based exercise (more similar to SIT) Stuart et al. (2010) reported that 
increases in GLUT4 content occurred only in type II muscle fibres (Stuart et al., 2010).  
Consecutive bouts of exercise increase GLUT4 content until a steady state is reached which is 
maintained for the duration of training (Ojuka et al., 2012). GLUT4 gene transcription is 
controlled by the transcription factors myocyte enhancer factor (MEF) 2, which binds the 
GLUT4 promoter as a heterodimer MEF2A/D and GLUT4 enhancer factor (GEF), an as yet 
unidentified histone acetyltransferase (HAT), and the histone deacetylase HDAC5 (Ojuka et 
al., 2012). A single bout of exercise increases MEF2A/D and GEF interaction with the 
GLUT4 gene in human skeletal muscle (McGee et al., 2006). Acetylation of histones 
associated with the GLUT4 gene is required for GLUT4 gene transcription, therefore HDAC5 
must be inhibited (Ojuka et al., 2012). This is thought to be achieved through the 
phosphorylation of HDAC5 by AMPK (McGee et al., 2008) and CAMKII (Ojuka et al., 
2012). Increases in the protein content of the transcriptional coactivator PGC1α are seen 
following ET and SIT (Burgomaster et al., 2008) and are thought to be involved in the 
upregulation of GLUT4 gene expression through MEF2 binding and in turn promoting 
histone acetylation (Rockl et al., 2008, Ojuka et al., 2012). 
Increases in GLUT4 protein content resulting from training will enhance glucose uptake 
capacity of skeletal muscle, and therefore are likely to contribute to the improvement in 
insulin sensitivity that is observed with an OGTT or hyperinsulinaemic-euglcyaemic clamp 
following training (Goodyear and Kahn, 1998). Further research should investigate the 
mechanisms by which increases in GLUT4 content can improve insulin sensitivity measured 
in this way. One possibility is that following training GLUT4 content of insulin responsive 
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stores in particular is increased therefore increasing the GLUT4 available for translocation in 
response to a given insulin stimulus (Ivy, 2004). 
1.9. Overview and aims of thesis 
As described in this introductory chapter skeletal muscle is the major site of glucose uptake 
(Katz et al., 1983, Ferrannini et al., 1985) and GLUT4, as the main glucose transporter 
isoform expressed in skeletal muscle (Mueckler, 1994, Bell et al., 1993), has a significant role 
to play in the successful, or unsuccessful, maintenance of glucose homeostasis. Previously 
published literature, which observed an increased GLUT4 content using Western blots in 
isolated PM fractions following glucose feeding (Goodyear et al., 1996) and exercise 
(Kennedy et al., 1999), has implicitly assumed that this increase in PM GLUT4 content is the 
primary mechanism behind the increase in skeletal muscle glucose uptake that is seen in 
response to insulin and exercise. Furthermore it has been assumed that failure to achieve this 
increase in GLUT4 PM content is a major cause of insulin resistance in the muscle of 
individuals with obesity and metabolic syndrome (Zierath et al., 1996). As results obtained in 
these PM fractionation methods have been criticised (section 1.4.1), an overriding aim of this 
thesis is to develop an immunofluorescence microscopy method to visualise GLUT4 in 
human skeletal muscle and to subsequently investigate the above assumptions. Current 
literature relating to the subcellular distribution and storage of GLUT4 and the time profile of 
GLUT4 translocation following glucose ingestion, during a hyperinsulinaemic-euglycaemic 
clamp and after exercise in human skeletal muscle in particular is fragmented. Therefore the 
immunofluorescence microscopy method developed in this thesis, will be used to investigate 
GLUT4 intracellular storage sites and colocalisation of GLUT4 with the PM marker 
dystrophin in human skeletal muscle as a measure of GLUT4 translocation to the PM. This 
PhD project was part of a collaborative project between Eindhoven University of Technology, 
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AstraZeneca and the University of Birmingham and as such aimed to generate information on 
the time profiles of insulin- and contraction-mediated GLUT4 translocation in human skeletal 
muscle. 
Chapter 2 of this thesis describes the development and validation of an immunofluorescence 
method to visualise GLUT4 in human skeletal muscle and has for the first time used a PM 
marker to assess colocalisation of GLUT4 with the PM marker as a measure of GLUT4 
present in PM regions in human skeletal muscle. The method is used in chapter 3 to 
investigate the effect of training on GLUT4 content and spatial distribution to include 
colocalisation with the PM marker dystrophin in the basal state in type I and type II muscle 
fibres. Furthermore chapter 3 aims to add to the understanding of whether endurance and 
sprint interval training-induced improvements in glucose homeostasis and insulin sensitivity 
that are seen during an OGTT are driven by increases in GLUT4 content in specific 
subcellular locations. 
Chapter 4 aims to visualise and quantify the redistribution of GLUT4 to the PM in human 
skeletal muscle following glucose feeding and exercise. In particular GLUT4 PM localisation 
was investigated 30, 60 and 90 min after glucose feeding to determine the time profiles and 
kinetics of GLUT4 translocation in human skeletal muscle. GLUT4 PM localisation is also 
investigated immediately after 30 min cycling exercise. In addition chapter 4 aims to quantity 
GLUT4 PM localisation following a combination of glucose feeding and exercise. 
Chapter 5 uses the novel method developed to investigate GLUT4 PM localisation in the 
skeletal muscle of the obese Zucker rat model of obesity and compares GLUT4 PM 
localisation before and after an 80 min hyperinsulinaemic-isoglycaemic clamp in both lean 
and obese Zucker rats. The a priori hypothesis was that there would be an increased GLUT4 
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PM localisation following hyperinsulinaemic-isoglycaemic clamp in the LZR, which would 
not occur in the OZR because of insulin resistance.  
Chapter 6 aims to characterise the effect of prolonged hyperglycaemia on GLUT4 PM 
localisation in human skeletal muscle. Glucose disposal and GLUT4 PM localisation are 
assessed during a hyperglycaemic glucose clamp (5.4 mM above the overnight fasted level) in 
normal glucose tolerance (NGT) after 2 and 24 of hyperglycaemia and in patients with type 2 
diabetes (T2D) after 2 h only. It is hypothesised that glucose disposal and GLUT4 PM 
localisation following 2 h hyperglycaemia would be higher in NGT compared to T2D. We 
further hypothesized that insulin-mediated glucose disposal and GLUT4 PM localisation 
would be reduced in response to 24 h hyperglycaemia in NGT due to hyperglycaemia-induced 
insulin resistance.  
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2.1. Ethical approval 
Ethical approval for all the studies included in this thesis was granted by NHS Research 
Ethics Committees in the Birmingham and West Midlands region or the Ethics Committee of 
the Capital Region of Denmark. Written informed consent was obtained from all participants, 
prior to their commencement of a study. All animal studies were conducted according to the 
UK Animal (Scientific Procedures) Act 1984. 
 
2.2. Human skeletal muscle biopsy collection 
Human skeletal muscle samples (~100 mg wet weight) for studies described in chapters 3, 4 
and 6 were obtained under local anaesthesia (1 % lidocaine) from the vastus lateralis muscle 
using the Bergström percutaneous needle biopsy technique with suction (Bergstrom, 1975). 
Small incisions (~1 cm) were made in the skin and fascia over the vastus lateralis muscle, 
through which the biopsy needle was inserted. Samples were blotted to remove excess blood 
and any visible collagen or fat was discarded. For immunofluorescence microscopy analysis 
part of the sample was embedded in Tissue Tek OCT (Sakura, 4583) compound and 
immediately frozen in liquid nitrogen-cooled isopentane (Sigma Aldrich, 270342). The 





C. The remaining sample was snap frozen in liquid nitrogen to be used for 
Western blot analysis where relevant.  
 
2.3. Rat skeletal muscle collection 
Immediately after completion of the experimental protocol (described fully in chapter 5) 
animals were sacrificed by anaesthetic overdose, via intraperitoneal administration of Inactin, 
followed by cervical dislocation. The tibialis anterior muscle was dissected free and any 
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visible non-muscle tissue or tendon was removed and discarded. The muscle was embedded 
to enable transverse sectioning of the tissue in Tissue Tek OCT (Sakura, 4583) compound and 
immediately frozen in liquid nitrogen-cooled isopentane (Sigma Aldrich, 270342). The 




C until use. 
 
2.4. Sample homogenisation for Western blotting 
Snap-frozen muscle samples of 20-50 mg, were homogenised in liquid nitrogen using a pestle 
and mortar. Radio-Immunoprecipitation Assay (RIPA) buffer (20 mM Tris-HCl (pH 7.5), 150 
mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM 
sodium pyrophosphate, 1 mM -glycerophosphate, 1 mM Na3VO4, 1 μg/ml leupeptin, Cell 
Signalling) with a protease inhibitor cocktail (Roche, 11836153001) was added to the muscle 
sample and the homogenate was left on ice for 10 min before being vortexed and again left on 
ice for 3 hr on a shaker. Further homogenisation was achieved using a polytron (Digital 





 MicroR centrifuge, Fisher Scientific) and the resulting supernatant was 
aliquoted. A bicinchoninic acid (BCA) assay was run on the homogenate samples to 
determine the protein concentration, so concentration could be normalised to 2 µg/µl for all 
samples (BCA kit, Thermo Scientific, 23227). To achieve this 100 µl Laemmli buffer (0.004 
% bromophenol blue, 400 mM DTT, 20 % glycerol, 4 % SDS, 0.125 M Tris, Sigma Aldrich) 
and an appropriate volume of RIPA buffer was added to the sample. Samples were not boiled 
prior to immunoblotting due to the tendency of hydrophobic membrane proteins to aggregate 





2.5. VO2max determination 
All participants recruited for the studies in chapters 3 and 4 performed an incremental 
exercise test to exhaustion on an electronically braked cycle ergometer (Lode BV, Groningen, 
The Netherlands) to determine their maximal aerobic capacity (VO2max) using an on-line gas 
collection system (Oxycon Pro, Jaeger, Germany). The test began with cycling at a workload 
of 95 W with subsequent increases of 35 W every 3 min. The test was terminated when the 
participant’s cadence dropped below 50 rpm. The VO2max was recorded as the highest value 
reached within the final 30 s of the test. The data from the VO2max test were also used to 
estimate the workload that corresponded to 65% VO2max. 
 
2.6. Venous blood sampling and plasma glucose and insulin analysis 
Venous blood samples were collected from a cannula inserted into a forearm vein into 
ethylenediaminetetraacetic acid (EDTA)-containing tubes (BD vacutainer, USA). Samples 
were kept on ice before centrifuging for 15 min at 3500 rpm at 4
o
C. Plasma was aliquoted and 
stored at -80
o
C. Plasma glucose was analysed in duplicate in all samples 
spectrophotometrically using an ILab 600 analyser and the glucose oxidase kit 
(Instrumentation Laboratory Ltd, UK).  Plasma insulin was analysed in duplicate in all 
samples using commercially available insulin ELISA kits (Invitrogen, UK). 
 
2.7. Matsuda index calculation 
Insulin sensitivity during OGTT in chapters 3, 4 and 6 was calculated using the Matsuda 
index, which was originally proposed by Matsuda and DeFronzo (1999), and has been shown 
to correlate highly with the gold standard assessment of insulin sensitivity using the 
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hyperinsulinaemic-euglycaemic clamp (Matsuda and DeFronzo, 1999). The Matsuda index 
was calculated as follows: 
            
     
                   
, 
where FPG is fasting plasma glucose, FPI is fasting plasma insulin, MPG is mean plasma 
glucose during OGTT and MPI is mean plasma insulin during OGTT. 
 
2.8. GLUT4 immunofluorescence microscopy method development 
2.8.1. Sample preparation 
Cryosections (5 µm) were cut using a Bright 5040 (Bright Instrument Company limited, 




C. Sections were cut onto uncoated glass microscope slides (VWR international) and were 




C for staining on a subsequent occasion. 
Following storage slides were left at room temperature for 30 min prior to staining. 
2.8.2. GLUT4 immunofluorescence staining protocol.  
The GLUT4 staining protocol was optimised by checking different fixatives, antibody 
dilutions and incubation times to produce the optimal images. The fully optimised protocol is 
outlined below. Pre-cut cryosections on slides were fixed for 5 min in solution of 75 % 
acetone and 25 % ethanol. Following this sections were washed 3 times for 5 min in 
phosphate buffered saline (PBS, 1x, 137 mM sodium chloride, 3 mM potassium chloride, 8 
mM sodium phosphate dibasic, 3 mM potassium phosphate monobasic, all Sigma Aldrich). 
For anti-GLUT4 staining sections were incubated in 1:200 anti-GLUT4 polyclonal antibody 
(abcam, UK, ab654) diluted in PBS with 5 % normal goat serum (NGS, Invitrogen) for 2 h at 
room temperature.  Following primary antibody incubation, sections were again washed 3 
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times for 5 min in PBS. Sections were then incubated in a 1:200 dilution of appropriately 
targeted secondary antibodies diluted in PBS for 30 min at room temperature. GLUT4 
antibody was targeted with goat anti-rabbit IgG 488 (Invitrogen, UK). Following secondary 
antibody incubation, sections were washed 3 times for 5 min in PBS and glass coverslips were 
mounted with 20 µl mowiol mounting medium (6 g glycerol (Sigma Aldrich, G5150), 2.4 g 
mowiol 4-88 (Fluka, 81381) and 0.026 g 1,4-diazobicyclo-[2,2,2]-octane (DABCO) (Fluka, 
33490) dissolved in 18 ml 0.2M Tris-buffer (pH 8.5) (Sigma Aldrich, T5030)) to protect the 
sample and preserve the fluorescence signal. Slides were left to dry overnight before 
immunofluorescence visualisation. 
GLUT4 staining has been combined with a number of different markers. The plasma 
membrane (PM) was stained with a monoclonal antibody against the protein dystrophin 
(1:400, Sigma Aldrich, UK, D8168) and T-tubule membranes were stained with a monoclonal 
antibody against dihydropyridine receptor (DHPR; 1:25, Abcam, UK, ab2864). Type I and 
type IIa muscle fibres were identified using monoclonal antibodies against myosin heavy 
chain type I (MHCI, 1:100, A4.840) and myosin heavy chain type IIa (MHCIIa. 1:100, 
N2.261), respectively (both DSHB, USA, developed by Dr Blau). The appropriately targeted 
secondary antibodies are as follows; dystrophin was targeted with goat anti-mouse (GAM) 
IgG2b 594 (Invitrogen, UK) or GAM IgG2b 633 (Invitrogen, UK), DHPR with GAM IgG2a 594 
(Invitrogen, UK), MHCI with GAM IgM 594 (Invitrogen, UK) or GAM IgM 488 (Invitrogen, 
UK) and MHCIIa with GAM IgG1594. 4,6-Diamidino-2-phenylindole dihydrochloride 
(DAPI, Sigma Aldrich, UK) was used to identify cell nuclei and was applied with secondary 
antibody at a 1:500 dilution. Further details of these staining combinations will be provided in 
the individual chapters.  
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SNAP23 was stained in human muscle sections using an anti-SNAP23 polyclonal antibody 
(1:50, Synaptic Systems, Germany, 111 202) in combination with dytrophin. However due to 
limitations of antibody species GLUT4 and SNAP23 staining were not combined. These 
limitations will be further discussed in section 2.10 of this chapter. 
 
2.8.3. Antibody validation.  
The performance of accurate immunofluorescence microscopy requires a primary antibody 
which specifically targets only the desired protein of interest. There are a number of methods 
used to determine the specificity of an antibody (as described in (Saper, 2009, Saper, 2005, 
Burry, 2011)), but as there are inherent advantages and disadvantages of each method, in this 
thesis a number of methods were combined to provide convincing evidence of antibody 
specificity.  
Western blotting was performed to confirm the antibody selected a single protein at the 
expected molecular weight. Protein extract (60 µg) was loaded onto a 7.5 % resolving gel 
(Biorad, UK) with 5 µl molecular weight markers (Biorad, UK) and run for 1 h at 40 mA in 
1x Tris/Glycine/SDS buffer (Biorad, UK). Proteins were transferred to a PVDF membrane 
(Biorad, UK) for 2 h at 350mA in 1x Tris/Glycine buffer (Biorad, UK) with 20 % methanol. 
The membrane was blocked for 1 h in 5 % non-fat dry milk (Cell Signalling, USA) made up 
in tris-buffered saline (50mM Tris-HCl (Sigma Aldrich, UK), 150 mM NaCl (Sigma Aldrich, 
UK) with 0.05 % tween 20 (Sigma Aldrich, UK)) (TBST) and then incubated overnight at 
4
o
C in 1:2000 dilution of GLUT4 primary antibody (ab654, Abcam, UK) in 5 % milk. 
Membrane was subsequently washed 3 times for 10 min in TBST and blocked again for 1 h in 
5 % milk prior to incubation in 1:2000 dilution of goat-anti rabbit IgG HRP conjugated 
secondary antibody (Cell Signalling, USA) in 5 % milk for 1 h. Membrane was then washed 
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twice in TBST and once in TBS without tween. Membrane was incubated in ECL substrate 
(GE Healthcare, UK) for 5 min prior to exposure to film (GE Healthcare, UK) and 
development of film. To confirm GLUT4 antibody specificity and selectivity in an 
immunofluoresence application experiments were carried out onsite at AstraZeneca in an L6 
cell line overexpressing GLUT4 with a myc protein tag (GLUT4-myc) and non-transfected 
L6 cells. L6-GLUT4myc cells were purchased by AstraZeneca from Dr. Amira Klip and Dr. 
Philip Bilan (Department of Biochemistry, University of Toronto) and have been described 
previously (Kanai et al., 1993, Wang et al., 1998). GLUT4-myc and non-transfected cells 
(20,000 per well) were differentiated to myotubes and were fixed in 4 % formaldehyde for 5 
min on ice and then kept for 20 min at room temperature. Cells were washed twice in PBS 
and 100 µl 0.1M glycine was added to quench the formaldehyde reaction. Cells were 
permeabilised in 100 µl 0.1 % triton X-100 in PBS for 5 min at room temperature and then 
washed once in PBS. Cells were blocked for 1 h at room temperature in 3 % BSA in PBS and 
then incubated in 25 µl 1:50 GLUT4 antibody in 3 % BSA with 1:50 mouse anti-myc (Sigma 
Aldrich, UK) for 1 h at room temperature. Some cells did not have GLUT4 primary antibody 
applied as a negative control to confirm secondary antibody specificity. Cells were then 
washed once in PBS and secondary antibodies were applied for 40 min at room temperature in 
3 % BSA with a 1:500 Hoechst 33342 (Invitrogen, UK) counterstain for cell nuclei. Goat 
anti-rabbit IgG 594 (1:500) was used to detect GLUT4 primary antibody and 1:500 goat anti-
mouse IgG 488 was used to detect myc primary antibody. Cells were then washed three times 
in PBS and left in PBS for viewing. Viewing was completed using ImageXpress with a 10x 
objective and contrast was adjusted consistently across all images. To confirm specificity of 
the GLUT4 antibody for the immunogen peptide the antibody was incubated with saturating 
concentrations (5 times higher than the antibody concentration) of the GLUT4 immunogen 
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peptide composed of the C terminal 15 amino acids of rat GLUT4 (Abcam, UK, ab115831) 
for 24 h at 4
o
C, prior to application onto human skeletal muscle sections in place of primary 
antibody. All other stages of the staining protocol remained identical and the competition 
staining was completed alongside a positive control with primary antibody and a negative 
control in which primary antibody was omitted completely. 
The specificity of the antibodies targeting MHCI and MHCII to identify muscle fibre type 
(Webster et al., 1988, Shepherd et al., 2013), dystrophin to mark the PM (Nguyen et al., 1990, 
Sedgwick et al., 1991, Koenig et al., 1988) and DHPR to identify the T-tubule  membranes 
(Wilson et al., 2012) have all been confirmed in earlier studies. 
2.8.4. Antibody controls 
For each tissue, species and staining protocol certain controls were carried out. To confirm 
there was no tissue autofluorescence or non-specific secondary antibody binding PBS 
containing 5 % NGS was applied to the tissue in place of primary antibody. When visualised, 
an image free of positive staining confirmed there was no tissue autofluorescence or non-
specific secondary antibody binding. 
To ensure secondary antibodies did not cross react with the incorrect primary antibody, 
controls were performed in which only one primary antibody was applied to the tissue section 
with all secondary antibodies. Correct staining was confirmed with images in which signal 
was only observed from the secondary antibody targeted to the primary antibody applied to 
the tissue section. 
To ensure each fluorophore only emitted signal that was detected in a single channel, controls 
were carried out in which only one target was stained. Images were captured in all channels to 
confirm signal was only detected in the channel specific to the target stained. It was important 
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to confirm there was no bleedthrough into other channels as this would have affected the 
images analysis. 
2.8.5. Microscopy 
Images were captured using a widefield or confocal fluorescence microscope. In widefield 
fluorescence microscopy fluorophores are illuminated through the entire depth of the muscle 
section not just in the plane of focus, which can result in images appearing blurry and out of 
focus (Smith, 2008). In contrast a confocal microscope only collects light from a single focus 
plane. In focus light is allowed through the confocal microscope pinhole aperture and reaches 
the detector, whereas out-of-focus light does not (Smith, 2008). Furthermore the lasers used 
for excitation in a confocal microscope lead to intense excitation of the fluorophores (Smith, 
2008). Taken together these features allow generation of higher resolution images with less 
out-of focus light. Confocal microscopy was therefore used for colocalisation analysis, to 
reduce false colocalisation that would be caused by out-of-focus light with widefield 
microscopy. All staining was carried out in triplicate on separate slides, and subsequent image 
capture and analysis was completed on all three slides. 
Widefield immunofluorescence images were visualised using a Nikon E600 microscope and 
captured with a SPOT RT KE colour three shot CCD camera (Diagnostic Instruments Inc., 
MI, USA). A 170 W Xenon light source was used for illumination. The Alexa Fluor 594 and 
488 fluorophores were visualised using Texas red (540-580 nm) and FITC (465-495 nm) 
excitation filters, respectively, while the DAPI UV (340-380 nm) excitation filter was used to 
visualise cell nuclei stained with DAPI. Filters were changed using a semi-automated 
filterwheel (10B 10 Position Filterwheel, Sutter, USA). All widefield images were obtained 
using a 40x objective (0.75 NA). 
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In order to obtain higher resolution images suitable for colocalisation analysis, an inverted 
confocal microscope (Leica DMIRE2, Leica Microsystems) with a 63x oil immersion 
objective (1.4 NA) was used. AlexaFluor 488 fluorophores were excited with a 488 nm line of 
the argon laser and 498-571 nm emission. Alexa Fluor 594 fluorophores were excited with the 
594 nm line of the helium-neon laser and 601-713 nm emission. Alexa Fluor 633 
fluorophores were excited with the 633 nm line of the helium-neon laser and 639-734 nm 
emission. 
2.8.6. Immunofluorescence image analysis 
Images were processed and analysed using Image-Pro Plus 5.1 software (Media Cybernetics, 
MD, USA). The colocalisation of GLUT4 and dystrophin used to estimate PM GLUT4 was 
measured using the Pearson’s correlation coefficient which was calculated by the ImagePro 
Plus 5.1 colocalisation tool.  Prior to colocalisation all images underwent an ImagePro Plus 
5.1 no neighbour deconvolution algorithm as a filter. Pearson’s correlation coefficient has 
been routinely used to measure colocalisation of two proteins in immunofluorescence images 
(Dunn et al., 2011, Bolte and Cordelieres, 2006, Landmann and Marbet, 2004, Sedarat et al., 
2004, Lachmanovich et al., 2003). All image processing and analysis was kept consistent 
between images across each analysis method.  
 
2.9. Results of GLUT4 immunofluorescence method development 
2.9.1. GLUT4 antibody validation 
The online UniProt database Basic Local Alignment Search Tool (BLAST; 
http://www.uniprot.org) indicated that the immunogen sequence corresponding to the C 
terminal 15 amino acid sequence of rat GLUT4 was not present in any protein other than 
GLUT4 in human skeletal muscle. Therefore an antibody raised against this immunogen 
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sequence should only detect GLUT4 in human skeletal muscle sections. To confirm this 
experimentally Western blotting (Fig. 2.1A) was applied to human skeletal muscle and the 
GLUT4 antibody detected a single band at the expected molecular weight (approximately 45 
kDa). In L6 cells overexpressing GLUT4 with a myc tag (GLUT4-myc), antibody staining 
against myc demonstrated extensive colocalisation with the staining generated by the GLUT4 
antibody (Fig. 2.1B). Furthermore in non-transfected L6 cells, which exhibit very low 
expression of GLUT4, no positive GLUT4 staining was observed. The residual myc signal is 
attributable to endogenous myc in L6 cells (Denis et al., 1987). Incubation of the primary 
antibody with the immunogen peptide prior to application to the muscle section abolishes 
antibody staining, leaving only background fluorescence and confirming specificity of the 
antibody for the immunogen sequence (Fig. 2.1C, right panel). Omission of the GLUT4 
primary antibody results in no staining, confirming secondary antibody specificity and 
absence of tissue autofluorescence (Fig. 2.1C, middle panel). Taken together these data 





Fig. 2.1. Validation of GLUT4 antibody. A) Human skeletal muscle Western blot. B) GLUT4-
myc transfected L6 cells (and non-transfected L6 cells) stained with GLUT4 antibody (red) 
and myc antibody (green). Myc staining is apparent in non-transfected L6 cells because they 
express endogenous myc (Denis et al., 1987). C) Positive control GLUT4 antibody staining 
for comparison to primary antibody omission negative and peptide competition staining. 
Scale bars 50 µm. 
 
2.9.2. Basal GLUT4 localisation in human skeletal muscle 
GLUT4 staining in human skeletal muscle appears as large clusters of staining with smaller 
spots dispersed throughout the cell interior as can be seen in Fig.2. 2. GLUT4 clusters are also 
observed close to or incorporated in the PM as indicated by the distinct colocalisation of 
GLUT4 with the PM marker dystrophin (Fig. 2.2). Another clear feature of human skeletal 
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muscle GLUT4 localisation is a perinuclear distribution, which is shown in Fig. 2.3 where 
GLUT4 staining surrounds the DAPI stain for cell nuclei. Importantly, the localisation of 
GLUT4 in human skeletal muscle revealed in this thesis is very similar to the results of 
published fluorescence microscopy studies in rodent skeletal muscle in which large and small 
clusters of GLUT4 staining were observed predominantly at the fibre periphery and at a high 
density in perinuclear regions (Ploug et al., 1998, Lauritzen et al., 2006). As well as staining 
in PM regions, Fig. 2.4 shows that GLUT4 is also localised at the T-tubule membranes in 
human skeletal muscle in the basal state. In longitudinally oriented muscle fibre sections 
staining for DHPR, a receptor found in high concentrations in the T-tubule membranes and 
therefore used as a marker for the T-tubule membranes, generates a striated pattern in which 
the striations run perpendicular to the long axis of the fibre (Fig. 2.4, middle panel). GLUT4 
staining demonstrates the same striation pattern (Fig. 2.4, left panel), which correspond to the 
DHPR striations when the two stains are overlaid (Fig. 2.4, right panel). In Fig. 2.5 no 
difference in GLUT4 signal intensity is apparent between the type I fibres, which positively 






Fig. 2.2. Representative confocal immunofluorescence microscopy images of GLUT4 (green) 
in human skeletal muscle stained in combination with dystrophin (red) to mark the PM. 




Fig. 2.3. Representative widefield immunofluorescence microscopy images of GLUT4 (green) 
in human skeletal muscle stained in combination with DAPI (blue) to mark the cell nuclei. 




Fig. 2.4. Representative confocal immunofluorescence microscopy images of GLUT4 (green) 
in human skeletal muscle stained in combination with DHPR (red) to mark the T-tubule 
membranes. 




Fig. 2.5. Representative widefield immunofluorescence microscopy images of GLUT4 (green) 
in human skeletal muscle stained in combination with MHCI (red) to mark the type I muscle 
fibres.  
 
2.9.3. Coefficient of variation of the Pearson’s correlation coefficient to measure GLUT4 and 
dystrophin colocalisation 
The Pearson’s correlation coefficient to measure GLUT4 in PM regions has been used in all 
chapters of this thesis. During the development of this method staining was carried out on five 
serial sections of the same muscle piece each on a separate slide in order to determine the 
coefficient of variation of the analysis method. As with the full analysis carried out in each 
study of this thesis, five GLUT4 and dystrophin images were captured per section. The mean 
Pearson’s correlation coefficient for each section is displayed in Fig. 2.6. The coefficient of 




Fig. 2.6. Pearson’s correlation coefficient measuring GLUT4 and dystrophin colocalisation 
in five serial sections. Coefficient of variation between sections is 1 %. Mean ± SEM. N = 5. 
 
2.10. Attempts made to co-stain GLUT4 and SNAP23 
Combined staining of GLUT4 and SNAP23 at the PM would enable assessment of whether 
regions of GLUT4 and SNAP23 staining overlap at the PM. If this were confirmed to be the 
case it would support the idea that GSV fusion with the PM occurs at specific PM domains 
(Chamberlain and Gould, 2002).  Furthermore combination of GLUT4 and SNAP23 staining 
would allow further investigation of the SNARE highjacking hypothesis (Sollner, 2007) by 
determining whether increased lipid content reduces the colocalisation of GLUT4 and 
SNAP23 in the insulin stimulated state in T2D compared to insulin sensitive individuals. 





2.10.1. Problem of species cross-reactivity 
The GLUT4 and SNAP23 antibodies that have been fully validated, either as part of this 
thesis or in the thesis of Dr. Juliette Clark (Clark, 2012), are both the same isotype and were 
raised in the same species; rabbit IgG. Therefore the primary antibodies could not be targeted 
with secondary antibodies specific to each primary antibody (depicted in Fig. 2.7A). 
Alternative approaches were attempted and will be outlined in the sections below. A 
fundamental difference is that each target was stained sequentially. In brief, following fixation 
GLUT4 primary antibody and after subsequent washing a secondary detection system against 
the GLUT4 primary antibody were applied to the skeletal muscle section, followed by further 
washing and application of SNAP23 antibody, washing and application of a secondary 
detection system against the SNAP23 primary antibody. Finally sections were again washed 
and mounted. The potential pitfalls are; avoiding SNAP23 primary antibody binding to any 
available sites in the GLUT4 secondary detection system and avoiding the SNAP23 
secondary detection system binding to any available sites on the GLUT4 primary antibody.  
2.10.2. Fluorophore conjugated Fab fragment (Fig.2.7B) 
Secondary antibodies have more than one binding site available for binding to a primary 
antibody. Therefore once the GLUT4 secondary antibody has bound to the GLUT4 primary 
antibody binding sites would still be available when the SNAP23 primary antibody was 
subsequently applied. A fab fragment only has one binding site available for primary antibody 
binding and, therefore, use of appropriate fab fragments could prevent binding of SNAP23 
primary antibody to the GLUT4 secondary detection system. Furthermore, an excess of Fab 
fragments can be used to saturate all GLUT4 primary antibody binding sites. 
Despite a number of different attempts using different fab fragment dilutions and with a 
fixation step after GLUT4 staining, Fig. 2.8E demonstrates that the fab fragment did not block 
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all GLUT4 primary antibody binding sites and the attempt to block binding between the 
SNAP23 secondary antibody and the GLUT4 primary antibody therefore was not successful. 
2.10.3. Biotin-labelled primary antibody (Fig.2.7C) 
In order to avoid the above pitfall an alternative SNAP23 secondary detection system was 
investigated. GLUT4 was labelled the same as above but a biotin-labelled SNAP23 primary 
antibody would be used to allow detection of SNAP23 with AlexaFluor 488 conjugated 
streptavidin, which has a high affinity for biotin. The same SNAP23 antibody was provided 
by Synaptic Systems with a biotin label (111-203BT), however staining with this antibody 
(Fig. 2.9B) differed to staining with the original antibody (Fig. 2.9A). Furthermore a control 
in which only streptavidin was applied to the muscle sections showed streptavidin binds to 
endogenous biotin in skeletal muscle (Fig. 2.9C). Therefore use of biotin-labelled SNAP23 
antibody was also not an option. 
2.10.4. GLUT4 and SNAP23 co-staining conclusions 
As explained above, the attempts to co-stain GLUT4 and SNAP23 were not successful. 
Further options would be to use alternative antibodies raised in a different species. However 
time was not available to fully validate new antibodies. Therefore for this thesis where 
SNAP23 staining was required, it was completed on different sections to GLUT4 staining. 
This, however, prevented us from generating evidence that GLUT4 docking and fusion 
preferentially occurred in SNAP23 rich lipid rafts as previously observed in adipose tissue 




Fig. 2.7. Methodological problems and attempted solutions associated with GLUT4 and 
SNAP23 primary antibodies of the same species. A) Cross reactivity of goat-anti rabbit 
secondary antibodies against GLUT4 and SNAP23 secondary antibodies. B) Use of a goat 
anti-rabbit fab fragment to saturate all GLUT4 primary antibody and fab fragment binding 
sites prior to incubation with SNAP23 primary and then secondary antibody. C) Biotin-




Fig. 2.8. Confocal immunofluorescence microscopy images demonstrating attempts made to 
eliminate secondary antibody cross reactivity by targeting rabbit anti-GLUT4 primary 
antibody with goat anti-rabbit Dylight 594 fluorophore conjugated Fab fragment. A and D) 
GLUT4 staining with rabbit anti-GLUT4 primary antibody and goat anti-rabbit Dylight 594 
fluorophore conjugated Fab fragment. B) Subsequent staining of SNAP23 with rabbit anti-
SNAP23 primary antibody and AlexaFluor 488 conjugated goat anti-rabbit secondary 
antibody. C) Merged image of GLUT4 (red) and SNAP23 (green) staining. E) Omission of 
SNAP23 primary antibody with application of AlexaFluor 488 conjugated goat anti-rabbit 
secondary antibody shows binding of this secondary antibody to the GLUT4 primary 




Fig. 2.9. Widefield immunofluorescence microscopy images captured at the same settings 
demonstrating testing of biotin-labelled rabbit SNAP23 primary antibody. A) Rabbit anti-
SNAP23 primary antibody targeted with AlexaFluor 488 conjugated goat anti-rabbit 
secondary antibody. B) Biotin-labelled rabbit anti-SNAP23 primary antibody targeted with 
AlexaFluor 488 conjugated streptavidin. C) Omission of biotin-labelled rabbit anti-SNAP23 
primary antibody, therefore demonstrating direct binding of AlexaFluor 488 conjugated 




2.11. Attempts to quantify GLUT4 in the T-tubule membranes 
The T-tubule membrane system comprises invaginations of the muscle PM which extend deep 
into the muscle fibre and is well characterised as a site of insulin- and contraction-mediated 
GLUT4 translocation in rodent muscle (Ploug et al., 1998, Lauritzen et al., 2006, Lauritzen et 
al., 2010). Therefore attempts were made to quantify GLUT4 in the T-tubule membranes with 
the aim to assess whether GLUT4 translocation to the T-tubule membranes of human skeletal 
muscle occurred following feeding and exercise. The first method considered was to create a 
mask from DHPR staining in longitudinally-oriented muscle fibres and to subsequently 
measure GLUT4 fluorescence intensity within this mask (Fig. 2.10A-D). The second method 
considered was to measure GLUT4 fluorescence intensity along a line drawn perpendicular to 
the GLUT4 striations in a longitudinally oriented muscle fibre (Fig. 2.10E-F) and to take the 
mean of the intensity peaks. Unfortunately, due to the nature of cryosections cutting through a 
single plane of muscle which was unlikely to correspond to the plane of an individual muscle 
fibre, the T-tubule membrane system network comes in and out of focus along the length of 
the fibre therefore making it difficult to achieve a repeatable and objective measure of 
GLUT4 in the T-tubule membrane using either of the above methods. Images of DHPR in 
three different Z positions in Fig. 2.11 demonstrate that the T-tubule membranes (DHPR 
stained regions) come in and out of focus even in different planes of an image stack. As 
discussed again in chapter 7, a potential solution may be to use these quantitation suggestions 
in single muscle fibres where the fibre can be visualised in one plane rather than cut through 
as in a cryosection. However unfortunately time constraints prevented development of the 






Fig. 2.10. Quantitation methods attempted for GLUT4 in the T-tubule membranes. A-D 
GLUT4 fluorescence intensity within DHPR mask. E-F GLUT4 intensity along line running 




Fig. 2.11. Confocal immunofluorescence images of DHPR staining at three different Z 
positions in image stack. Scale bars 5 µm. 
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Increases in insulin-mediated glucose uptake following both endurance training (ET) and 
sprint interval training (SIT) have in part been attributed to concomitant increases in glucose 
transporter 4 (GLUT4) protein content in skeletal muscle. This study applied 
immunofluorescence methods developed in chapter 2 to investigate changes in GLUT4 
content and subcellular localisation in human skeletal muscle in response to ET and SIT in 
order to further understand the mechanisms underpinning training-induced increases in 
insulin-mediated glucose uptake. Percutaneous muscle biopsy samples were taken from the 
vastus lateralis of 16 sedentary males in the rested overnight fasted state before and after 6 
weeks of either ET or SIT. Large and smaller GLUT4-containing structures were located 
predominantly at the fibre periphery with a less dense punctate distribution in the rest of the 
muscle fibre. Total GLUT4 fluorescence intensity increased in type I and type II fibres 
following both ET and SIT. Number and staining area per fibre of intracellular clusters of 
GLUT4 staining increased both in type I and type II fibres. Large clusters (> 1 µm) increased 
predominantly in number, while the smaller clusters (< 1 µm) increased in size. There was no 
statistically significant increase in colocalisation of GLUT4 with the PM marker dystrophin. 
In conclusion, the immunofluorescence method developed in chapter 2 has been applied to 
human skeletal muscle to visualise GLUT4 distribution and content following ET and SIT. 
The increase in GLUT4 content observed following ET and SIT appears to be due primarily 
to an increase in the number of large intracellular GLUT4 storage clusters and the size of 
small GLUT4 storage clusters therefore increasing the GLUT4 available for translocation and 






Skeletal muscle is the primary site of insulin-mediated glucose uptake (Katz et al., 1983, 
Wasserman et al., 2011) and is therefore important in determining whole body glucose 
disposal rates. Glucose transporter 4 (GLUT4) is the major facilitative glucose transporter 
isoform expressed in human skeletal muscle (Mueckler, 1994). Previous research in rat 
muscle has shown that GLUT4 is located in intracellular storage clusters which are 
predominantly located at the fibre periphery but also in deeper regions (Ploug et al., 1998). 
Following insulin stimulation GLUT4 storage vesicles (GSVs) dissociate from the larger 
intracellular storage clusters and translocate to fuse with both the plasma membrane (PM) and 
T-tubule membranes. This is assumed to lead to increases in PM GLUT4 content which 
enables increased glucose uptake into the muscle cell (Ploug et al., 1998, Lizunov et al., 2012, 
Bell et al., 1993, Lauritzen et al., 2008, Lauritzen et al., 2006). 
Experimental increases in total muscle GLUT4 content are known to increase insulin 
stimulated glucose uptake rate, as demonstrated in animal models overexpressing GLUT4 in 
skeletal muscle (Ren et al., 1995, Leturque et al., 1996, Hansen et al., 1995). Similarly, in 
humans improvements in glucose homeostasis and increases in insulin sensitivity (measured 
during a hyperinsulinemic-euglycaemic clamp and/or an oral glucose tolerance test), that are 
seen following endurance exercise training (ET) and various forms of high intensity interval 
training (HIT), occur in parallel with robust increases in total skeletal muscle GLUT4 protein 
content (Hughes et al., 1993, Dela et al., 1996, Cox et al., 1999, Babraj et al., 2009, Richards 
et al., 2010, Houmard et al., 1991, Phillips et al., 1996, Daugaard et al., 2000, Burgomaster et 
al., 2007, Hood et al., 2011, Little et al., 2010). Increases in insulin-stimulated leg glucose 
uptake that occur in humans after training (Dela et al., 1996, Frosig et al., 2007, Dela et al., 
1995, Dela et al., 1992) are driven by multiple mechanisms (Wasserman et al., 2011). The 
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main candidate mechanisms are training induced increases in: 1) insulin sensitivity leading to 
more GLUT4 translocation for the same insulin stimulus; 2) total number of GLUT4 
molecules able to translocate to the PM (Hughes et al., 1993, Dela et al., 1996, Cox et al., 
1999, Houmard et al., 1991, Phillips et al., 1996, Daugaard et al., 2000, Burgomaster et al., 
2007); 3) mitochondrial oxidative capacity leading to steeper glucose gradients between 
capillary blood and the muscle cytosol (Hood et al., 2011, Little et al., 2010); and 4) capillary 
density leading to increased insulin induced microvascular dilation and a larger surface area 
available for the transendothelial transport of both insulin and glucose (Barrett et al., 2009, 
Barrett et al., 2011).  
Studies in adipocytes have revealed that GLUT4 is stored in 50 – 70 nm insulin responsive 
vesicles termed GLUT4 storage vesicles (GSVs) and endosomal membranes estimated to be 
approximately 150 – 200 nm (Bogan, 2012, Bogan and Kandror, 2010, Larance et al., 2008, 
Stockli et al., 2011). GSVs in adipose tissue cells are formed by insulin stimulated budding of 
endosomal and trans-Golgi network (TGN) membranes (Bogan, 2012, Bogan and Kandror, 
2010, Larance et al., 2008) followed by GSV translocation, docking and fusion with the PM 
to allow increased glucose uptake (Foley et al., 2011). Studies combining confocal 
immunofluorescence microscopy techniques with immunogold labelling electron microscopy 
(EM) applied to whole single fibres of rat soleus muscle have also demonstrated the presence 
of GLUT4 in TGN, endosomal membranes and GSVs (Lizunov et al., 2012, Lauritzen et al., 
2008, Ploug et al., 1998, Rodnick et al., 1992). Immunofluorescence images have defined 
TGN GLUT4 stores as > 1 µm in size (Lauritzen et al., 2008), while based on EM images 
endosomal membrane stores appear to be smaller than TGN stores (Ploug et al., 1998) but 
larger than GSVs which have been reported as 40 nm (Lizunov et al., 2012). In muscle, 
GLUT4 stores are predominantly located at the fibre periphery in the basal state, with some 
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areas of intense intracellular staining. Large and smaller clusters of GLUT4 staining have 
been observed with a particularly high density in the perinuclear region. Staining in the PM 
region was present in the basal state, but was not continuous (Ploug et al., 1998, Lauritzen et 
al., 2006).  
Other observations made in rodent muscle are that the large GLUT4 clusters did not 
translocate with insulin stimulation, rather they remained stationary and were locally depleted 
(Lauritzen et al., 2008). Similarly TGN stores of GLUT4 have been shown to reduce in size 
while endosomal stores and GSVs reduced in number following insulin stimulation (Ploug et 
al., 1998). Furthermore, total internal reflection fluorescence (TIRF) microscopy studies using 
a fluorescently labelled form of GLUT4 have shown that following insulin stimulation of 
isolated mouse muscle more than 80 % of insulin-stimulated fusion events emanated from 
stationary vesicles that had been pre-tethered at the PM or T-tubule membranes prior to 
stimulation, with only 10 % of all GLUT4 structures shown to be mobile (Lizunov et al., 
2012). Taken together these data suggest that GLUT4 movement following stimulation is 
minimal and, therefore, implying basal state GLUT4 localisation close to the PM could impart 
a benefit for insulin action on glucose uptake. Brozinick et al. (1993) used membrane 
isolation and Western blotting methods to show increases in GLUT4 in the PM fraction of 
obese Zucker rat skeletal muscle following training (Brozinick et al., 1993). This led to the 
suggestion that GLUT4 localisation in regions close to the PM, as well as GLUT4 content, is 
important in the training-mediated increase in insulin stimulated glucose uptake (Ivy, 2004).  
Two recent publications from our laboratory have shown that ET and sprint interval training 
(SIT, an extreme form of HIT involving 4-6 repeated 30 sec Wingate sprints) lead to similar 
magnitude increases in whole body insulin sensitivity, skeletal muscle mitochondrial content 
and skeletal muscle microvascular density and eNOS content (Shepherd et al., 2013, Cocks et 
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al., 2013). These observations support contributions of mechanism 1, 3 and 4 (introduced 
above) to the improved glucose homeostasis that is seen after training. In the current study we 
aimed to measure GLUT4 total protein content and subcellular distribution in muscle samples 
taken previously (studies published by Shepherd et al. (2013) and Cocks et al. (2013)) using 
the confocal immunofluorescence microscopy method developed in chapter 2 of this thesis to 
further investigate the contribution of GLUT4 total protein content (mechanism 2) to the 
improvements in glucose homeostasis after training. The immunofluorescence microscopy 
method was used to confirm the increase in total GLUT4 protein content observed previously 
in the literature and to further investigate whether any changes in GLUT4 subcellular 
distribution occur that may improve glucose homeostasis following training. In particular the 
immunofluorescence microscopy method was used to assess whether there are increases in 
colocalisation of GLUT4 and the PM marker dystrophin in the basal state or increases in the 
amount of the large and smaller intracellular GLUT4 clusters that would increase the amount 




Ethics, recruitment and informed consent. Sixteen sedentary, but otherwise healthy men 
(mean ± SEM, age 21 ± 1 y, BMI 23.7 ± 0.8 kg.m
-2





gave written informed consent before being randomly divided into two age-, BMI- and 
VO2max-matched groups to complete 6 weeks of either ET or SIT. Ethical approval was 
granted for the study by the Black Country Research Ethics Committee and all procedures 
conformed to the Helsinki declaration. 
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Training and testing. All procedures for pre- and post-training experiments and training 
interventions have been previously reported (Cocks et al., 2012, Shepherd et al., 2012). 
Briefly, all participants underwent a fasting muscle biopsy and a 2 h oral glucose tolerance 
test prior to and following 6 weeks of training. All post-training experiments were performed 
at least 48 h following the last training bout. On a separate day, participants performed an 
incremental exercise test to exhaustion on an electronically braked cycle ergometer to 
determine their VO2max as an indicator of fitness and to set the exercise intensity during 
training sessions. ET consisted of 5 sessions per week of cycling on an electronically braked 
cycle ergometer at 65 % of VO2 max, with session duration increasing from 40 min to 60 min 
over the 6 week training period. SIT subjects completed 3 sessions per week each consisting 
of 4-6 Wingate tests (increasing over the 6 week training period). Each Wingate required a 30 
s ‘all out’ sprint against a resistance of 0.075 kg/kg body mass followed by 4.5 min low 
intensity cycling on an electronically braked cycle ergometer. 
Sample collection, preparation and storage. Full details of skeletal muscle biopsy and blood 
sample collection, processing and storage are provided in chapter 2. Skeletal muscle biopsy 
samples were processed for immunofluorescence staining and Western blotting; both are 
described in chapter 2. 
Immunofluorescence staining protocol. The GLUT4 immunofluorescence staining protocol is 
described in full in chapter 2. In brief, muscle sections were fixed for 5 min in 75 % acetone 
25 % ethanol and subsequently washed 3 times for 5 min in PBS. GLUT4 antibody (Abcam, 
UK) was applied to the sections at a dilution of 1:200 in 5 % normal goat serum (NGS, 
Invitrogen, UK) for 2 h at room temperature. GLUT4 primary antibody was combined with 
dystrophin (1:400, Sigma Aldrich, UK) and myosin heavy chain (MHCI; 1:100, developed by 
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Dr. Blau, DSHB, USA) antibodies. Following primary antibody incubation sections were 
washed 3 times for 5 min in PBS. Secondary antibodies were applied to sections for 30 min at 
room temperature at a dilution of 1:200 in PBS. GLUT4 antibody was targeted with goat anti-
rabbit IgG 488 (Invitrogen, UK), dystrophin with goat anti-mouse IgG2b 633 (Invitrogen, UK) 
and MHCI with goat anti-mouse IgM 594 (Invitrogen, UK). After secondary antibody 
incubation sections were washed 3 times for 5 min in PBS and coverslips were mounted with 
20 µl mowiol. 
Image capture. Confocal image capture was completed using an inverted confocal microscope 
(Leica DMIRE2, Leica Microsystems) with a 63x oil immersion objective (1.4 NA). 
AlexaFluor 488 fluorophores were excited with a 488 nm line of the argon laser and 498-571 
nm emission. Alexa Fluor 594 fluorophores were excited with the 594 nm line of the helium-
neon laser and 601-713 nm emission. Alexa Fluor 633 fluorophores were excited with the 633 
nm line of the helium-neon laser and 639-734 nm emission. 
Image quantitation. For each subject, 3 slide replicates, each with a pre-training and a post-
training section, were stained, imaged and quantified. At least 5 type I fibre images and 5 type 
II fibre images were captured per section, therefore for each subject at least 30 images (15 
type I fibres and 15 type II fibres) were analysed for both pre and post training. All image 
processing and quantitation was carried out in ImagePro Plus 5.1 and was kept consistent 
between images. GLUT4 fluorescence intensity was quantified by measuring the signal 
intensity within the intracellular regions of a mask created by the dystrophin stain in a fibre 
type specific manner as determined from the MHCI stain. No image processing was carried 
out prior to intensity analysis. Intracellular spot number and staining area per fibre was 
quantified by setting uniform threshold intensity and size values to identify spots within 
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intracellular regions of the dystrophin mask in a fibre type specific manner. In rodent muscle 
large GLUT4 stores which were stationary were greater than 1 µm in size. The small, mobile 
stores in rodent muscle were reported as < 1 µm in size (Lauritzen et al., 2008). Large and 
small spots in this paper were determined by limiting the threshold size values, whereby spots 
> 1 µm in diameter were classed as large spots and spots < 1 µm in diameter were classified 
as small spots. The mean size of spots was calculated by dividing the total area of spot 
staining by the number of spots per fibre. An ImagePro Plus no neighbour deconvolution 
algorithm and a HiGauss filter were applied to GLUT4 images prior to spot detection. 
Colocalisation in GLUT4 and dystrophin image pairs, to estimate GLUT4 PM content, was 
determined using the colocalisation tool in ImagePro Plus 5.1, to calculate the Pearson’s 
correlation coefficient. Prior to colocalisation all images underwent an ImagePro Plus 5.1 no 
neighbour deconvolution algorithm as a filter. 
Western blotting for GLUT4 content. Equal total protein quantities (60 µg) of all ET and SIT 
samples were separated by electrophoresis on 12 % polyacrylamide gels in 1x 
Tris/Glycine/SDS buffer (National Diagnostics, USA) for 20 min at 80 V and 2 hr at 120 V. 
Proteins were then transferred to nitrocellulose membrane using Invitrogen iblot apparatus 
(Invitrogen, UK) and Invitrogen iblot gel transfer stacks (Invitrogen, UK). Following transfer 
membranes were washed briefly in phosphate buffered saline (PBS, tablets, Merck Millipore, 
Germany) with 0.1 % tween-20 (Sigma Aldrich, UK) and bands were visualised with Ponceau 
S to confirm successful transfer. Ponceau S staining was removed with 3 washes for 2 min in 
PBST. Membranes were blocked for 1 h in 5 % milk (dried skimmed milk, Marvel) and 
incubated overnight at 4
o
C on a shaker in 1: 2000 GLUT4 primary antibody in 5 % milk. 
Following incubation membranes were washed 4 times for 15 min in PBST and incubated in 
1:15000 goat anti-rabbit IgG HRP secondary antibody (DAKO, Denmark) in 5 % milk at 
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room temperature for 1 h. Membranes were again washed 4 times for 15 min in PBST and 
were incubated for 5 min in ECL substrate (GE Healthcare, UK)) prior to exposure of 
membrane to film (Kodak, UK). Film was developed using a Xograph Imaging Systems 
Compact X4. To carry out protein loading control, membrane was washed 4 times for 15 min 
in PBST and incubated for 1 h in 1:2000 GAPDH (Cell Signalling, USA) antibody in 5 % 
milk. Following washing, membranes were incubated in 1:15000 goat anti-rabbit IgG HRP 
secondary antibody in 5 % milk for 1 h and after incubation were washed for the final time. 
Membranes were incubated in ECL for 5 min, exposed to film and developed as before. 
Imaging of blots was performed using a BIORAD GS-800 calibrated densitometer with 
QuantityOne 4.5.1 software (BIORAD) and band quantitation, normalised to a pooled 
standard and GAPDH, was carried out using ImagePro Plus 5.1. 
Statistical analyses. Statistical analysis was carried out using PASW Statistics 18.0. Age-, 
BMI- and VO2max-matched groups were confirmed using independent t-tests. Training effects 
were investigated using a repeated measures ANOVA with training and exercise mode as 
within and between group factors and post hoc Bonferroni pairwise comparisons. Graphical 
data show mean ± SEM. 
 
3.4. Results 
Participant characteristics. Participant characteristics are displayed in table 3.1. Participants 
were insulin sensitive before the start of training. The full description of training adaptations 
including insulin sensitivity improvements has been previously reported (Cocks et al., 2012, 
Shepherd et al., 2012) with the same insulin sensitivity data as displayed in this chapter. 
Insulin sensitivity, measured using the Matsuda insulin sensitivity index (Matsuda-ISI), and 
VO2max improved following 6 weeks of both ET and SIT (see table 3.1). 
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Table 3.1 Participant characteristics before and after training    
 
ET 
N = 8 
SIT 
N = 8 
 Pre Post Pre Post 
Age (y) 21 ± 1 - 22 ± 1 - 
Height (m) 1.77 ± 0.03 1.77 ± 0.03 1.74 ± 0.02 1.74 ± 0.02 
Body mass (kg) 70.8 ± 4.4 70.8 ± 4.5 75.1 ± 3.0 75.2 ± 3.1 
BMI (kg.m
-2









253.8 ± 16.0* 
221.1 ± 
11.4 
241.5 ± 14.3* 
Fasting plasma glucose (mmol.L
-1
) 5.6 ± 0.4 4.8 ± 0.6 4.9 ± 0.2 5.1 ± 0.2 




7.0 ± 0.6 6.1 ± 0.3 6.3 ± 0.5 5.6 ± 0.4 
Fasting plasma insulin (µIU.ml
-1
) 12.3 ± 3.0 13.2 ± 3.2 13.1 ± 2.1 7.2 ± 0.5 
HOMA-IR 3.1 ± 0.7 2.7 ± 0.6 2.9 ± 0.5 1.6 ± 0.1 
Matsuda-ISI 3.7 ± 0.5 4.7 ± 0.7* 3.9 ± 0.3 5.8 ± 0.4* 
Data displayed are mean ± SEM. Statistical significance was determined using a repeated 
measures ANOVA with post hoc Bonferroni analysis, pre- to post- training * P < 0.001. 
Immunofluorescence visualisation of baseline GLUT4 localisation in human skeletal muscle. 
GLUT4 staining in human skeletal muscle appears as large clusters of staining (> 1 µm) with 
smaller spots dispersed throughout the cell interior as can be seen in Fig. 3.1. GLUT4 clusters 





Fig. 3.1. Representative confocal immunofluorescence images of type I and type II human 
skeletal muscle fibres in the basal state before and after ET. The images obtained after SIT 
look very similar and therefore are not shown. GLUT4 immunofluorescence staining is in 
green, staining for MHC1 to mark type I fibres is in red and staining for dystrophin to mark 
the PM is in blue. Scale bars 20 µm. 
 
Immunofluorescence visualisation of GLUT4 content and localisation following exercise 
training. Representative confocal immunofluorescence images in Fig. 3.1 show increased 
GLUT4 staining in both type I and type II muscle fibres following 6 weeks of training. 
GLUT4 fluorescence intensity increased with training (P = 0.018) with no significant 
difference between the magnitude of increase observed with each training type or between 
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type I and type II fibres (Fig. 3.2). In type I fibres GLUT4 fluorescence intensity increased by 
15 ± 6 % following ET and 14 ± 5 % following SIT. In type II fibres GLUT4 fluorescence 
intensity increased by 16 ± 6 % following ET and 16 ± 5 % following SIT. These increases 
were confirmed using Western blotting which detected a 30 ± 12 % increase in GLUT4 






Fig. 3.2. Total GLUT4 fluorescence intensity of type I and type II muscle fibres in the basal 
state before and after ET or SIT. Graph shows mean ± SEM relative to type I fibres pre 
training (n=8 per group). Repeated measures ANOVA training effect P = 0.018, training type 





Fig. 3.3. Representative Western blots of two ET and two SIT subjects showing skeletal 
muscle GLUT4 content before and after ET or SIT (A). B) GLUT4 content normalised to 
GAPDH and internal standard. Graph shows mean ± SEM relative to pre training (n=8 per 
group). Repeated measures ANOVA training effect P = 0.05, training type P = 0.626, 
interaction P = 0.43. * P < 0.05. C) and D) Individual responses in GLUT4 skeletal muscle 
content normalised to GAPDH and internal standard after ET and SIT, respectively. 
 
Training-induced increases in intracellular GLUT4 stores. GLUT4 immunofluorescence 
staining generates large bright clusters of GLUT4 staining as well as smaller stores which are 
dispersed throughout the cell interior (Fig. 3.1) and appear as a diffuse background stain in 
lower magnification images. Total (large plus small) intracellular spot number increased (P = 
0.03) following ET (25 ± 9 % in type I fibres and 26 ± 13 % in type II fibres) and SIT (36 ± 
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16 % in type I fibres and 48 ± 16 % in type II fibres). As a result of the increase in number of 
spots, total intracellular GLUT4 spot area per fibre increased (P = 0.025) following ET (70 ± 
30 % in type I fibres and 61 ± 26 % in type II fibres) and SIT (82 ± 34 % in type I fibres and 
100 ± 33 % in type II fibres). Furthermore these intracellular spots can be quantified in 
subcategories of large and smaller spots by setting threshold limits on the spot sizes detected 
(> 1 µm diameter or < 1 µm diameter, as in Lauritzen et al. (2008)) (Lauritzen et al., 2008). 
Large intracellular spot number increased (P = 0.002) following ET (24 ± 15 % in type I 
fibres and 32 ± 6 % in type II fibres) and SIT (46 ± 12 % in type I fibres and 46 ± 13 % in 
type II fibres) (Fig. 3.4A). The total area covered by large intracellular spots per fibre also 
increased (P = 0.001) following ET (44 ± 15 % in type I fibres and 40 ± 8 % in type II fibres) 
and SIT (76 ± 18 % in type I fibres and 72 ± 19 % in type II fibres) (Fig. 3.4B). Mean 
individual large spot size in each fibre type increased (P = 0.011) following ET (10 ± 3 % in 
type I fibres and 4 ± 5 % in type II fibres) and SIT (21 ± 88 % in type I fibres and 17 ± 6 % in 
type II fibres) (Fig. 3.6A). There was no change in the number of small intracellular spots 
following ET or SIT (Fig. 3.5A). However the total area covered by small intracellular spots 
per fibre increased (P = 0.009) following ET (19 ± 7 % in type I fibres and 17 ± 9 % in type 
II fibres) and SIT (38 ± 12 % in type I fibres and 39 ± 12 % in type II fibres) (Fig. 3.5B), 
suggesting increased individual small spot size. Indeed, mean individual size of small spots 
increased (P = 0.028) following ET (17 ± 8 % in type I fibres and 18 ± 8 % in type II fibres) 
and SIT (36 ± 11 % in type I fibres and 31 ± 11 % in type II fibres) (Fig.3.6B). The response 
to training of large and small GLUT4 spot number, area and size was the same for ET and SIT 




Fig. 3.4. Quantitation of large spots of GLUT4 staining in type I and type II fibres in the basal 
state before and after ET or SIT. A) Number of large clusters per fibre area. Repeated 
measures ANOVA training effect P = 0.002, training type P = 0.35, fibre type 0.054. B) Area 
of large clusters per fibre area. Repeated measures ANOVA training effect P = 0.001, 
training type 0.241, fibre type 0.084. * P < 0.01. Graphs show mean ± SEM relative to pre 




Fig. 3.5. Quantitation of smaller spots of GLUT4 staining in type I and type II fibres in the 
basal state before and after ET or SIT. A) Number of spots per fibre area. Repeated measures 
ANOVA training P = 0.230, training type P = 0.858, fibre type P = 0.834. B) Area of spots 
per fibre area. Repeated measures ANOVA training effect P = 0.009, training type P = 0.438, 
fibre type P = 0.283. Graphs show mean ± SEM relative to pre training in type I fibres (n=8 




Fig. 3.6. Quantitation of size of large (A) and smaller (B) spots of GLUT4 staining in type I 
and type II fibres in the basal state before and after ET or SIT. Large spots repeated measures 
ANOVA training effect P = 0.011, training type 0.245, fibre type 0.587. # P < 0.05. Small 
spots repeated measures ANOVA training P = 0.002, training type P = 0.053, fibre type P = 
0.082. Graphs show mean ± SEM (n=7). * P < 0.01.Graphs show mean ± SEM relative to pre 
training in type I fibres (n=8).  
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Quantitation of baseline PM GLUT4 content. Colocalisation of GLUT4 with the PM marker 
dystrophin can be quantified using the Pearson’s correlation coefficient. This has been used as 
an estimate of baseline GLUT4 PM content. There was no significant change in baseline 
GLUT4 PM content following training (P = 0.075); before ET r = 0.33 ± 0.01 while after ET 
r = 0.38 ± 0.00, in comparison to before SIT r = 0.33 ± 0.02, while after SIT r = 0.33 ± 0.01 




This study has demonstrated the immunofluorescence method developed in chapter 2 of this 
thesis is able to detect the well-established increase in total muscle GLUT4 protein content 
that occurs following training. Furthermore use of the immunofluorescence method has 
extended current knowledge by demonstrating the increase in total GLUT4 protein content is 
primarily due to an increase in number and area of intracellular clusters of GLUT4 staining, in 
particular large GLUT4 clusters increased in number while small clusters increased in size. 
No evidence was found to support the presence of increased GLUT4 content of the PM in the 
basal state.  
Total GLUT4 protein content following ET and SIT. Six weeks of SIT and ET in the present 
study induced similar increases in the total protein content of GLUT4 in comparison to 
previous studies (Burgomaster et al., 2007, Little et al., 2010).  The application of the 
immunofluorescence microscopy method in the current study also confirms the increase in 
GLUT4 protein expression and extends these findings by demonstrating that both modes of 
exercise increase GLUT4 expression in both type I and type II fibres. No fibre type 
differences in GLUT4 content were detected pre-training or following ET and SIT and 
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GLUT4 content increased in type I and type II fibres to the same extent following both ET 
and SIT. There is disparity in the current literature with some studies reporting higher GLUT4 
content in type I fibres (Daugaard et al., 2000, Houmard et al., 1991, Houmard et al., 1993, 
Gaster et al., 2000), some finding no relationship between GLUT4 content and fibre type 
(Hardin et al., 1995, Andersen et al., 1993, Hughes et al., 1993) and one other observing 
higher GLUT4 content in type II fibres (Borghouts et al., 2000). In support of the current data 
Shepherd et al. (2013) showed increases in mitochondrial content in type I and type II fibres 
following both ET and SIT (Shepherd et al., 2013). Taken together these data suggest that 
PGC1α-regulated training adaptations (Ojuka et al., 2012), such as increases in GLUT4 and 
mitochondrial content (Shepherd et al., 2013), occur in response to both types of training in 
both type I and type II fibres. In summary, regardless of the discrepancy in the literature 
surrounding fibre-type specific increases, it is clear that both ET and SIT induce increases in 
total muscle GLUT4 protein content which can be assessed using the immunofluorescence 
microscopy method developed in chapter 2 of this thesis and likely contributes to training-
induced increases in insulin mediated leg glucose uptake (Dela et al., 1996, Frosig et al., 
2007, Dela et al., 1995, Dela et al., 1992). 
GLUT4 storage structures in human skeletal muscle and their response to training. This study 
extends current knowledge on the training-induced increase in GLUT4 protein content in 
human skeletal muscle by demonstrating that the increase is primarily due to an increase in 
number and area of intracellular clusters of GLUT4 staining. Large clusters (> 1 µm diameter) 
increased predominantly in number, while the smaller clusters (< 1 µm diameter) increased in 
size, with no increases in number. The large GLUT4 stores visualised here in human skeletal 
muscle are likely to be TGN-associated stores, as large stores (> 1 µm) have been identified 
as such in rodent skeletal muscle (Rodnick et al., 1992, Ploug et al., 1998). Studies in 
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adipocytes report endosomal stores as approximately 150 - 200 nm and GSVs as 50 - 80 nm 
(Bogan, 2012, Bogan and Kandror, 2010, Larance et al., 2008, Stockli et al., 2011), while 
based on EM images endosomes appear to be in a similar range in rodent skeletal muscle 
(Ploug et al., 1998) and GSVs have been reported as 40 nm (Lizunov et al., 2012). Therefore 
due to the resolution of confocal miscroscopy (~ 200 nm) the small stores detected here in 
human skeletal muscle could be endosomal membrane stores or GSVs, either individually or 
in clusters of smaller vesicles (Stockli et al., 2011). It may confer an insulin-sensitivity 
advantage to have more TGN GLUT4 storage, as shown in this study, following training as 
this would increase the capacity for GSV budding at the TGN upon insulin stimulation 
(Bogan, 2012, Bogan and Kandror, 2010, Larance et al., 2008). The size of small GLUT4 
stores also increases. If the small stores visualised here in human skeletal muscle are 
endosomal this will increase the capacity for GSV biogenesis at endosomal membranes 
(Bogan, 2012, Bogan and Kandror, 2010, Larance et al., 2008). If the small stores are visible 
clusters of GSVs, this will increase the capacity for GLUT4 docking and fusion at the PM 
(Foley et al., 2011). Co-staining with TGN, endosomal and GSV markers such as TGN38, 
transferrin receptor (TfR) and vesicle-associated membrane protein (VAMP) 2, respectively, 
will be required to generate harder evidence on the identity of the GLUT4 storage 
compartments observed here in human skeletal muscle. In summary, assuming that the 
increase in number of large and area of small intracellular GLUT4 storage also increases 
GLUT4 available for translocation, this will augment the capacity to increase GLUT4 at the 
surface membranes in response to insulin, thereby increasing the total capacity for glucose 
uptake and contributing to the well described improvements in glucose homeostasis with both 
ET and SIT (Hughes et al., 1993, Dela et al., 1996, Cox et al., 1999, Babraj et al., 2009, 
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Richards et al., 2010, Houmard et al., 1991, Phillips et al., 1996, Daugaard et al., 2000, 
Burgomaster et al., 2007, Hood et al., 2011, Little et al., 2010).  
Peripheral GLUT4 localisation. In this study there was substantial colocalisation of GLUT4 
with the PM marker dystrophin, indicating GLUT4 localisation close to the PM in the basal 
unstimulated state. However, due to the limits of confocal fluorescence microscopy, it is not 
possible to differentiate between cytosolic GLUT4 that is immediately adjacent to the PM or 
in vesicles pre-tethered at the PM (see next paragraph) and GLUT4 that is fully incorporated 
into the PM (Marette et al., 1992). Authoritative reviews on adipose cells conclude that 
GLUT4 is excluded from the PM in the basal state (Bogan, 2012, Bogan and Kandror, 2010, 
Larance et al., 2008, Stockli et al., 2011, Foley et al., 2011). Furthermore EM studies in 
rodent skeletal muscle report very little GLUT4 in the PM in the basal state (Ploug et al., 
1998, Rodnick et al., 1992). The observed heterogeneous pattern of colocalisation of GLUT4 
and dystrophin in the basal state is in line with data in rodent skeletal muscle showing that 
large clusters remain stationary at sarcolemmal regions following insulin stimulation 
(Lauritzen et al., 2008). Lauritzen et al. (2008) suggested that these stationary vesicles release 
small GLUT4 vesicles (probably GSVs) which then translocate to and fuse with the PM 
(Lauritzen et al., 2008). Furthermore, recently Lizunov et al. (2012) using TIRF microscopy 
in live mouse muscle fibres generated evidence that there are stationary vesicles which are 
pre-tethered at the PM and that 80 % of the total number of GLUT4-PM fusion events 
actually emanated from these pre-tethered vesicles (Lizunov et al., 2012). Considering the 
stationary nature of the majority of GLUT4 stores (Lauritzen et al., 2008, Lizunov et al., 
2012), it may confer an insulin-sensitivity advantage to have more of these stores in close 
proximity to the PM following training. In the current study GLUT4 colocalisation with the 
PM marker dystrophin in the basal state did not change following training suggesting that 
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training does not increase the amount of GLUT4 located close to the PM. However future 
work should investigate this further and specifically assess the number and area of GLUT4 
stores in close proximity to the PM in human skeletal muscle both before and after training to 
determine whether training increases the number and area of stores located close to the PM in 
particular.  
Conclusions. This study has employed the immunofluorescence method developed in chapter 
2 to visualise the subcellular distribution and content of GLUT4 following ET and SIT. The 
results show that comparable increases in total skeletal muscle GLUT4 content occur 
following the two training modes primarily through increases in the number of large GLUT4 
clusters (> 1 µm; including TGN stores) and increases in size of the smaller GLUT4 clusters 
(< 1 µm; including endosomal membranes and clusters of GSVs). There were no differences 
between increases seen in type I and type II fibres, and there was no significant increase in the 
degree of colocalistion of GLUT4 with the PM marker dystrophin in the basal state following 
the two training modes. The increases in whole body insulin sensitivity observed following 
the two training modes (Table 3.1) and the training induced increases in insulin-stimulated leg 
glucose uptake in humans observed previously (Dela et al., 1996, Frosig et al., 2007, Dela et 
al., 1995, Dela et al., 1992) are therefore likely to be in part driven by increases in the number 
and size of intracellular GLUT4 storage compartments that are assumed to be the main 
sources for the biogenesis of GSVs and GLUT4 available for translocation.  
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Insulin- and contraction-stimulated increases in glucose uptake into skeletal muscle occur at 
least in part as a result of the translocation of glucose transporter 4 (GLUT4) storage vesicles 
(GSVs) to and subsequent fusion of the GSVs with the plasma membrane (PM). This study 
aimed to use the immunofluorescence microscopy method developed in chapter 2 of this 
thesis to visualise and quantify increases in colocalisation of GLUT4 with the PM in response 
to glucose feeding, exercise and a combination of glucose feeding and exercise. Percutaneous 
muscle biopsy samples were taken from ten insulin sensitive males (age 21 ± 1 yrs, BMI 23.1 
± 0.4 kg.m
-2




) in the basal state and 90 min following 
ingestion of 75 g glucose, immediately following 30 min cycling exercise (65 % VO2max) and 
90 min following glucose feeding with 30 min exercise completed between 60 – 90 min. 
Subsequently muscle biopsy samples were taken from a second cohort of ten insulin sensitive 
males (25 ± 2 y, BMI 22.6 ± 0.5 kg.m
-2




) in the basal state 
and 30 min and 60 min following glucose feeding. Colocalisation of GLUT4 with the PM 
marker dystrophin was measured with the Pearson’s correlation coefficient. Thirty minutes of 
cycling exercise resulted in a continuous GLUT4 signal at the PM and increased GLUT4 and 
dystrophin colocalisation (baseline r = 0.47 ± 0.01; post exercise r = 0.58 ± 0.02; P < 0.001). 
GLUT4 and dystrophin colocalisation increased 30 min after glucose ingestion (baseline r = 
0.42 ± 0.02; 30 min r = 0.46 ± 0.02; P < 0.05) but not at 60 min (baseline r = 0.42 ± 0.02; 60 
min r = 0.44 ± 0.02) or at 90 min (baseline r = 0.47 ± 0.01; 90 min r = 0.46 ± 0.01). Glucose 
ingestion 60 min prior to cycling exercise had no further effect on post-exercise GLUT4 and 
dystrophin colocalisation (baseline r = 0.47 ± 0.01; post glucose ingestion and exercise r = 
0.57 ± 0.02; P < 0.001). This study has successfully used the immunofluorescence 
microscopy method developed in chapter 2 to quantify increases in GLUT4 and dystrophin 
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colocalisation as evidence of net GLUT4 translocation to the PM in response to glucose 
ingestion and exercise. Furthermore, this study demonstrates that the increase in GLUT4 and 
dystrophin colocalisation in response to glucose ingestion is transient, occurring only at 30 
min following glucose ingestion, and appeared smaller than seen immediately following 30 
min endurance exercise. 
 
4.2. Introduction 
Insulin and contraction are potent physiological stimulators of glucose uptake into skeletal 
muscle. Skeletal muscle is the primary site of postprandial glucose uptake (Katz et al., 1983, 
Ferrannini et al., 1985, Wasserman et al., 2011) and plasma glucose contributes significantly 
to ATP production in the working skeletal muscle during endurance exercise (Katz et al., 
1991, Kjaer et al., 1991, van Loon et al., 2001). Glucose is taken up into the muscle cell via 
facilitated transport through glucose transporter proteins in the plasma membrane (PM) and 
T-tubule membranes (Bell et al., 1993). Glucose transporter 4 (GLUT4) translocates to the 
muscle cell PM in response to insulin and contraction and is the major glucose transporter 
isoform expressed in skeletal muscle (Mueckler, 1994, Gaster et al., 2000). Global or muscle-
specific GLUT4 knockout in mice resulted in reduced basal muscle glucose uptake and 
reduced insulin and contraction stimulated muscle glucose uptake in vitro, demonstrating the 
vital role of GLUT4 in glucose uptake into muscle cells (Ryder et al., 1999a, Ryder et al., 
1999b, Zisman et al., 2000).  
Leg glucose uptake increased 3-fold during the 4 h period following glucose feeding (Katz et 
al., 1983), approximately 5-fold during a hyperinsulinaemic-euglycaemic clamp (DeFronzo et 
al., 1985) and approximately 15-fold during cycling exercise at 50-60% VO2 max (Katz et al., 
1986, Martin et al., 1995). Previous studies aiming to investigate GLUT4 translocation to the 
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muscle cell PM in humans in response to increases in plasma insulin concentrations or cycling 
exercise have used density gradient centrifugation methods with the aim to isolate pure PM 
fractions of vastus lateralis muscle biopsies and measure their GLUT4 content with Western 
blots. In insulin sensitive individuals, these studies have demonstrated increases in GLUT4 
PM content of vastus lateralis of 27% 1 h following ingestion of 75 g of glucose (Goodyear et 
al., 1996) and of 60%, 30 - 40 min after the start of a hyperinsulinaemic-euglycaemic clamp 
(Guma et al., 1995). Furthermore, cycling exercise at 60 - 70% VO2max for 45 - 60 min 
resulted in 70% increases in GLUT4 content in the vastus lateralis PM fraction (Kennedy et 
al., 1999). Kristiansen et al. (1997) prepared PM giant vesicles from vastus lateralis muscle 
biopsies obtained from healthy men at rest and during cycling exercise at 75% VO2max and 
observed increases in GLUT4 content of 38% and 93% after 5 min and 40 min of exercise, 
respectively (Kristiansen et al., 1997). Subcellular membrane fractionation studies suggested 
that the effects of insulin and cycling exercise on GLUT4 translocation are additive in human 
vastus lateralis (Thorell et al., 1999). 
A series of detailed immunofluorescence and electron microscopy studies in rat and mouse 
skeletal muscle suggest that GLUT4 is present predominantly at the fibre periphery and in 
perinuclear regions in the basal state and appears as large and small GLUT4 storage clusters 
which are likely pretethered at the PM and T tubule membranes (Ploug et al., 1998, Lauritzen 
et al., 2006, Lauritzen et al., 2008, Lizunov et al., 2012). GLUT4 storage depots have been 
characterised as the membranes of the trans-Golgi network (TGN), endosomal membranes 
and GLUT4 storage vesicles (GSVs) (Rodnick et al., 1992, Ploug et al., 1998, Lizunov et al., 
2012). Furthermore studies in transgenic mouse muscle fibres using labelling of exofacially 
tagged GLUT4 demonstrate GLUT4 fusion with the PM in the basal state; with one study 
describing a small amount of exofacially-tagged GLUT4 labelling in the basal state (Lizunov 
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et al., 2012) and another reporting a more substantial amount with externalised myc labelling 
under basal conditions approximately 50 % of that after insulin stimulation (Schertzer et al., 
2009). A representation of the spatial distribution of intracellular GLUT4 stores is presented 
in Fig. 1.1 in chapter 1 of this thesis. 
Insulin injection and electrical muscle stimulation led to a redistribution of GLUT4 from 
intracellular clusters to the PM and T-tubule membranes in immunofluorescence microscopy 
studies in rodent muscle (Ploug et al., 1998) and in in vivo studies of rodent muscle transiently 
transfected with GFP-tagged GLUT4 (Lauritzen et al., 2006, Lauritzen et al., 2010). Immuno-
gold particle electron microscopy studies have demonstrated that the effects of insulin and 
contraction on GLUT4 redistribution to the PM and T-tubule membranes are additive in rat 
skeletal muscle with 14-fold increases in immunogold particle density in the PM, in 
comparison to 7-fold and 9-fold increases following insulin and exercise alone, respectively 
(Ploug et al., 1998).   
Once GSVs have translocated to and tethered at the PM, docking and fusion of GSVs with the 
PM is a critical step to permit glucose uptake via GLUT4. This process requires soluble N-
ethylmaleimide-sensitive factor attachment protein receptors (SNARES). Cognate vesicle (v)- 
and target (t)-SNARES must form a SNARE complex to bring the vesicle and target 
membranes into close proximity for fusion to occur (Chen and Scheller, 2001). GSVs have 
been shown to contain the v-SNARE VAMP2, which interacts with the t-SNARES syntaxin 4 
and SNAP23 at the PM (Bryant et al., 2002). This interaction has been shown to be vital for 
insulin-stimulated GLUT4 translocation (Kawanishi et al., 2000) and is likely to be the same 
for contraction stimulated GLUT4 translocation as VAMP2 has been shown to translocate to 
cell surface membranes, where the t-SNARES are already located, in response to contraction 
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(Rose et al., 2009). There is however also evidence that VAMP3 may be the v-SNARE 
responsible for contraction stimulated GLUT4 translocation (Schwenk et al., 2010). 
 In chapter 2 of this thesis a confocal immunofluorescence microscopy method for assessment 
of GLUT4 localisation in cross-sections and longitudinal sections of human skeletal muscle 
was developed to avoid the methodological flaws inherent in existing techniques (as described 
in chapter 1). The overarching aim of the current study was to visualise and characterise the 
translocation of GLUT4 in human skeletal muscle in response to physiological stimuli known 
to elevate rates of muscle glucose uptake using this newly developed technique. We 
specifically investigated changes in the colocalisation of GLUT4 with the PM marker 
dystrophin 30, 60 and 90 min following oral glucose ingestion to elevate insulin to 
physiological levels, in response to 30 min cycling exercise at 65% VO2max and following a 
combination of glucose ingestion and exercise. It was hypothesized that GLUT4 and 
dystrophin colocalisation will increase in response to both glucose ingestion and exercise, and 
that the effects of these interventions will be additive.  
 
4.3. Methods 
The data presented in this chapter were obtained from two separate participant cohorts and 
sets of experiments, which will be termed experiment 1 and experiment 2. 
Ethics, recruitment and informed consent. Ethical approval was granted by Birmingham East, 
North and Solihull and West Midlands Black Country NHS Research Ethics Committees, for 
experiment 1 and experiment 2, respectively. Ten healthy, lean, recreationally active men 
were recruited for each experiment (experiment 1 age 21 ± 1 y, BMI 23.1 ± 0.4 kg.m
-2
, 













) and written informed consent was obtained prior to their 
participation in the study. 
Study protocol. All participants performed an incremental exercise test to exhaustion on an 
electronically braked cycle ergometer (Lode BV, Groningen, The Netherlands) to determine 
their maximal aerobic capacity (VO2max) using an on-line respiratory gas collection system 
(Oxycon Pro, Jaeger, Germany). Workload began at 95 W and increased by 35 W every 3 min 
until volitional fatigue.  
Experiment 1. Following the incremental exercise test, there were three subsequent visits, 
which took place in a randomised order at least 1 week apart.  Participants were asked to 
refrain from strenuous physical activity for 48 hr prior to each visit. For all visits participants 
arrived at the laboratory at 7 am following an overnight fast. A blood sample was drawn from 
a forearm vein and a percutaneous needle biopsy sample (Bergstrom, 1975) was taken from 
the m. vastus lateralis under local anaesthesia (1 % lidocaine). To investigate insulin-
stimulated GLUT4 translocation, 75 g glucose was ingested as a 25 % solution and a second 
needle biopsy was taken 90 min after glucose ingestion. Blood samples were drawn 30, 60, 
75, 90 and 120 min after glucose ingestion. To investigate contraction-stimulated GLUT4 
translocation participants completed 30 min cycling exercise on an electronically braked cycle 
ergometer at a workload equivalent to 65 % VO2max and a second needle biopsy was taken 
immediately upon completion of exercise. Blood samples were taken after 15 and 30 min of 
exercise. To investigate whether glucose ingestion and exercise exert additive effects on 
GLUT4 translocation 75 g glucose was ingested as a 25 % solution and between 60 and 90 
min after glucose ingestion subjects completed 30 min of cycling exercise. A second needle 
biopsy was taken immediately at cessation of exercise. Blood samples were drawn 30, 60, 75 
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and 90 min after glucose ingestion, the final two samples being taken during exercise. The 
protocol is displayed in figure 4.1. 
Experiment 2. Following the incremental exercise test there was one subsequent visit. 
Participants were asked to refrain from strenuous physical activity for 48 hr prior to the visit 
and arrived at the laboratory at 7 am following an overnight fast. A percutaneous needle 
biopsy sample was taken from the m. vastus lateralis under local anaesthesia (1 % lidocaine) 
and a blood sample was drawn from a forearm vein. Participants then ingested 75 g glucose as 
a 25 % solution and subsequent needle biopsy samples were taken from the m. vastus lateralis 
30 min and 60 min after glucose ingestion. Blood samples were drawn 30, 60, 90 and 120 min 










Sample collection and storage. Full details of sample processing and storage are outlined in 
chapter 2. 
Plasma glucose and insulin analysis. Full details of plasma glucose and insulin analysis is 
provided in chapter 2.  
Immunofluorescence staining and microscopy. Frozen muscle biopsy samples were 
cryosectioned (Bright Instrument Company Limited, Huntingdon, England) to a thickness of 
5 µm onto uncoated glass microscope slides (VWR international, USA). For each participant 
in experiment 1, three slides were processed for GLUT4 and dystrophin and three slides for 
SNAP23 and dystrophin and on each slide was a section for all six samples. For experiment 2, 
three slides were processed for GLUT4 and dystrophin with a section for all three samples on 
each slide. Slides were either stained within 30 min of sectioning or stored at -20
o
C. 
Following storage slides were left at room temperature for 30 min prior to staining. The 
GLUT4 staining protocol is described in full in chapter 2. SNAP23 immunofluorescence 
staining followed the same protocol with SNAP23 primary antibody (Synaptic Systems, 
Germany) applied at a 1 in 50 dilution and the secondary antibody (AlexaFluor 488-
conjugated goat anti-rabbit IgG secondary antibody, Invitrogen, UK) applied at a 1 in 200 
dilution. Slides were left to dry overnight before confocal immunofluorescence visualisation. 
Confocal image capture was as described in chapter 2 using an inverted confocal microscope 
(Leica DMIRE2, Leica Microsystems) with a 63x oil immersion objective (1.4 NA).  
Immunofluorescence image analysis. Images were processed and analysed using Image-Pro 
Plus 5.1 software (Media Cybernetics, MD, USA). All image processing and analysis was 
kept consistent between images within each experiment. An average of 51 ± 2 muscle fibres 
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were analysed for each participant. See chapter 2 for a full description of the image 
processing and analysis, however in brief,  the Pearson’s correlation coefficient between two 
images was calculated using the colocalisation tool in Image-Pro Plus 5.1 to measure 
colocalisation of GLUT4 and dystrophin or SNAP23 and dystrophin. Pearson’s correlation 
coefficient has been routinely used to measure colocalisation of two proteins in 
immunofluorescence images (Lachmanovich et al., 2003, Landmann and Marbet, 2004, 
Sedarat et al., 2004, Bolte and Cordelieres, 2006, Dunn et al., 2011).  
Statistical analysis. Plasma glucose and insulin data were analysed for statistical significance 
using a repeated measures ANOVA separately for each experiment with post hoc Bonferroni 
pairwise comparisons to locate the significant differences. Pearson’s correlation coefficient 
data from immunofluorescence images for experiment 1 were analysed for statistical 
significance using paired t tests for each trial. For experiment 2 a repeated measures ANOVA 
was used to compare Pearson’s correlation coefficient at baseline and 30 min and 60 min after 
glucose ingestion, with post hoc Bonferroni pairwise comparisons used to locate the 
significant differences. The subject characteristics of the two groups were compared using 
independent T tests.  Data are displayed as mean ± SEM. Significance was set at P < 0.05. 
 
4.4. Results 
Subject characteristics. Subject characteristics are shown in table 4.1. Ten healthy, lean, 
recreationally active men were recruited separately for experiments 1 and 2. All subjects were 
insulin sensitive, according to classification of fasting plasma glucose of less than 5.6 mM 
and 2 h OGTT plasma glucose of less than 7.8 mM (Genuth et al., 2003). All subjects were in 
the normal BMI classification range of 18.5 – 25 kg.m
-2
. There were no significant differences 
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in VO2max, BMI, fasting plasma glucose, fasting plasma insulin or ISI-Matsuda between the 
cohorts for experiments 1 and 2. 
 
Table 4.1 Participant characteristics   
 Experiment 1 Experiment 2 
 
N = 10 N = 10 
Age (y) 21 ± 1 25 ± 2 
Height (m) 1.81 ± 0.02 1.83 ± 0.01 
Body mass (kg) 75.9 ± 2.4 75.3 ± 2.0 
BMI (kg.m
-2





) 52.5 ± 2.4 50.7 ± 2.2 
Wmax (W) 278 ± 15 285 ± 13 
Fasting plasma glucose (mmol.l
-1
) 5.3 ± 0.1 5.1 ± 0.2 




5.0 ± 0.3 5.4 ± 0.4 
Fasting plasma insulin (µIU.ml
-1
) 14.3 ± 1.4 12.7 ± 1.7 




31.4 ± 4.2 41.4 ± 7.3
#
 
ISI-Matsuda 3.1 ± 0.3 4.4 ± 0.6 
# Significant difference to fasting insulin concentration, P < 0.05, repeated measures 
ANOVA. 
 
Experiment 1 plasma glucose and insulin concentrations. Fig. 4.2 displays the mean glucose 
and insulin concentrations during the three trials for experiment 1. In the glucose ingestion 
only trial plasma glucose peaked at 30 min increasing significantly above baseline (baseline 
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5.3 ± 0.1 mM, 30 min 9.5 ± 0.5 mM, P < 0.001), then remained above baseline until 75 min 
(6.9 ± 0.2 mM, P < 0.001) and returned to baseline by 90 min (6.1 ± 0.3 mM, P > 0.05).  
Plasma insulin peaked at 30 min increasing significantly above baseline (baseline 14.3 ± 1.4 
µIU.mL
-1
, 30 min 97.6 ± 13.1 µIU.mL
-1
, P < 0.001), then remained above baseline until 90 
min (50.1 ± 6.2 µIU.mL
-1
, P < 0.01) and returned to baseline by 120 min (31.4 ± 4.2 µIU.mL
-
1
, P > 0.05). In the glucose ingestion and exercise trial plasma glucose peaked at 30 min 
increasing significantly above baseline (baseline 5.3 ± 0.1 mM, 30 min 9.1 ± 0.4 mM, P < 
0.01) and returned to baseline by 60 min (7.0 ± 0.4 mM, P > 0.05). After 75 min plasma 
glucose dropped below baseline (3.8 ± 0.3 mM, P < 0.01) and remained below baseline at 90 
min (4.4 ± 0.2 mM, P < 0.01). Plasma insulin peaked at 30 min increasing significantly above 
baseline (baseline 15.7 ± 1.3 µIU.mL
-1
, 30 min 90.8 ± 7.2 µIU.mL
-1
, P < 0.001), then 
remained above baseline until 60 min (67.7 ± 6.4 µIU.mL
-1
, P < 0.01) and returned to 
baseline by 75 min (23.1 ± 3.6 µIU.mL
-1
, P > 0.05). Both plasma glucose and insulin 




Fig. 4.2. Plasma glucose and insulin during OGTT, exercise and combination of glucose 
ingestion and exercise for experiment 1. Data presented are mean ± SEM. N = 10. Repeated 
measures ANOVA for OGTT and glucose ingestion and exercise glucose P < 0.001, insulin  P 
< 0.001, post hoc Bonferroni pairwise comparisons * P < 0.01 compared to baseline. 
 
Basal state GLUT4 localisation. Consistent with previous studies (Ploug et al., 1998, 
Lauritzen et al., 2006, Lauritzen et al., 2008) and as shown in chapter 2 of this thesis GLUT4 
immunofluorescence staining (Fig. 4.3A and 4.3B) is observed in large clusters, as well as 
smaller punctate structures which at a lower magnification appear as a diffuse background 
stain. The large clusters appear at the fibre periphery as well as intracellular regions. 
Immunofluorescence staining of the protein dystrophin (Fig. 4.3C) was used to mark the PM. 
Fig. 4.3D shows the colocalisation of GLUT4 and dystrophin. Perinuclear GLUT4 
distribution is also observed when stained in combination with 4,6'-diamidino-2-phenylindole 
(DAPI) (see Fig. 2.3 in chapter 2 for combined GLUT4 and DAPI staining, and Fig. 4.3B and 




Fig. 4.3. Representative confocal GLUT4 immunofluorescence of human skeletal muscle 
fibres in the basal state (A-D), 90 min post glucose ingestion (E-H), post exercise (I-L) and 
post glucose ingestion and exercise combined (M-P) from experiment 1. Images A, E, I and M 
show GLUT4 localisation in green (scale bars 50 µm). Images B, F, J and N show more 
detailed images of GLUT4 in PM regions, GLUT4 shown in green (scale bars 10 µm). Images 
C, G, K and O show the PM marker dystrophin in red (scale bars 10 µm). Merged images in 
D, H, L and P demonstrate colocalisation of GLUT4 with the PM marker dystrophin (scale 
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bars 10 µm). Open arrows indicate clusters of GLUT4 at the PM, while filled arrow heads 
indicate GLUT4 redistributed to a continuous PM signal. P indicates perinuclear GLUT4 
localisation. 
 
GLUT4 localisation 90 min after glucose ingestion and after 30 min exercise (experiment 1). 
Ninety minutes after glucose ingestion there was no apparent change in GLUT4 localisation 
(Fig.4.3E and 4.3F) with GLUT4 distributed in clusters at the PM and in intracellular regions. 
In line with the visual observations, Pearson’s correlation coefficient was unchanged 
following 90 min glucose ingestion (pre r = 0.47 ± 0.01, post r = 0.46 ± 0.01, P > 0.05, Fig 
4.4A), indicating no change in GLUT4 PM association (Fig. 4.3H). In contrast, immediately 
following 30 min of cycling exercise at 65 % of VO2max, GLUT4 staining redistributed around 
the PM (Fig. 4.3I and 4.3J). GLUT4 exhibited a continuous PM signal that demonstrated a 
clear increase in colocalisation between GLUT4 and dystrophin staining (Fig. 4.3L). 
Pearson’s correlation coefficient increased significantly from r = 0.47 ± 0.01 before exercise 
to r = 0.58 ± 0.02 after exercise (P < 0.001, Fig. 4.4B), indicating an increase in GLUT4 and 
dystrophin colocalisation and GLUT4 PM association. When glucose ingestion and exercise 
were combined, GLUT4 redistributed to a continuous PM signal (Fig. 4.3M and 4.3N) and 
increases in GLUT4 and dystrophin colocalisation (Fig. 4.3P) occurred. Similarly, following 
glucose ingestion and exercise Pearson’s correlation coefficient increased significantly from r 
= 0.47 ± 0.01 at baseline to r = 0.57 ± 0.02 after feeding and exercise (P < 0.001, Fig.4.4C), 




Fig. 4.4. Colocalisation of GLUT4 with PM marker dystrophin, measured using Pearson’s 
correlation coefficient, from experiment 1. A) Pre and post glucose ingestion, B) pre and post 
exercise and C) pre and post glucose ingestion and exercise combined. Mean ± SEM, n = 10, 




Fig. 4.5. Colocalisation of GLUT4 with PM marker dystrophin, measured using Pearson’s 
correlation coefficient, from individual participants in experiment 1. A) Pre and post glucose 
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ingestion, B) pre and post exercise and C) pre and post glucose ingestion and exercise 
combined. 
 
SNAP23 localisation 90 min after glucose ingestion and after 30 min exercise (experiment 1). 
Immunofluorescence staining of SNAP23 displays a strong PM signal which is confirmed by 
SNAP23 and dystrophin colocalisation (Fig. 4.6D, 4.5H, 4.5L and 4.5P). Pearson’s 
correlation coefficient measuring SNAP23 and dystrophin colocalisation did not change 
following glucose ingestion (pre r = 0.42 ± 0.01, post r = 0.42 ± 0.02, Fig. 4.7A), exercise 
(pre r = 0.47 ± 0.01, post r = 0.46 ± 0.02, Fig. 4.7B) or a combination of glucose ingestion 
and exercise (pre r = 0.41 ± 0.03, post r = 0.41 ± 0.04, Fig. 4.7C), indicating there are no 




Fig. 4.6. Representative confocal SNAP23 immunofluorescence images of human skeletal 
muscle fibres in the basal state (A-D), post glucose ingestion (E-H), post exercise (I-L) and 
post glucose ingestion and exercise combined (M-P) from experiment 1. Images A, E, I and M 
show SNAP23 localisation in green (scale bars 50 µm). Images B, F, J and N show more 
detailed images of SNAP23 in PM regions, SNAP23 shown in green (scale bars 10 µm). 
Images C, G, K and O show the PM marker dystrophin in red (scale bars 10 µm). Merged 
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images in D, H, L and P demonstrate colocalisation of SNAP23 with the PM marker 
dystrophin (scale bars 10 µm). 
 
 
Fig. 4.7. Colocalisation of SNAP23 with the PM marker dystrophin, measured using 
Pearson’s correlation coefficient, from experiment 1. A) Pre and post glucose ingestion, B) 
pre and post exercise and C) pre and post glucose ingestion and exercise combined. Mean ± 
SEM, N = 10. 
 
Experiment 2 plasma glucose and insulin concentrations. To further investigate the time 
course of GLUT4 translocation in response to glucose ingestion, GLUT4 and dystrophin 
colocalisation was investigated in vastus lateralis samples taken in the basal state and 30 min 
and 60 min after glucose ingestion. Fig. 4.8 displays plasma glucose and insulin 
concentrations during OGTT in experiment 2. Plasma glucose increased above baseline at 30 
min (baseline 5.1 ± 0.2 mM, 30 min 8.1 ± 0.6 mM, P < 0.05) and returned to baseline by 60 
min (6.5 ± 0.5 mM, P > 0.05). Plasma insulin peaked at 30 min increasing above baseline 
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(baseline 12.7 ± 1.7 µIU.mL
-1
, 30 min 61.3 ± 7.2 µIU.mL
-1
, P < 0.001) and remained 
increased above baseline at 120 min (41.4 ± 7.3 µIU.mL
-1
, P < 0.05).  
 
Fig. 4.8. Plasma glucose and insulin during OGTT for experiment 2. Data presented are 
mean ± SEM. N = 10. Repeated measures ANOVA glucose P < 0.001, insulin  P < 0.001, post 
hoc Bonferroni pairwise comparisons * P < 0.01, # P < 0.05 compared to baseline. 
 
GLUT4 localisation 30 min and 60 min after glucose ingestion (experiment 2). Thirty minutes 
after glucose ingestion, GLUT4 clusters localised to the PM remained clearly visible with the 
additional appearance of moderate continuous staining along the PM (Fig. 4.9E-H). Pearson’s 
correlation coefficient values to measure GLUT4 and dystrophin colocalisation increased 
significantly from baseline at 30 min post-glucose ingestion. GLUT4 and dystrophin 
colocalisation returned to baseline 60 min after glucose ingestion (pre r = 0.42 ± 0.02, 30 min 




Fig. 4.9. Representative confocal immunofluorescence images of GLUT4 immunofluorescence 
in human skeletal muscle fibres in the basal state (A,B), 30 min post glucose ingestion (E,F) 
and 60 min post glucose ingestion (I,J) from experiment 2. Images A, E and I show GLUT4 
localisation in green (scale bars 50 µm). Images B, F and J show more detailed images of 
GLUT4 in PM regions (scale bars 10 µm). Images C,G and K show the PM marker 
dystrophin in red (scale bars 10 µm). Merged images in D, H amd L demonstrate 
colocalisation of GLUT4 with the PM marker dystrophin (scale bars 10 µm). Open arrows 
indicate clusters of GLUT4 at the PM, while filled arrow heads indicate moderate continuous 




Fig. 4.10. Colocalisation of GLUT4 with the PM marker dystrophin, measured using 
Pearson’s correlation coefficient, in the basal state and 30 min and 60 min following glucose 
ingestion  from experiment 2. A) Data presented are mean ± SEM, N = 10. Repeated 
measures ANOVA P = 0.008, * post hoc Bonferroni pairwise comparisons P < 0.05 





Immunofluorescence visualisation of GLUT4 translocation following glucose ingestion and 
exercise. In the current study, the immunofluorescence microscopy method developed in 
chapter 2 of this thesis has been used successfully to detect GLUT4 translocation to the PM in 
human skeletal muscle 30 min following glucose ingestion, after 30 min of cycling exercise at 
65% VO2max and following a combination of glucose feeding and exercise. 
Cycling exercise at 60-70% VO2max has been shown to increase PM GLUT4 by 71 % in 
human vastus lateralis muscle using cellular subfractionation methods (Kennedy et al., 1999). 
In addition, just 5 min of electrical stimulation of rodent muscle induces a significant increase 
in GLUT4 PM content measured using fluorescence microscopy (Ploug et al., 1998, Lauritzen 
et al., 2010). In line with these previous observations, the immunofluorescence images 
presented in this study show marked redistribution of GLUT4 around PM regions in response 
to exercise. This can be observed by the clear appearance of a continuous GLUT4 signal 
along the cell border, which colocalised with the PM marker dystrophin following exercise 
(Fig 4.3). Furthermore, these observations are confirmed by the significant increase in 
GLUT4 and dystrophin colocalisation post-exercise.   
Furthermore, in the current study, the appearance of moderate continuous GLUT4 staining at 
the cell border was observed in skeletal muscle 30 min following glucose ingestion (Fig. 4.9) 
and was also confirmed by a significant increase in GLUT4 and dystrophin colocalisation. 
This finding was expected given that skeletal muscle accounts for the majority of insulin-
mediated glucose disposal (Katz et al., 1983, Ferrannini et al., 1985) and GLUT4 is the main 
insulin responsive GLUT isoform in skeletal muscle (Mueckler, 1994). These findings are in 
line with previous observations of increased GLUT4 content of isoloated PM fractions in 
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human vastus lateralis muscle 30-40 min following a hyperinsulinaemic-euglycaemic clamp 
(Guma et al., 1995) and the rapid translocation of GLUT4 into the PM region in rodent 
muscle following insulin injection (Lauritzen et al., 2006). However, we did not observe a 
significant increase above baseline in GLUT4 and dystrophin colocalisation either at 60 or 90 
min following glucose ingestion, contrary to the original hypothesis. This finding is in 
contrast to previous studies using subcellular fractionation techniques, which reported a 27 % 
increase in GLUT4 in the PM 60 min after ingestion of an OGTT load (Goodyear et al., 1996) 
and is somewhat surprising given previous observations that rates of glucose disposal 
(Ferrannini et al., 1985, Breen et al., 2011) and leg glucose uptake (Katz et al., 1983) are still 
elevated 90 min following glucose ingestion. 
Glucose ingestion 60 min prior to cycling exercise had no further effect on post-exercise 
GLUT4 and dystrophin colocalisation, therefore no additive effect on GLUT4 translocation 
was observed of combined glucose feeding and exercise. However while the muscle biopsy 
was sampled immediately after 30 min cycling exercise, this was 90 min after glucose 
ingestion; the time point at which no insulin-mediated GLUT4 translocation was detected.  
Interestingly and perhaps of relevance, the GLUT4 translocation measured in the current 
study following glucose ingestion appears to mirror the peak concentration of plasma insulin, 
which peaked 30 min following glucose ingestion. The results from this study suggest that 
physiological GLUT4 translocation to the PM in response to glucose ingestion is transient. 
Furthermore the GLUT4 translocation response following glucose ingestion appears to be 
modest in comparison to that following exercise. This suggestion will be discussed further in 
a subsequent paragraph.  
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Importance of peripheral GLUT4 localisation. In previous rat and mouse studies skeletal 
muscle GLUT4 was located predominantly at the fibre periphery in both the basal and 
stimulated states (Ploug et al., 1998, Lauritzen et al., 2006, Lizunov et al., 2012). The images 
presented in this study confirm that this also is the case in human skeletal muscle as GLUT4 
and dystrophin colocalisation was present in both the basal and stimulated states. Two 
previous studies using different transgenic mouse models with specific GLUT4 exofacial 
labelling techniques have visualised the incorporation of GLUT4 in the PM and both detected 
GLUT4 in the PM in the basal state (Schertzer et al., 2009, Lizunov et al., 2012). One study 
described a small amount of exofacially-tagged GLUT4 labelling in the basal state (Lizunov 
et al., 2012) and the other reported a more substantial amount with externalised myc labelling 
under basal conditions approximately 50 % of that after insulin stimulation (Schertzer et al., 
2009). This suggests there is GLUT4 incorporation into the PM even in the basal state, which 
is in agreement with data indicating a role for GLUT4 in basal glucose uptake (Hansen et al., 
1995). 
TIRF microscopy studies in skeletal muscle have shown that eighty percent of insulin-
mediated GSV fusion events emanated from vesicles that were within 100 nm of the PM and 
pre-tethered at the PM prior to insulin stimulation (Lizunov et al., 2012). Therefore the limit 
of resolution of confocal microscopy (~ 200 nm) dictates that it is not possible to distinguish 
between a vesicle that is fused at the PM, pre-tethered at the PM or simply in close proximity 
to the PM (Schertzer et al., 2009). Therefore, it should be noted that the transition from 
tethered to fused GLUT4 may not have been detected in the current study. This potentially 
limits the sensitivity of measuring increases in GLUT4 and dystrophin colocalisation using 
this method.  
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Comments on the magnitude of glucose ingestion- and exercise-mediated increases in GLUT4 
and dystrophin colocalisation. In adipocytes a mode of GLUT4 exocytosis has been proposed 
to occur whereby in the basal state GLUT4 is retained in clusters in PM regions, while insulin 
stimulation increased the prevalence of these clusters but also elicited dispersal of GLUT4 
molecules into the PM (Stenkula et al., 2010). The observations presented here in human 
skeletal muscle have similarities to this data. Clusters of GLUT4 are clearly observed in PM 
regions in the basal state (Fig. 4.3 and Fig. 4.9). However, following exercise, the clusters of 
GLUT4 staining are absent and GLUT4 staining is instead continuous along the PM, 
indicative of GLUT4 dispersal in the PM. On the other hand, following glucose ingestion, 
GLUT4 clusters localised to the PM remain clearly visible despite the appearance of moderate 
continuous staining along the PM at 30 min following glucose ingestion. This suggests that 
the magnitude of GLUT4 redistribution around the PM in human skeletal muscle is greater 
following exercise at 65% VO2max than 30 min following glucose ingestion. Supporting this 
suggestion is a significant difference between the magnitude of increase in Pearson’s 
correlation coefficient following 30 min exercise at 65% VO2max and 30 min following 
glucose ingestion (mean increase following exercise r = 0.11 ± 0.02, mean increase following 
glucose ingestion r = 0.04 ± 0.01, independent samples t test P < 0.01). Furthermore the 
suggestion that GLUT4 redistribution around the PM is greater following exercise compared 
to glucose ingestion is consistent with previous studies in which leg glucose uptake increased 
3-fold during the 4 h period following glucose feeding (Katz et al., 1983) and approximately 
15-fold during cycling exercise at 50-60% VO2 max (Katz et al., 1986, Martin et al., 1995). 
SNAP23 localisation following glucose feeding and exercise. SNAP23 is a t-SNARE, which, 
in combination with another t-SNARE syntaxin 4 and the v-SNARE VAMP2, is required for 
insulin mediated GLUT4 fusion at the PM (Kawanishi et al., 2000, Chen and Scheller, 2001). 
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The SNAREs required for contraction-mediated GLUT4 fusion at the PM are yet to be fully 
characterised, but are likely to be the same as insulin-mediated GLUT4 translocation as 
VAMP2 has been shown to translocate to cell surface membranes, where the t-SNARES are 
already located, in response to contraction (Rose et al., 2009). In the present study, GLUT4 
redistribution in response to exercise occurred without any changes in basal state SNAP23 
localisation. This is consistent with SNAP23 being a t-SNARE, therefore constitutively 
present at the PM (Bryant et al., 2002). The images presented here, in particular highlighted in 
Fig. 4.11, suggest SNAP23 and post-exercise GLUT4 staining of the PM are heterogeneous. 
Chamberlain and Gould (2002) observed that the majority of SNAP23 was present in PM 
lipid rafts in 3T3-L1 adipocytes (Chamberlain and Gould, 2002). Future studies should 
therefore explore whether this also is the case in human skeletal muscle, implying that the 






Fig. 4.11. Post exercise SNAP23 and GLUT4 staining in combination with the PM marker 
dystrophin highlighting inhomogeneity in SNAP23 and GLUT4 staining at the PM. Arrows 
indicate regions of greater SNAP23 and GLUT4 staining at the PM. Scale bars 5 µm. 
 
Other factors contributing to insulin- and contraction-mediated increases in glucose uptake. 
The magnitude of increase in PM GLUT4 association following glucose feeding and exercise 
in this study and GLUT4 in PM subfractions in others (Goodyear et al., 1996, Kennedy et al., 
1999) does not seem to account for the large increases in glucose uptake observed in the 4 h 
period following glucose feeding (3-fold) (Katz et al., 1983), during hyperinsulinaemic-
euglycaemic clamp (5-fold) (DeFronzo et al., 1985) and during exercise at 50-60% VO2 max 
(15-fold) (Katz et al., 1986, Martin et al., 1995). Therefore it appears that mechanisms other 
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than GLUT4 translocation to the PM contribute to the large increases in glucose uptake 
following either stimulus. In Chapter 2 of this thesis we observed that GLUT4 staining was 
present in the T-tubule membranes of human skeletal muscle in the basal state as there was 
substantial colocalisation of GLUT4 and dihydropyridine receptor (DHPR) staining. 
However, colocalisation of GLUT4 with DPHR was not quantified in the current chapter, due 
to the methodological difficulties as explained in chapter 2 leading to large variability in the 
data. It, nevertheless, cannot be excluded that translocation to T-tubule membranes was more 
prominent at the sampled time-points than to the PM. 
Other mechanisms that may contribute to the increases in glucose uptake following glucose 
ingestion and during endurance exercise are  increases in GLUT4 intrinsic activity (Furtado et 
al., 2002, Michelle Furtado et al., 2003), increases in hexokinase (HKII) activity and glycogen 
synthesis resulting in increased glucose phosphorylation and a steeper glucose concentration 
gradient between the interstitium and muscle cell interior (Wasserman et al., 2011) and 
increases in skeletal muscle microvascular recruitment, leading to increases in capillary 
permeability surface area product (Steinberg et al., 1994, Gudbjornsdottir et al., 2003, Vincent 
et al., 2006) and therefore increases in transendothelial transport rates of insulin and glucose. 
Future investigation of a potential additive effect of glucose ingestion and exercise on GLUT4 
translocation. In order to investigate whether the effects of exercise and glucose ingestion on 
GLUT4 translocation are additive the following study design was chosen; ingestion of 75 g of 
glucose was followed after 1 h with 30 min of exercise. The rationale behind this design was 
that increases in leg glucose uptake were maintained 90 min after glucose ingestion (Katz et 
al., 1983). Therefore a biopsy, and measurement of GLUT4 colocalisation with dystrophin, 90 
min after glucose ingestion should be a time-point at which GLUT4 translocation was 
maximal and that the 30 min of exercise could lead to an additional increase in GLUT4 
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translocation. However, significant increases in GLUT4 and dystrophin colocalisation were 
only observed 30 min after oral glucose ingestion. Therefore, in hindsight, a better study 
design to investigate whether glucose ingestion and exercise exert additive effects on GLUT4 
translocation, would be to start the exercise immediately after glucose ingestion with the 
biopsy therefore taken 30 min after both glucose ingestion and the start of exercise. The data 
in Fig. 4.2 and 4.8 show that 30 min after glucose ingestion the mean plasma insulin 
concentration was higher than the very low plasma insulin concentration seen when exercise 
was performed 60-90 min after glucose ingestion. This higher plasma insulin concentration 30 
min after glucose ingestion could better allow investigation of additive effects of glucose 
ingestion and exercise using the alternative study design proposed above. 
Another possible design would have been to start with 30 min of exercise, and follow this 
immediately with glucose ingestion and take biopsies 30, 60 and 90 min after glucose 
ingestion. It is difficult to suggest what the outcome would be as there are a number of 
variables. Firstly, it is unknown how long the contraction-induced increase in GLUT4 and 
dystrophin colocalisation is maintained. Data obtained in rodents suggest that exercise-
mediated increases in skeletal muscle GLUT4 PM content are reduced by 20% 30 min after 
the termination of exercise and return to baseline by 2 h (Ivy and Kuo, 1998). Secondly, if the 
exercise bout occurs before glucose ingestion, post-exercise improvements in glucose 
tolerance may affect GLUT4 translocation rather than an assessment of whether the individual 
glucose ingestion and exercise responses are additive. However it is not known whether the 
30 min of prior exercise leads to sufficient glycogen depletion to increase the rate of insulin-
stimulated glycogen resynthesis (Wojtaszewski et al., 2000) and contribute to potential post-
exercise increases in insulin-mediated GLUT4 translocation. In summary, reversing the order 
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of glucose ingestion and exercise would be complicated by many unanswered questions that 
need further research to comprehend. 
Conclusions. This study has successfully used the immunofluorescence technique developed 
in chapter 2 of this thesis to demonstrate increases in GLUT4 and dystrophin colocalisation 
30 min following glucose ingestion and immediately after 30 min exercise performed at 65% 
VO2 max; indicative of GLUT4 translocation to the PM stimulated by insulin and contraction, 
respectively. GLUT4 translocation following glucose ingestion was transient and did not 
mirror the prolonged elevated rates of glucose disposal previously observed following oral 
glucose ingestion. This methodology raises the possibility to further explore the mechanisms 
regulating glucose uptake in response to insulin and contraction in human skeletal muscle, the 
mechanisms underlying the development of insulin resistance in obesity and ageing and the 
beneficial effects of lifestyle changes and pharmaceutical interventions. 
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The Obese Zucker rat (OZR) is a genetic model of the metabolic syndrome and previous 
research has shown that OZR in comparison to Lean Zucker rats (LZR) exhibit a marked 
reduction in insulin-mediated skeletal muscle glucose uptake during a hyperinsulinaemic-
isoglycaemic clamp. The aim of this study was to use immunofluorescence microscopy to 
assess the translocation of GLUT4 to the plasma membrane (PM) in LZR and OZR in 









 and glucose clamped at approximately 4 mM and 6mM in LZR and 
OZR, respectively. Seven rats in each group (LZR basal, LZR stimulated, OZR basal and 
OZR stimulated) were sacrificed either in the post-absorptive state or 80 min after the start of 
a hyperinsulinaemic-isoglycaemic clamp. Colocalisation of GLUT4 with the PM marker 
dystrophin in tibialis anterior (TA) muscle was measured using the Pearson’s correlation 
coefficient. GLUT4 and dystrophin colocalisation was not different between LZR and OZR in 
the post-absorptive state (LZR basal r = 0.40 ± 0.02, OZR basal r = 0.38 ± 0.02) and did not 
increase in either LZR or OZR following the 80 min hyperinsulinaemic-isoglycaemic clamp 
(LZR stimulated r = 0.38 ± 0.02, OZR stimulated r = 0.38 ± 0.03). There were no differences 
in fibre type composition of the TA between LZR and OZR, with approximately 1 % type I 
fibres, 21 % type IIa fibres and 78 % type IIb fibres. Total intracellular GLUT4 fluorescence 
intensity was highest in type IIa fibres both in LZR and OZR with no difference between the 
groups. In conclusion, 80 min of insulin stimulation did not increase the colocalisation of 
GLUT4 with the PM marker dystrophin in the fast twitch TA muscle of LZR and OZR. This 
suggests that mechanisms other than GLUT4 translocation to the skeletal muscle PM in the 
TA muscle are responsible for the gradual increase in whole body glucose disposal rates 
during the 80 min hyperinsulinaemic-isoglycaemic clamps in both groups. Furthermore 
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impairments in GLUT4 translocation to the skeletal muscle PM in TA muscle do not seem to 
explain the insulin resistance in the OZR during the hyperinsulinaemic-isoglycaemic clamp. 
 
5.2. Introduction 
Skeletal muscle is the major site of insulin-mediated glucose disposal (Katz et al., 1983) and 
glucose transporter 4 (GLUT4) is the primary insulin responsive glucose transporter 
expressed in skeletal muscle (Mueckler, 1994). Chapters 1-4 of this thesis describe in detail 
the spatial distribution of the intracellular storage depots of GLUT4 and the increases that 
have been observed in GLUT4 content of the plasma membrane (PM) region in response to 
insulin stimulation in rodent and human skeletal muscle. In brief, immunofluorescence 
microscopy studies in rodent soleus, quadriceps and flexor digitorum brevis muscles have 
shown GLUT4 is present predominantly at the fibre periphery and in perinuclear regions and 
appears as large and small GLUT4 storage clusters which are likely pretethered at the PM and 
T-tubule membranes (Ploug et al., 1998, Lauritzen et al., 2006, Lizunov et al., 2012). 
Following insulin stimulation resulting from insulin injection into a tail vein, GLUT4 
redistributed to the PM and T-tubule membranes whereby continuous staining of the PM and 
T-tubule membranes was observed (Ploug et al., 1998, Lauritzen et al., 2006). Maximal 
GLUT4 staining of the PM occurred 20 min after insulin stimulation (Lauritzen et al., 2006) 
and was maintained for 150 min (Lauritzen et al., 2008).   
Obesity is associated with insulin resistance of the skeletal muscle. This is characterised by 
lower rates of insulin-stimulated glucose uptake from the blood into skeletal muscle, which 
results in hyperglycaemia (Krook et al., 2004). The obese Zucker rat (OZR) has a mutation in 
the leptin gene and is characterised by hyperphagia, hyperlipidaemia, hyperinsulinaemia, and 
insulin resistance (Oana et al., 2005, Mathe, 1995). Therefore the OZR is considered a good 
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model of the metabolic syndrome; a condition which results from accumulation of the 
pathologies listed above (Frisbee and Delp, 2006). A previous study has measured hind-limb 
(which primarily reflects skeletal muscle) glucose uptake at the end of a 2 h 
hyperinsulinaemic-isoglycaemic clamp in the lean Zucker rat (LZR) and OZR and observed a 
marked reduction in hind-limb glucose uptake in the OZR in comparison to the LZR (Wallis 
et al., 2002). 
The reduction in insulin-stimulated glucose uptake in skeletal muscle of OZR in comparison 
to LZR has been suggested to be a consequence of reductions in protein content and activation 
of insulin signalling cascade proteins in all skeletal muscle fibre types (Ivy, 2004, Sherman et 
al., 1988). There were no differences in the total protein content of GLUT4 between OZR and 
LZR in red quadriceps or gastrocnemius muscle, though GLUT4 total protein content was 
lower in white quadriceps muscle in OZR compared to LZR (Banks et al., 1992, Friedman et 
al., 1990). To further explore the reduction in skeletal muscle glucose uptake in the OZR upon 
insulin stimulation, the GLUT4 content of the isolated PM fraction has been measured in LZR 
and OZR.  King et al. (1992) observed a 40 % increase in GLUT4 content of the PM fractions 
of the soleus and gastrocnemius muscle 30 min following intraperitoneal insulin injection in 
LZR, but there was no significant increase in the OZR (King et al., 1992). In contrast, Galante 
et al. (1994) observed a 1.9-fold increase in GLUT4 content of the PM fraction of hind-limb 
muscles in both LZR and OZR 20 min following intraperitoneal insulin injection with no 
difference between groups (Galante et al., 1994). However in this study the insulin dose was 
increased in the OZR to achieve a decline in blood glucose comparable to that seen in the 
LZR, therefore implying more insulin was required in OZR compared to LZR to achieve the 
same increase in GLUT4 content of the PM fraction. 
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As the use of isolated PM fractions to measure PM GLUT4 content has been criticised due to 
potential contamination with intracellular membranes (Schertzer et al., 2009, Fazakerley et 
al., 2009), we here used the immunofluorescence microscopy method developed in chapter 2 
of this thesis to investigate  insulin-mediated GLUT4 translocation in LZR and OZR. 
This study, therefore, aimed to visualise the localisation of GLUT4 in tibialis anterior (TA) 
muscle fibres of LZR and OZR in the post-absorptive state and at the end of an 80 min 
hyperinsulinaemic-isoglycaemic clamp. GLUT4 translocation to the PM was assessed using 
the Pearson’s correlation coefficient to measure the colocalisation of GLUT4 and the PM 
marker dystrophin (as described in chapter 2 of this thesis). This was a collaborative study 
between the School of Sport and Exercise Sciences, the Medical School and AstraZeneca with 
multiple aims to investigate both the vascular and skeletal muscle responses to insulin 
stimulation. The hypotheses investigated in this chapter of the thesis were that: 1) the 
colocalisation of GLUT4 with dystrophin in TA muscle fibres will be increased at the end of 
the hyperinsulinaemic-isoglycaemic clamp in the LZR in comparison to the post-absorptive 
state; and 2) this increase will be absent or blunted in the OZR in comparison to the LZR.  
 
5.3. Methods 
Animals. All in vivo rat experiments were carried out at AstraZeneca in Alderley Park 
(Cheshire, UK). All procedures conformed to the Animal (Scientific Procedures) Act 1986 
(UK). Lean (Fa/Fa or Fa/fa) and obese (fa/fa) male, 20 week old Zucker rats (Charles River 
Laboratories, France) were fed standard rat chow and water ad libitum and were housed on a 
12 hr light-dark cycle . 
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Hyperinsulinaemic-isoglycaemic clamp protocol. LZR and OZR were randomly divided into 
two groups; either fasted or insulin stimulated (N = 7 per group). On the day prior to the 
experiment rats received a controlled portion of rat chow (16g obese, 10g lean) at 16:00 hours 
with the aim to provide sufficient food until midnight and obtain the post-absorptive state, 
rather than starved, for the clamp protocol. LZR and OZR in the insulin-stimulated group 
underwent a hyperinsulinaemic-isoglycaemic clamp as follows. Rats were anaesthetised at 9 
am (160-190 mg.kg
-1
 Inactin, intraperitoneal) and catheters were placed in the right jugular 
vein for insulin and glucose infusion and the left carotid artery for blood sampling. A 60 min 
recovery period was then allowed following surgical procedures and the hyperinsulinaemic-









insulin. Different infusion rates 
were chosen to reflect the increases in plasma insulin normally seen in LZR and OZR. 
Similarly blood glucose concentration was maintained at 4 mM in the LZR and 6 mM in the 
OZR to reflect physiological conditions. Blood glucose concentrations were measured with an 
automated glucose analyser (AccuChek Aviva Glucose Meter, Roche Diagnostics GmbH, 
Mannheim, Germany) and appropriate adjustments in glucose infusion rates were made. 
Immediately following the clamp animals were sacrificed by intraperitoneal overdose of 
Inactin and cervical dislocation and the TA muscle was then immediately dissected free and 
embedded in Tissue Tek OCT (Sakura Finetek, The Netherlands) before freezing in liquid 
nitrogen-cooled isopentane (Sigma Aldrich, UK) for storage at -80
o
C. LZR and OZR in the 
fasted state were sacrificed in the same way without any prior experimentation. 




) was calculated and was assumed 
to equal the rate of disappearance of glucose from the blood into skeletal muscle and other 
tissues. The assumption was made because blood glucose concentration was maintained at a 
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constant level. During the 60-80 min steady state period insulin sensitivity was calculated 




) divided by plasma insulin (pmol.L
-1
) values at 
each time point (Muniyappa et al., 2008). Lean body mass was calculated from formulae 
developed in-house at AstraZeneca (Cardiovascular and Gastrointestinal Group, AstraZeneca, 
Alderley Park); LZR lbm (g) = 31 + (0.77 x body mass (g)), OZR lbm (g) = 59 + (0.5 x body 
mass (g)). 
Immunofluorescence staining protocol. The GLUT4 immunofluorescence staining protocol is 
described in detail in chapter 2. All analysis was completed in triplicate. Seven sets of slides 
were prepared with each set comprising a LZR basal and insulin stimulated and OZR basal 
and insulin stimulated section on each slide. For analysis of GLUT4 and dystrophin 
colocalisation, dystrophin primary antibody was included in the primary antibody incubation 
step of the protocol described in chapter 2 at a 1:400 dilution (Sigma Aldrich, UK). For fibre 
type analysis, MHCI primary antibody at 1:100 dilution (developed by Dr. Blau, DSHB, 
USA) or MHCIIa primary antibody at 1:100 dilution if targeted with AlexaFluor488-
conjugated secondary antibody or 1:200 dilution if targeted with AlexaFluor594-conjugated 
secondary antibody (developed by Dr. Blau, N2.261, DSHB, University of Iowa) were added 
to the primary antibody incubation. Dystrophin was targeted with AlexaFluor594-conjugated 
goat anti-mouse IgG2b (Invitrogen, UK), MHCI with either AlexaFluor488- or 
AlexaFluor594-conjugated goat anti-mouse IgM (Invitrogen, UK) and MHCIIa with 
AlexaFluor488- or AlexaFluor594-conjugated goat anti-mouse IgG1 (Invitrogen, UK). For 
staining of the muscle fibre border during fibre type analysis, sections were incubated in 
AlexaFluor350-conjugated wheat germ agglutinin (WGA, Invitrogen, WGA) after secondary 
antibody incubation for 15 min at a 1:50 dilution in PBS and finally were washed for 2 min in 
PBS and subsequently mounted. Negative control staining was also completed. GLUT4 
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primary antibody was omitted from the fibre type staining to confirm MHCIIa signal did not 
bleed through into the channel in which GLUT4 was imaged. In separate staining MHCIIa 
antibody was also omitted from GLUT4 staining to confirm that some fibres retain stronger 
fluorescence intensity even when MHCIIa antibody is absent. These images are shown in Fig. 
5.1. and confirmed that MHCIIa signal did not bleed through into the channel in which 




Fig. 5.1. Representative widefield immunofluorescence microscopy images of negative control 
staining for fibre type analysis of rat TA muscle. In the top row of images GLUT4 primary 
antibody was omitted. In the bottom row of images MHCIIa antibody was omitted. GLUT4 
was stained in green, MHCIIa in red and WGA was used to mark cell borders in blue. These 





Immunofluorescence image capture, processing and analysis. Further details of image 
capture, processing and analysis are provided in chapter 2. GLUT4 and dystrophin images for 
colocalisation analysis were captured using an inverted confocal microscope (Leica DMIRE2, 
Leica Microsystems) with a 63x oil immersion objective (1.4 NA). For each animal 5 images 
were captured per muscle section, with sections analysed in triplicate for each condition. 
GLUT4 and dystrophin images for colocalisation analysis had a no neighbour deconvolution 
algorithm inbuilt into Image-Pro Plus 5.1 applied to them. The colocalisation tool in Image-
Pro Plus 5.1 was then used to calculate the Pearson’s correlation coefficient of each image 
pair. Images for fibre type composition analysis and fibre-type specific GLUT4 fluorescence 
intensity analysis were captured using a Nikon E600 microscope coupled to a SPOT RT KE 
colour three shot CCD camera (Diagnostic Instruments Inc., MI, USA). To ensure fibre type 
composition was consistent across all sections analysed images were captured of MHCI (594) 
for type I fibres, MHCIIa (488) for type IIa fibres and WGA (350) to mark the cell borders 
across a single section for each animal using a 20x objective (0.4 NA). Unstained fibres were 
considered type IIb. The number of type I, type IIa and type IIb muscle fibres in each image 
were counted and the sum for each section calculated. The mean number of fibres counted per 
section was as follows; total fibres 488 ± 58, type I fibres 5 ± 1, type IIa fibres 121 ± 23 and 
type IIb fibres 362 ± 38. The percentage composition of type I, type IIa and type IIb fibres of 
each section was then calculated. For analysis of fibre type specific GLUT4 fluorescence 
intensity serial sections were imaged from 7 lean basal and 7 obese basal animals. On one 
section images were captured of MHCI (594), MHCIIa (488) and WGA (350) using the 20x 
objective, then corresponding fibres were found on the serial section stained for GLUT4 
(488), MHCIIa (594) and WGA (350) and images were captured using both the 20x and 40x 
(0.75 NA) objectives. Analysis of GLUT4 fluorescence intensity was completed using the 
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GLUT4 images captured with the 40x objective in 250 ± 37 fibres (type  I; 4 ± 2, type IIa; 51 
± 16, type IIb; 195 ± 26) per lean animal section and 278 ± 46 fibres (type  I; 2 ± 1 , type IIa 
66 ± 20, type IIb 210 ± 36) per obese animal section. No processing was carried out on the 
GLUT4 images. The appropriate WGA image was used to create an outline of fibres; firstly a 
flatten background filter was applied and fibres were identified using consistent intensity and 
size thresholds. The WGA fibre outline was applied to the raw GLUT4 image to measure 
GLUT4 fluorescence intensity in a fibre type specific manner, with fibre type determined 
using the 20x serial sections stained for MHCI and MHCIIa. 
Statistical analysis. All statistical analysis was performed using SPSS version 19 (Chicago, 
IL). Significant differences in animal characteristics between LZR and OZR were detected 
using independent T tests. Statistical analysis of Pearson’s correlation coefficient data to 
measure GLUT4 translocation was completed using a repeated measures ANOVA with 
obesity and stimulation state as independent factors. Equivalent fibre type compositions of 
sections across the groups were confirmed using a repeated measures ANOVA with group 
and fibre type as independent factors. Significant main effects were investigated using 
Bonferroni pair-wise comparisons within the significant factor. Differences in GLUT4 
fluorescence intensity between LZR and OZR and between fibre types were analysed using a 
repeated measures ANOVA with obesity and fibre type as independent factors. Where 
significant main effects were detected Least Significant Difference (LSD) pair-wise 
comparisons were performed within the significant factor. GLUT4 fluorescence intensity data 
of one animal was more than 2 standard deviations away from the mean and were therefore 





Animal characteristics. Seven rats were studied in each group (LZR and OZR) both in the 
fasted state and at the end of an 80 min hyperinsulinaemic-isoglycaemic clamp (insulin-
stimulated). Characteristics of LZR and OZR are shown in Table 5.1. Body mass (LZR 300 ± 
7 g, OZR 422 ± 21 g, P = 0.001) and basal blood glucose (LZR 4.1 ± 0.1 mM, OZR 6.1 ± 0.3 
mM, P = 0.001) were significantly higher in the OZR, while insulin sensitivity in the final 20 













, P < 0.001).  
 
Table 5.1 Animal characteristics 
 LZR OZR 
 N = 7 N = 7 
Body mass (g) 300 ± 7 422 ± 21 * 
Basal blood glucose (mM) 4.1 ± 0.1 6.1 ± 0.3 * 
Insulin sensitivity at 60-80 min steady state 







0.048 ± 0.004 0.009 ± 0.002 * 
Data shown are mean ± SEM for animals that underwent a hyperinsulinaemic-isoglycaemic 
clamp. Independent samples T test * P < 0.01. 
 
Blood glucose, plasma insulin and glucose infusion rate (GIR). Blood glucose concentration 
was clamped at the blood glucose concentration in the post-absorptive state; approximately 4 
mM in the LZR and 6 mM in the OZR (Fig 5.2). Plasma insulin concentration data (Fig. 5.3) 
were obtained at three time-points (basal, 40 min, 80 min). Plasma insulin concentration was 
significantly higher in OZR compared to LZR at all time points (P < 0.05) and plasma insulin 
concentration was significantly increased above basal levels in both LZR and OZR (P < 
0.05). GIR during the hyperinsulinaemic-isoglycaemic clamp is shown in Fig. 5.4. There was 
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no significant difference between the mean GIR for LZR and OZR during the steady state 60-









, P = 0.257). 
 
 
Fig. 5.2. Blood glucose concentration during 80 min hyperinsulinaemic-isoglycaemic clamp 
in LZR (filled diamonds) and OZR (open diamonds). Graph shows mean ± SEM. This data 






Fig. 5.3. Plasma insulin concentration during 80 min hyperinsulinaemic-isoglycaemic clamp 
in LZR (filled diamonds) and OZR (open diamonds) (A). Plasma insulin values (mean ± SEM) 









 in OZR. * P < 0.05 compared to basal. 
#
 P < 
0.05 OZR compared to LZR. Graph shows mean ± SEM. This data has been obtained from the 





Fig. 5.4. Glucose infusion rate during 80 min hyperinsulinaemic-isoglycaemic clamp in LZR 









 in OZR. Graph shows mean ± SEM. This data has been obtained from 
the thesis of Ann Stride (University of Birmingham, 2012, Fig. 4.6). 
 
GLUT4 localisation in TA muscle from LZR and OZR. Intracellular GLUT4 staining of LZR 
and OZR TA muscle fibres appears as large and small clusters, the latter of which appear as a 
diffuse background stain under lower magnification (Fig. 5.5). Strong staining is present at 
the fibre periphery in both the basal and insulin stimulated rats. A striking feature of the 





Fig. 5.5. Representative confocal immunofluorescence microscopy images of GLUT4 (green) 
and dystrophin (red), a PM marker, in TA muscle from LZR and OZR sampled in the basal 
state and at the end of an 80 min hyperinsulinaemic-isoglycaemic clamp. Scale bars 50 µm. 
 
GLUT4 and dystrophin colocalisation. Fig. 5.5. shows immunofluorescence images of 
GLUT4 in green and dystrophin in red stained in TA muscle of LZR and OZR sampled in the 
basal state and at the end of an 80 min hyperinsulinaemic-isoglycaemic clamp. Merged 
images display colocalisation of GLUT4 and dystrophin. There was no difference in 
Pearson’s correlation coefficient, therefore no difference in GLUT4 and dystrophin 
colocalisation, between the TA of LZR and OZR in the fasted state (LZR r = 0.40 ± 0.02, 
OZR r = 0.38 ± 0.02) (Fig. 5.6). Furthermore there was no increase in Pearson’s correlation 
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coefficient following insulin stimulation in either LZR or OZR, indicating there was no 
increase in GLUT4 and dystrophin colocalisation (LZR post r = 0.38 ± 0.02, OZR post r = 
0.38 ± 0.03) (Fig. 5.6). 
 
 
Fig. 5.6. Pearson’s correlation coefficient values representing GLUT4 and dystrophin 
colocalisation in TA muscle of LZR and OZR sampled in the basal state and following an 80 
min hyperinsulinaemic-isoglycaemic clamp. Graph shows mean ± SEM. Repeated measures 
ANOVA group effect P = 0.763, stimulation effect P = 0.732, interaction effect P = 0.539. 
 
Fibre type composition of TA sections. Staining of MHCI for type I fibres, MHCIIa for type 
IIa fibres and WGA to mark the cell borders (Fig. 5.7) across a single section for each animal 
confirmed that there were no significant differences in the percentage composition of type I, 
type IIa and type IIb fibres between the four groups of animals (repeated measures ANOVA 
group effect, P = 0.315). For all four groups of animals type I fibres composed approximately 
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Fig. 5.7. Representative widefield immunofluorescence images showing fibre type 
composition of TA muscle of LZR. Type I muscle fibres are stained in red for MHCI, type II 
muscle fibres are stained in green for MHCIIa, while WGA, shown in blue, marks the cell 





Fig. 5.8. Fibre type composition of TA muscle sections analysed for GLUT4 and dystrophin 
colocalisation from LZR and OZR sampled in the basal state and following an 80 min 
hyperinsulinaemic-isoglycaemic clamp. Graph shows mean ± SEM. Repeated measures 
ANOVA fibre type effect P < 0.001, group effect P = 0.315, interaction effect P = 0.996. Post 
hoc Bonferroni pairwise comparisons * P < 0.001. 
 
Fibre type specific GLUT4 expression. To investigate GLUT4 content in different fibre types, 
total intracellular GLUT4 fluorescence intensity was analysed in a fibre type specific manner 
in TA muscle of LZR and OZR in the basal state. Total GLUT4 fluorescence intensity was 
measured within each fibre with the border delineated using the WGA stain (Fig. 5.9). Total 
intracellular GLUT4 fluorescence intensity was highest in type IIa fibres (LZR 20 ± 3, OZR 
23 ± 1), intermediate in type I fibres (LZR 17 ± 1, OZR 20 ± 1) and lowest in type IIb fibres 
(LZR 14 ± 1, OZR 17 ± 1) (Fig. 5.10). The difference in total GLUT4 content between fibre 
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type was significant (P = 0.013) with no difference in total GLUT4 content between lean and 




Fig. 5.9. Representative widefield immunofluorescence microscopy images demonstrating 
analysis of GLUT4 fluorescence intensity in a fibre type specific manner in TA muscle of LZR 
and OZR in the basal state. Serial sections were stained for either MHCI in green, MHCIIa in 
red and WGA in blue or GLUT4 in green, MHCIIa in red and WGA in blue. Lower 
magnification images taken with 20x objective (100 µm scale bars) show section stained for 
fibre type, while higher magnification images taken with 40x objective (50 µm scale bar) 
show equivalent fibres in section stained for GLUT4 from which fluorescence intensity 




Fig. 5.10. GLUT4 fluorescence intensity in type I, type IIa and type IIb fibres of the TA in LZR 
and OZR in the basal state. Graph shows mean ± SEM. Repeated measures ANOVA fibre type 
effect P = 0.013, group effect P = 0.668, interaction effect P = 0.423. Least Significant 
Difference (LSD) pair-wise comparisons were performed to investigate the effect of fibre 
type, * P < 0.05. 
 
5.5. Discussion 
The immunofluorescence techniques developed and tested in human skeletal muscle in 
chapter 2-4 of this thesis have been used in this study to investigate the colocalisation of 
GLUT4 with the PM marker dystrophin in the fast twitch TA muscle fibres of LZR and OZR 
in the basal state and at the end of an 80 min hyperinsulinaemic-isoglycaemic clamp. In 
contrast to the a priori hypothesis and despite substantially elevated rates of whole body 
glucose disposal during the clamp there was no increase in colocalisation of GLUT4 with the 
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PM marker dystrophin 80 min after the onset of a hyperinsulinaemic-isoglycaemic clamp in 
TA muscle fibres of the LZR. Furthermore, there were no differences in GLUT4 and 
dystrophin colocalisation in TA muscle fibres between LZR and OZR either in the fasted state 
or at the end of the hyperinsulinaemic-isoglycaemic clamp.  
Glucose infusion rate (GIR) and insulin sensitivity. GIR during the clamp was recorded for 
LZR and OZR and the data is presented in Fig. 5.4. There was no significant difference in 
mean GIR between LZR and OZR during the 60-80 min steady state time period. Also, area 
under the GIR curve over the 80 min clamp period was not different between LZR and OZR 
(LZR 837 ± 45 µmol.lbm kg
-1
, OZR 752 ± 91 µmol.lbm kg
-1
, P = 0.458). It is important to 
note that similar increases in GIR were obtained by using different insulin infusion rates in 








 for OZR). The difference in 
infusion rate was chosen to achieve the same proportional increases in plasma insulin levels in 
a range that is normally seen in the LZR and OZR. Also for this reason blood glucose 
concentration was maintained at 4 mM in the LZR and at 6 mM in the OZR. This implies that 
the same GIR was achieved in the LZR and OZR with markedly higher blood glucose and 
insulin concentrations at the end of the hyperinsulinaemic-isoglycaemic clamp in OZR which 
explains why the insulin sensitivity over the 60-80 min time period was approximately 5-fold 














GLUT4 translocation in LZR. The observation that GLUT4 and dystrophin colocalisation in 
TA muscle fibres did not change at the end of 80 min hyperinsulinaemic-isoglycaemic clamp 
in LZR was in contrast to the a priori hypothesis. The expectation was that in the LZR 
GLUT4 translocation would remain high for at least the 80 min of the hyperinsulinaemic-
isoglycaemic clamp and this expectation was based on the following previously published 
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observations. Previous work has shown that insulin stimulation via intraperitoneal injection 
(King et al., 1992, Galante et al., 1994) increases GLUT4 content of skeletal muscle isolated 
PM fractions between 1.5- and 1.9-fold above basal levels in LZR 20-30 min after insulin 
injection. However as indicated in the introduction the measurement of the GLUT4 content in 
isolated PM fractions has been criticised. Lauritzen et al. (2006) used immunofluorescence 
microscopy to visualise in vivo GLUT4-GFP and observed that GLUT4 accumulated close to 
the mouse muscle fibre border 10 min after injection of insulin into a tail vein and suggested 
that this reflected GLUT4 translocation without investigating colocalisation with a PM 
marker (Lauritzen et al., 2006). Maximum values were reached after 20 min (Lauritzen et al., 
2006) and the accumulation of GLUT4 clusters in the PM region remained elevated for 150 
min (Lauritzen et al., 2008). It should, however, be noted that the amount of insulin injected 
was very high in the latter study and that the plasma insulin concentrations reached were 
equally high. Peak plasma insulin concentrations in LZR during hyperinsulinaemic-
isoglycaemic clamp in the current study (presented in the PhD thesis of Ann Stride, 
University of Birmingham, 2012 and in Fig. 5.3 of this chapter) were approximately 320 
µIU.mL
-1
, in comparison to 200 000 µIU.mL
-1
 in the study by Lauritzen et al. (Lauritzen et 
al., 2008). 
Wallis et al. (2002) have previously measured hind-limb (which primarily reflects skeletal 
muscle) glucose uptake at the end of a 2 h hyperinsulinaemic-isoglycaemic clamp using a 




) in LZR and OZR. This led to a 3-fold higher 
increase in whole body GIR in the LZR than the OZR. Furthermore the increase in hind-limb 
glucose uptake rate in the LZR was 5-fold greater than the fasted state, while this increase in 
the OZR was only 30% greater than in the fasted state (Wallis et al., 2002). On the basis of 
these findings it comes as a surprise that increases in colocalisation of GLUT4 and dystrophin 
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in skeletal muscle were not observed at the end of the 80 min hyperinsulinaemic-isoglycaemic 
clamp in the LZR in the current study. 
A possible explanation is that GLUT4 translocation occurred at an earlier time point than 80 
min after the start of the hyperinsulinaemic-isoglycaemic clamp in LZR. Chapter 4 of this 
thesis showed modest but significant increases in GLUT4 and dystrophin colocalisation in 
human skeletal muscle at 30 min after oral glucose ingestion and not after 60 and 90 min in 
response to physiological rises in plasma insulin. Therefore, it is possible that GLUT4 
translocation is an early and transient event in LZR, which had returned to basal levels at 80 
min. Unfortunately, due to the study design (collaborative study with AstraZeneca and the 
Medical School, UoB) it was not possible to collect muscle samples from earlier time points 
in the current study.  
In addition it must be noted that the current study examined GLUT4 translocation in TA 
muscle, which is a fast twitch muscle composed primarily of type IIb fibres (Fig. 5.8). 
Therefore it remains possible that in soleus or quadriceps muscle with a much higher 
proportion of oxidative muscle fibres (Sherman et al., 1988) GLUT4 translocation may have 
been detected at the end of the 80 min hyperinsulinaemic-isoglycaemic clamp, therefore 
accounting for the increased hindlimb glucose uptake observed previously (Wallis et al., 
2002). TA was the only muscle available for use in the current study due to damage incurred 
in other muscles during the freezing process. 
GLUT4 translocation in OZR. Hind-limb glucose uptake has been shown to increase 5-fold in 
LZR during a 2 h hyperinsulinaemic-isoglycaemic clamp, while in contrast increases in hind-
limb glucose uptake in OZR were only 30% (P < 0.05 in comparison to LZR) (Wallis et al., 
2002). On the basis of these glucose uptake rates the a priori hypothesis was that the GLUT4 
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translocation to the PM TA muscle fibres in the OZR would be blunted. Our data are in line 
with the a priori hypothesis as no increase was seen in the colocalisation of GLUT4 with 
dystrophin at the end of an 80 min hyperinsulinaemic-isoglycaemic clamp in OZR. Previous 
studies measuring the GLUT4 content of isolated PM fractions also have come to the 
conclusion that no increase in GLUT4 content was seen following intraperitoneal insulin 
injections in OZR (King et al., 1992). Furthermore, the colocalisation of GLUT4 with 
dystrophin in the fasted state in the current study was the same for LZR and OZR. This is 
consistent with previous studies that have shown equivalent fasted state GLUT4 content of 
PM fractions isolated from skeletal muscles of LZR and OZR (King et al., 1992, Etgen et al., 
1996).  
Other factors apart from PM GLUT4, which may influence insulin-mediated increases in 
glucose disposal in LZR and OZR at end of 80 min hyperinsulinaemic-isoglycaemic clamp. 
Glucose disposal in LZR and OZR was elevated throughout the 80 min clamp as shown in the 
glucose infusion rate graph in Fig. 5.4. Wallis et al. (2002) observed 5-fold increases in 
insulin-mediated hind-limb glucose uptake during 2 h hyperinsulinaemic-isoglycaemic clamp 
in LZR (Wallis et al., 2002), therefore suggesting that insulin-mediated increases in glucose 
disposal in LZR in the current study likely reflect skeletal muscle glucose uptake. This leads 
to the conclusion that other mechanisms apart from GLUT4 translocation to the PM in TA 
muscle fibres are responsible for insulin-mediated increases in skeletal muscle glucose uptake 
in LZR. Insulin-mediated terminal arteriole vasodilation allows recruitment of previously 
underperfused skeletal muscle capillaries. This will increase insulin and glucose delivery to 
the skeletal muscle (Clark, 2008). Insulin-mediated skeletal muscle microvascular 
vasodilation begins 5-10 min into a hyperinsulinaemic-euglycaemic clamp in rats and is 
maintained for 120 min (Steinberg et al., 1994, Vincent and Barrett, 2002, Vincent et al., 
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2004). Furthermore Gudbjornsdottir et al. (2003) have provided evidence that increases in 
capillary permeability surface area (PSA) product resulting from microvascular recruitment 
contribute to the increases in glucose uptake that occur 90-120 min after the start of an OGTT 
or a hyperinsulinaemic-euglycaemic clamp with physiological insulin levels (Gudbjornsdottir 
et al., 2003). Other mechanisms receiving attention that could explain increases in glucose 
uptake at later time points without increased GLUT4 at the PM is the intrinsic activation of 
GLUT4 already present in the PM (Furtado et al., 2002) and increased hexokinase (HKII) 
activity and glycogen synthesis, therefore leading to increased glucose phosphorylation and a 
steeper glucose concentration gradient between the muscle interstitium and fibre interior 
(Wasserman et al., 2011).  
Although glucose disposal in OZR was elevated throughout the 80 min clamp in the current 
study (Fig. 5.2), Wallis et al. (2002) observed that insulin-mediated increases in hind-limb 
glucose uptake during 2 h hyperinsulinaemic-isoglycaemic clamp were negligible in OZR 
(Wallis et al., 2002), therefore suggesting that the majority of glucose disposal in OZR in the 
current study occurred into tissues other than skeletal muscle. GLUT4 and dystrophin 
colocalisation was not different between LZR and OZR after an 80 min hyperinsulinaemic-
isoglycaemic clamp. Therefore the current study suggests the reduction in skeletal muscle 
glucose uptake observed by Wallis et al. (2002) was due to mechanisms that did not involve 
impairments in GLUT4 translocation to the PM in TA muscle fibres. Impaired insulin-
mediated increases in skeletal muscle microvascular volume which occur early in a 
hyperinsulinaemic-euglycaemic clamp in LZR is a likely candidate mechanism for the 
reduced skeletal muscle glucose uptake observed in OZR (Steinberg et al., 1994, Rattigan et 
al., 2013). In support capillary PSA available for insulin and glucose delivery is reduced in 
OZR due to reductions in insulin-mediated recruitment of the microvasculature (Wallis et al., 
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2002) and capillary rarefaction (Frisbee, 2003). Considering that capillary PSA has a major 
impact on glucose uptake 90-120 min into an OGTT or hyperinsulinaemic-euglycaemic clamp 
with physiological insulin levels (Gudbjornsdottir et al., 2003), the reduced capillary PSA in 
the OZR may be a major determinant in the reduced skeletal muscle glucose uptake observed 
previously in OZR (Wallis et al., 2002). 
Intracellular GLUT4 localisation and total GLUT4 protein content. GLUT4 
immunofluorescence staining of TA muscle sections from LZR and OZR generated a staining 
pattern featuring large bright intracellular clusters of GLUT4 staining and smaller clusters of 
GLUT4 which contribute to a diffuse background stain. Clusters of staining appear 
predominantly at the muscle fibre periphery but also in deeper regions (Fig. 5.5). These 
images are consistent with previous immunofluorescence data in rodent muscle (Ploug et al., 
1998, Lauritzen et al., 2006, Lauritzen et al., 2008), as well as the images shown in chapter 2 
of this thesis in the development of GLUT4 immunofluorescence staining in human skeletal 
muscle.  
Strikingly, the staining in some fibres of LZR and OZR TA muscle is more intense than 
others (Fig. 5.5). This was confirmed to be due to differences in GLUT4 content of type I, 
type IIa and type IIb muscle fibres (Fig. 5.9 and Fig. 5.10). Type I and IIa muscle fibres had 
the highest GLUT4 content with lower GLUT4 content in type IIb muscle fibres. Similar 
GLUT4 expression patterns have been reported previously in rat muscle with higher GLUT4 
content in oxidative fibres (Marette et al., 1992, Daugaard and Richter, 2001, Henriksen et al., 
1990). There were no differences in total GLUT4 content of the different fibre types between 
LZR and OZR (Fig. 5.9) which is in line with previous studies in the Zucker rat  (Banks et al., 
1992, Friedman et al., 1990) and studies comparing insulin sensitive and insulin resistant 
human skeletal muscle (Handberg et al., 1990, Pedersen et al., 1990). Therefore, these 
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findings confirm that impairments in insulin-mediated glucose uptake in the muscle of the 
OZR are not due to a reduction in total GLUT4 protein content.   
There are differing fibre type compositions along the proximal-distal length of the TA muscle 
(Wang and Kernell, 2000). While it is unknown from which region of the TA muscle sections 
were taken in this study, the fibre type compositions were consistent with sectioning from the 
more distal TA region (Wang and Kernell, 2000).  In addition, as it was confirmed in the 
current study there were no differences in fibre type composition between the sections 
analysed for GLUT4 and dytrophin colocalisation, differences in fibre type composition could 
not have affected the results. 
Conclusions. In conclusion using immunofluorescence microscopy techniques which were 
developed in chapter 2 of this thesis, this study has shown a higher GLUT4 protein content in 
type I and type IIa fibres of LZR and OZR TA muscle compared to type IIb fibres, with no 
differences in GLUT4 protein content between fibre types in LZR and OZR. Furthermore 
there were no differences in GLUT4 and dystrophin colocalisation between LZR and OZR in 
the basal state in TA muscle fibres. There was no increase in GLUT4 and dystrophin 
colocalisation in OZR at the end of an 80 min hyperinsulinaemic-isoglycaemic clamp which 
was in line with the a priori hypothesis. However in contrast to the a priori hypothesis GLUT4 
and dystrophin colocalisation also did not increase at the end of an 80 min hyperinsulinaemic-
isoglycaemic clamp in LZR. The absence of an increase in colocalisation of GLUT4 and 
dystrophin in LZR at the end of an 80 min hyperinsulinaemic-isoglycaemic clamp is in line 
with the observation of chapter 4 of this thesis that GLUT4 and dystrophin colocalisation is 
transiently increased 30 min after glucose feeding and returned to baseline by 60 min 
therefore suggesting that GLUT4 translocation may also be transient in TA muscle fibres of 
LZR and OZR despite sustained insulin stimulation. In addition the data presented in the 
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current study suggest differences in insulin sensitivity between LZR and OZR in the final 20 
min of an 80 min hyperinsulinaemic-isoglycaemic clamp are not due to differences in skeletal 
muscle GLUT4 translocation in fast twitch TA muscle fibres.  
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Hyperglycaemia, a feature of type 2 Diabetes Mellitus, has been shown to reduce insulin-
mediated glucose disposal in experiments performed in isolated rat muscles and cultured 
skeletal muscle cells. This occurred in combination with reductions in glucose transporter 4 
(GLUT4) translocation to the plasma membrane (PM). The aim of this study was to 
investigate the hypothesis that 24 h of hyperglycaemia would lower insulin sensitivity and 
reduce colocalisation of GLUT4 with the PM marker dystrophin. Ten overweight normal 
glucose tolerant (NGT) volunteers underwent a hyperglycaemic clamp (5.4 mM above the 
overnight fasted state) and muscle biopsies were collected from the vastus lateralis muscle in 
the overnight fasted state and after 2 h and 24 h of hyperglycaemia. The same measurements 
were taken in 10 age and weight matched type 2 diabetes patients (T2D) in the overnight 
fasted state and after 2 h of a hyperglycaemic clamp (again 5.4 mM above the blood glucose 
concentration seen in these subjects in the overnight fasted state). Two and 24 hours of 
hyperglycaemia increased plasma insulin concentration (NGT overnight fasted 12.9 ± 1.9 
µIU.mL
-1
, 2 h 73.1 ± 16.2 µIU.mL
-1
, 24 h 166.5 ± 30.3 µIU.mL
-1
, P < 0.001; T2D overnight 
fasted 12.8 ± 1.4 µIU.mL
-1
, 2 h 36.1 ± 8.9 µIU.mL
-1
, P < 0.05) and elicited increased rates of 













, P < 0.05). In comparison, rates of whole 
body glucose disposal did not increase as a result of 2 h hyperglycaemia in T2D (overnight 








). Following 24 h of 
hyperglycaemia in NGT, insulin sensitivity was significantly reduced to levels observed after 
2 h of hyperglycaemia in the T2D patients. Hyperglycaemia did not change colocalisation of 
GLUT4 with the PM marker dystrophin, expressed as the Pearson’s correlation coefficient, in 
either group (NGT overnight fasted r = 0.38 ± 0.01, 2 h r = 0.37 ± 0.01, 24 h r = 0.38± 0.01, 
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P = 0.525; T2D overnight fasted r = 0.39 ± 0.01, 2 h r = 0.38 ± 0.01, P = 0.160). Collectively 
these data suggest that the increased rate of whole body glucose disposal in NGT observed 
after 2 h and 24 h of hyperglycaemia is not the result of an increase in the PM GLUT4 content 
of skeletal muscle. Furthermore, the lack of increase in whole body glucose disposal in T2D 
and inhibition of insulin sensitivity observed in NGT after 24 h of hyperglycaemia are likely 
to involve other mechanisms than impairments in GLUT4 translocation to the PM. 
 
6.2. Introduction 
Skeletal muscle is the major site of insulin-mediated glucose uptake (Katz et al., 1983, 
Ferrannini et al., 1985). As reported in previous chapters glucose transporter 4 (GLUT4) is the 
best characterised glucose transporter isoform responsible for the transmembrane transport of 
glucose during insulin-mediated glucose uptake (Mueckler, 1994). A detailed description of 
GLUT4 localisation and redistribution in response to insulin is provided across chapters 1-4. 
In brief, immunofluorescence microscopy studies in rodent soleus, quadriceps and flexor 
digitorum brevis skeletal muscle have reported large and small intracellular GLUT4 storage 
clusters located predominantly at the fibre periphery, from which GLUT4 storage vesicles 
(GSVs) translocate following insulin stimulation and dock and fuse with the plasma 
membrane (PM) (Ploug et al., 1998, Lauritzen et al., 2006). Furthermore chapters 2-4 of this 
thesis have demonstrated the presence of large and small clusters of intracellular GLUT4 
staining in human skeletal muscle and a significant increase in colocalisation of GLUT4 with 
the PM marker dystrophin in human skeletal muscle 30 min after the start of an oral glucose 
tolerance test. 
Type 2 Diabetes Mellitus (T2D) is characterized by a failure to increase glucose uptake into 
peripheral tissues such as skeletal muscle in response to physiological increases in plasma 
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insulin concentration that results in chronic hyperglycaemia. Skeletal muscle is regarded to be 
the most significant site of insulin resistance with leg glucose uptake, presumably 
representative of skeletal muscle, being reduced by 45 % in patients with T2D compared to 
insulin sensitive controls (DeFronzo et al., 1985). Impairments in insulin-induced 
translocation of GLUT4 to the PM of skeletal muscle are assumed to make an important 
contribution to skeletal muscle and whole body insulin resistance. The underlying 
mechanisms have been described in chapter 1 of this thesis (Zierath et al., 1996). 
Chronic hyperglycaemia plays a key role in the pathogenesis and complications of T2D in 
humans in vivo by impairing insulin secretion and exacerbating peripheral insulin resistance 
(Zierath et al., 2000). A number of studies, which are outlined below, have also explored the 
acute effect of hyperglycaemia on whole body glucose disposal and skeletal muscle and 
endothelial cell insulin sensitivity in vivo and in vitro. Two hour glucose infusion, with 
somatostatin to inhibit insulin release, raised plasma glucose concentration to approximately 
26 mM and increased whole body glucose disposal in healthy insulin sensitive participants 
(Katz et al., 1991). In contrast perfusion of rat hindquarters with 5 – 25 mM glucose for 2 h 
has been shown to reduce insulin-mediated skeletal muscle glucose uptake (Hansen et al., 
1992). Similarly 5 h of hyperglycaemia reduced insulin-stimulated glucose uptake in rat 
hindlimbs (Richter et al., 1988). Furthermore incubation of human myotubes in 
hyperglycaemic conditions (20 mM glucose) reduced insulin sensitivity and glucose uptake 
(Aas et al., 2011). Human satellite cells from the vastus lateralis differentiated in 20 mM 
glucose for 4-7 days exhibited reduced insulin-stimulated glucose uptake compared to cells 
incubated in 5 mM glucose with no differences in GLUT4 protein content or mRNA 
concentration (Aas et al., 2004, Green et al., 2012). Furthermore, exposure of bovine aortic 
endothelial cells to high glucose (25 mM) for 24 h impaired insulin-mediated activation of 
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eNOS and production of NO (Kim et al., 2005), potentially suggesting that 24 h of 
hyperglycaemia in vivo may impair insulin-mediated capillary recruitment and, therefore, 
reduce glucose uptake in skeletal muscle (Steinberg et al., 1994, Vincent et al., 2003). Finally, 
normalising plasma glucose concentrations through 3 week subcutaneous insulin infusion in 
T2D patients improved insulin sensitivity as measured using a hyperinsulinaemic-
euglycaemic clamp (Garvey et al., 1985). 
Intraperitoneal injection of Wistar rats with glucose (2 ml, 15 mM) and somatostatin, the 
latter to inhibit the endogenous insulin response, increased the GLUT4 content of isolated PM 
fractions 20 min after injection by 150 % suggesting that acute increases in glycaemia induce 
GLUT4 translocation to the PM (Galante et al., 1995). A 70 % increase in GLUT4 content of 
the PM fraction was also seen after a rat hind-limb perfusion with 25 mM glucose (Galante et 
al., 1995).  To the author’s knowledge no measurements have been made of GLUT4 content 
of the PM in response to acute hyperglycaemia in skeletal muscle obtained from normal 
glucose tolerant (NGT) and T2D human volunteers. Furthermore in the published experiments 
presented above GLUT4 content of the PM was measured by isolation of the PM fraction by 
centrifugation followed by a Western blot to measure GLUT content. This method has been 
criticised previously (Schertzer et al., 2009, Fazakerley et al., 2009) as isolated PM fractions 
can be contaminated in such studies with intracellular GLUT4-containing membranes and 
because this method does not discriminate between GLUT4 in the vicinity of the PM or fused 
with the PM. 
This study, therefore aimed to investigate the effect of acute hyperglycaemia on whole body 
glucose disposal rates, insulin sensitivity and colocalisation of GLUT4 with the PM marker 
dystrophin in human skeletal muscle using the immunofluorescence microscopy method 
described in chapter 2 of this thesis. Measurements are made following 2 h hyperglycaemia in 
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individuals with NGT and in patients with T2D and following 24 h hyperglycaemia in the 
NGT group only. We investigate the hypotheses that whole body glucose disposal rates and 
the colocalisation of GLUT4 and dystrophin are higher in NGT compared to T2D following 2 
h of hyperglycaemia. Secondly we hypothesise that insulin sensitivity and colocalisation of 
GLUT4 and dystrophin are reduced in response to 24 h hyperglycaemia in the NGT group due 
to hyperglycaemia-induced impairments in translocation of GLUT4.  
 
6.3. Methods 
Ethics and recruitment. All protocols in this study were approved by the Ethics Committee of 
the Capital Region of Denmark and conformed to the Declaration of Helsinki. Inclusion 
criteria were age 18 – 30 y, BMI 20 – 35 kg.m
-2
, < 150 min exercise per week, free from 
cardiovascular, pulmonary, renal and hepatic disease and non-insulin treated. Ten gender-, 
age- and BMI-matched individuals with NGT and patients with T2D were recruited and gave 
written informed consent before participating. Type 2 diabetes was controlled with metformin 
(n = 7), sulfonylureas (n = 1), and liraglutide (n = 2). Drugs were withdrawn 7 days before 
testing. All participants completed preliminary testing consisting of an oral glucose tolerance 
test (OGTT) and VO2peak determination. For the OGTT an overnight fasted baseline venous 
blood sample was collected prior to ingestion of 300 ml of a 25 % glucose solution. 
Subsequent blood samples were then collected 60 min and 120 min after glucose ingestion to 
analyse plasma glucose and insulin concentration and determine insulin sensitivity through 
calculation of the Matsuda index. VO2peak was determined using a modified Bruce protocol on 
a treadmill. There was a 2% increase in incline every 2 min with subjects at a constant self-
determined fast-paced walking speed. VO2 and VCO2 were measured on-line using a CPET 
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system (Cosmed; Rome, Italy). VO2peak was taken as the mean of the 3-values of VO2 
measured around the maximum recorded VO2 value. 
Testing protocol. All NGT and T2D participants arrived at the laboratory after an overnight 
fast at 8 am (day 1) for experiment 1 of the testing procedures. All procedures were carried 
out at The Centre of Inflammation and Metabolism in Copenhagen and have been detailed in 
full previously (Solomon et al., 2012). The protocol is depicted in Fig. 6.1. An overnight 
fasted baseline muscle biopsy sample was taken from the vastus lateralis using the Bergström 
percutaneous needle biopsy technique (Bergstrom, 1975) and the sample was immediately 
processed as below. The following morning (day 2) one antecubital iv line was placed for 
glucose infusion and one dorsal hand iv line for blood sampling. Blood was arterialised by 
placing the sampling hand in a heated blanket (~60
o
C) and an overnight fasted baseline 
sample was collected. At t = -2 h (~8 am) a primed (20 µmol.kg
-1
 multiplied by fasting 




) infusion of [6,6-
2
H2] glucose 
commenced. At t = 0 h a 2 h variable rate glucose infusion was initiated to elevate plasma 
glucose by 5.4 mM above basal (2 h hyperglycaemia). The infusion rate of [6,6-
2
H2] glucose 




. Arterialised blood samples were taken every 5 min, 
glucose concentrations were measured (ABL 725; Radiometer, Copenhagen, Denmark), and 
the glucose infusion rate was adjusted as required to clamp glucose 5.4 mM above basal. At t 
= 2 h a second muscle biopsy was taken and processed as below. On a separate occasion, 
NGT participants also completed experiment 2.  Participants arrived at the laboratory after an 
overnight fast (day 1); two iv lines were placed and a variable rate glucose infusion was 
initiated (at ~ 8 am) as in experiment 1 on this occasion to elevate plasma glucose 5.4 mM 
above basal for 24 h (24 h hyperglycaemia). The following day (day 2) a final muscle biopsy 
was taken 24 h after the commencement of hyperglycaemia and processed as below. After 22 
225 
 




) infusion of [6,6-
2
H2] 
glucose was commenced for 2 h to measure whole body glucose disposal rate. Blood samples 
were collected into plain vacuettes for determination of plasma insulin concentration and 
sodium fluoride (NaF, Greiner Bio-One, Kremsmünster, Austria) vacuettes to determine 
plasma glucose tracer enrichment by GC-MS. Plasma was separated by centrifugation for 15 
min at 2000 g at 4
o
C and stored at -80
o
C until analysis. 
 
 
Fig. 6. 1. Hyperglcyaemic glucose clamp participant testing protocol. 
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Calculation of insulin sensitivity. A single pool model was used to calculate glucose flux rates 
(Steele, 1959). Glucose disposal rate was corrected for urinary glucose output. Glucose 
kinetics data have been published previously (Solomon et al., 2012) and are duplicated in the 
results section of this chapter (section 6.4) to enable interpretation of the GLUT4 and 
dystrophin colocalisation data. 
To calculate whole-body insulin sensitivity, glucose disposal rate was divided by mean 
plasma insulin (Rd/[I]) during the final 30 min of the hyperglycaemic clamp. As subjects were 
clamped ~5.4 mM above basal glucose concentration each subject was clamped at a different 
absolute glucose concentration. In order to correct for this, insulin sensitivity was divided by 
mean plasma glucose during the final 30 min of the glucose-only stage of the clamp. 
Therefore insulin sensitivity was calculated as glucose disposal rate divided by plasma insulin 
multiplied by plasma glucose (Rd/[I][G]). 
Muscle sample collection and processing. All post-sample collection processing and storage 
is described in detail in chapter 2. 
Immunofluorescence staining protocol. NGT and T2D participants were pair matched and for 
each pair NGT cryosections for overnight fasted baseline (NGT baseline), 2 h hyperglyaemia 
(NGT 2 h) and 24 hr hyperglycaemia (NGT 24 h) and T2D cryosections for overnight fasted 
baseline (T2D baseline) and 2 h hyperglycaemia (T2D 2 h) were cut onto one slide. Slides 
were prepared and analysed in triplicate. Sections were either stained immediately or stored at 
-20
o
C prior to use. 
Full details of the GLUT4 and dystrophin immunofluorescence staining protocol are provided 
in chapter 2. 
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Image capture. Images were captured using an inverted confocal microscope (Leica DMIRE2, 
Leica Microsystems) with a 63x oil immersion objective (1.4 NA). AlexaFluor 488 
fluorophores were excited with a 488 nm line of the argon laser and 498-571 nm emission. 
Alexa Fluor 594 fluorophores were excited with the 594 nm line of the helium-neon laser and 
601-713 nm emission. For all subjects (N = 20) images were captured from 3 sections for 
each condition (NGT baseline, 2 h and 24 h hyperglycaemia and T2D overnight fasted 
baseline and 2 h hyperglycaemia), with 5 images captured per section. This equated to 179 ± 
19, 154 ± 17, 145 ± 24, 161 ± 12 and 123 ± 16 fibres analysed for NGT pre, post 2 h, post 24 
h, T2D pre and post 2 h, respectively. 
Image quantitation. Full details of image analysis of GLUT4 and dystrophin colocalisation 
are presented in chapter 2. In brief, GLUT4 and dystrophin image pairs had a no neighbour 
deconvolution algorithm inbuilt into Image-Pro Plus 5.1 applied to them. The colocalisation 
tool in Image-Pro Plus 5.1 was then used to calculate the Pearson’s correlation coefficient of 
each image pair. Analysis of GLUT4 fluorescence intensity within each muscle fibre was 
completed using the GLUT4 images with muscle fibres delineated based on the dystrophin 
image. No processing was carried out on the GLUT4 images. The appropriate dystrophin 
image was used to create an outline of fibres; firstly a flatten background filter was applied 
and fibres were identified using consistent intensity and size thresholds. The dystrophin fibre 
outline was applied to the GLUT4 images to measure GLUT4 fluorescence intensity within 
each fibre. 
Statistics. All statistical testing was completed using SPSS statistics 19 (Chicago, IL). Age-, 
BMI- and VO2max-matched NGT and T2D groups were confirmed using independent samples 
T tests. Statistical significance of insulin sensitivity data during hyperglycaemia was assessed 
using a repeated measures ANOVA with post hoc Bonferroni used to investigate significance 
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of pairwise comparisons. Plasma glucose and insulin, GLUT4 and dystrophin colocalisation 
and GLUT4 fluorescence intensity were assessed using a repeated measures ANOVA in NGT 
subjects, with post hoc Bonferroni analysis of significant main effects, and a paired T test in 
T2D subjects. Independent T tests were used to compare overnight fasted baseline NGT and 
T2D data and 2 h NGT and T2D data. Significance was set at P < 0.05. Data is displayed at 
mean ± SEM. 
 
6.4. Results 
Subject characteristics. Subject characteristics and OGTT-derived insulin sensitivity 
measures are shown in Table 6.1. Ten NGT and 10 T2D were matched according to gender 
(male:female, 8:2), age (NGT 56 ± 3 y, T2D 54 ± 2 y), BMI (NGT 31.3 ± 1.2 kg.m
-2
 , T2D 
28.9 ± 1.0 kg.m
-2













Table 6.1. Participant characteristics   
 
NGT T2D 
 N = 10 N = 10 
Gender (M/F) 8/2 8/2 
Age (y) 56 ± 3 54 ± 2 
BMI (kg.m
-2





) 32.1 ± 1.7 28.3 ± 1.2 
Fasting plasma glucose (mM) 5.3 ± 0.2 9.1 ± 1.0* 





) 12.9 ± 1.9 12.8 ± 1.4 
HOMA-IR 3.7 ± 1.0 6.6 ± 0.6* 
Matsuda ISI 5.7 ± 1.7 2.2 ± 0.2* 
Data shown is mean ± SEM. * T2D significantly different to NGT, independent samples T test, 
P < 0.05. 
#
2 hr plasma glucose significantly different to baseline, paired samples T test, P < 
0.01. 
 
Plasma glucose and insulin concentrations in the overnight fasted state and during 
hyperglycaemia. Plasma glucose and insulin at time of biopsy are shown in Fig. 6.2. In the 
overnight fasted state plasma glucose was 5.8 ± 0.2 mM in NGT and 10.0 ± 1.3 mM in T2D 
(P = 0.006). Plasma glucose was increased by approximately 5.4 mM following 2 h 
hyperglycaemia in both groups (NGT 10.8 ± 0.1 mM, T2D 15.3 ± 1.3 mM) and remained at 
this level following 24 h hyperglycaemia in NGT (11.3 ± 0.1 mM). There were no differences 





, T2D 12.8 ± 1.4 µIU.mL
-1
, P = 0.997). In NGT plasma insulin was significantly 
increased above the overnight fasted baseline following 2 h (73.1 ± 16.2 µIU.mL
-1
, P = 
0.007) and 24 h hyperglycaemia (166.5 ± 30.3 µIU.mL
-1
, P = 0.001). Plasma insulin 
increased significantly from 2 h to 24 h hyperglycaemia (P = 0.002). In T2D plasma insulin 
increased significantly above the overnight fasted baseline following 2 h hyperglycaemia 
(36.1 ± 8.9 µIU.mL
-1






Fig. 6.2. Plasma glucose and insulin concentrations in the overnight fasted state and during 
hyperglycaemia. Graphs shown mean ± SEM. NGT repeated measures ANOVA P < 0.001 for 
glucose and insulin, post hoc Bonferroni * significantly different to overnight fasted state P < 
0.01, 
$
 2 h significantly different to 24 h P < 0.01. T2D paired T test, 
#
 significantly different 
to baseline P < 0.05. Independent samples T test to compare NGT and T2D plasma glucose 




Glucose disposal, endogenous glucose production and insulin sensitivity. Rates of glucose 
disposal (Rd) and endogenous glucose production (EGP) have been previously reported 
(Solomon et al., 2012) and are displayed in Fig. 6.3. Baseline Rd was higher in T2D than 
NGT. Rd during the final 30 min of 2 h and 24 h hyperglycaemic clamp was increased above 













, P < 0.05). In contrast, Rd during the final 30 min of 
2 h hyperglycaemic clamp in T2D was not significantly elevated above baseline (T2D 








). Rd during the final 
30 min of hyperglycaemic clamp was significantly lower in T2D 2 h compared to both NGT 2 









, P < 0.05). EGP was suppressed in 














 for 2 h and 24 h, respectively). When glucose disposal was corrected for 
plasma insulin concentration (Rd/[I]) there was no difference between NGT 2 h, 24 h or T2D 




















.L, P = 0.138, Fig. 6.4A). Rd/[I][G], which is a measure of insulin sensitivity, was 
significantly lower during the final 30 min of the hyperglycaemic clamp in NGT 24 h and 
































.L, P = 0.004, Fig 6.4B). There was no difference between 





Fig. 6.3. Mean glucose disposal rate (Rd, A) and mean endogenous glucose production (EGP, 
B) at baseline and during the final 30 min of 2 h and 24 h hyperglycaemic clamp. Graph 
shows mean ± SEM. * P < 0.05 compared to NGT baseline. 
#
 P < 0.05 compared to NGT 2 h. 
$
 P < 0.05 compared to NGT 24 h. ^ P < 0.05 compared to T2D baseline. Glucose kinetics 





Fig. 6.4. Mean glucose disposal corrected for plasma insulin concentration (A) and corrected 
for both plasma insulin and plasma glucose concentration (B) during final 30 min of 2 h and 
24 h hyperglycaemic clamp. Insulin sensitivity is calculated from mean glucose disposal rate 
corrected for plasma glucose and insulin concentrations. Repeated measures ANOVA (A) P = 
0.138 and (B) P = 0.004. Post hoc Bonferroni pairwise comparisons *significantly different 
to NGT 2hr P < 0.05, # significantly different to NGT 24 hr P < 0.001. 
 
GLUT4 and dystrophin colocalisation. The Pearson’s correlation coefficient was used to 
measure the degree of colocalisation between GLUT4 and dystrophin immunofluorescence 
staining. GLUT4 and dystrophin images are shown in Fig. 6.5. The merged images display 
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the degree of colocalisation between GLUT4 and dystrophin. The Pearson’s correlation 
coefficient data is shown in Fig. 6.6. There were no differences in Pearson’s correlation 
coefficient between NGT and T2D in the overnight fasted state (NGT r = 0.38 ± 0.01, T2D r 
= 0.39 ± 0.01, P = 0.665). In NGT there was no difference in Pearson’s correlation coefficient 
from the overnight fasted state following 2 h (r = 0.37 ± 0.01) and 24 h (r = 0.38± 0.01) of 
hyperglycaemia (P = 0.525). Similarly in T2D subjects there was no difference in Pearson’s 
correlation coefficient between the overnight fasted state and following 2 h of hyperglycaemia 
(r = 0.38 ± 0.01, P = 0.160). Furthermore there were no differences in Pearson’s correlation 
coefficient between NGT and T2D following 2 hr hyperglycaemia (P = 0.420). Therefore the 




Fig. 6.5. Representative confocal images of GLUT4 (green) and dystrophin (red) in skeletal 
muscle fibres of NGT and T2D participants in the overnight fasted state and following 2 h and 
24 h (NGT only) hyperglyaemia. Merged images represent GLUT4 and dystrophin 




Fig. 6.6. Pearson’s correlation coefficient to measure colocalisation of GLUT4 and 
dystrophin in skeletal muscle fibres of NGT and T2D participants in the overnight fasted state 
and following 2 hr and 24 hr (NGT only) of hyperglyaemia. Graph shows mean ± SEM. NGT 
repeated measures ANOVA P = 0.525. T2D paired T test P = 0.160. Independent samples T 
test to compare NGT and T2D in the overnight fasted state P = 0.665. Independent samples T 
test to compare NGT and T2D 2 h P = 0.420. 
 
GLUT4 fluorescence intensity. The total GLUT4 protein content in the overnight fasted state 
and following 2 h and 24 h of hyperglycaemia was assessed by measuring the fluorescence 
intensity of the GLUT4 stain within the muscle fibres (mean of > 100 fibres in each 
condition). The data is shown in Fig. 6.7. There were no differences in GLUT4 fluorescence 
intensity, therefore no differences in total GLUT4 protein content, between NGT and T2D in 





Fig. 6.7. GLUT4 fluorescence intensity as a measure of total GLUT4 protein content in 
skeletal muscle fibres of NGT and T2D participants in the overnight fasted state and 
following 2 h and 24 h (NGT only) hyperglycaemia. Graph shows mean ± SEM. NGT 
repeated measures ANOVA P = 0.089. T2D paired T test P = 0.696. Independent samples T 
test to compare NGT and T2D in the overnight fasted state P = 0.460. Independent samples T 
test to compare NGT and T2D 2 h P = 0.760. 
 
6.5. Discussion 
In the current study, 2 h of hyperglycaemia in both NGT and T2D was sufficient to raise 
plasma insulin concentrations above values seen in the overnight fasted state and was 
sufficient to increase rates of whole body glucose disposal above baseline in NGT. However, 
despite this increase in whole body glucose disposal following 2 h hyperglycaemia in NGT 
and in contrast to our initial hypothesis, there was no increase in the colocalisation of GLUT4 
with the PM marker dystrophin. Furthermore, colocalisation of GLUT4 and dystrophin was 
the same in NGT and T2D following 2 h hyperglycaemia despite significantly higher whole 
body glucose disposal rates in NGT compared to T2D. These results indicate that GLUT4 PM 
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content was not responsible for the increased whole body glucose disposal rates that occurred 
following 2 h hyperglycaemia in NGT nor the lower glucose disposal rate observed in T2D. 
Following 24 h of hyperglycaemia in NGT, insulin sensitivity, measured as Rd/[I][G] (Rd 
corrected for prevailing insulin and glucose concentrations), was reduced to comparable 
levels as seen in T2D after 2 h of hyperglycaemia, however there were again no significant 
changes in GLUT4 and dystrophin colocalisation. 
Glucose disposal rates. Baseline endogenous glucose production and glucose disposal rates 
were higher in T2D than NGT. This is in agreement with previous studies (DeFronzo et al., 
1989) and is in line with the well described mass action effect on glucose transport, which is 
explained by the higher prevailing glucose concentrations in T2D (Yki-Jarvinen et al., 1987a, 
Yki-Jarvinen et al., 1987b). Glucose disposal rates increased significantly above baseline in 
the final 30 min of 2 h and 24 h hyperglycaemic clamp in NGT. In contrast glucose disposal 
rates were not increased above baseline in the final 30 min of hyperglycaemic clamp in T2D 
and furthermore were significantly lower in T2D compared to NGT in the final 30 min of 2 h 
hyperglycaemic clamp. This is likely due to a combination of lower insulin secretion rates 
resulting in lower plasma insulin concentrations and peripheral insulin resistance, which both 
characterise T2D. Interestingly, when corrected for plasma insulin concentrations there were 
no differences in glucose disposal between NGT and T2D. This can be explained by the 
ability of glucose to increase its own uptake (termed mass action effect of glucose) given the 
higher plasma glucose concentrations in T2D. This is in line with previous studies where 
glucose disposal is not different in T2D when measured using a hyperinsulinemic-
isoglycemic clamp, where plasma glucose is clamped at fasting glucose concentration 
(Mandarino et al., 1990, Vaag et al., 1992). In the current study, impairments in insulin 
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sensitivity are observed in T2D when corrected for both prevailing plasma glucose and 
plasma insulin concentrations. 
GLUT4 and dystrophin colocalisation after 2 h hyperglycaemia. Acute elevations in plasma 
glucose and insulin concentrations have been shown to independently induce GLUT4 
translocation in skeletal muscle of Wistar rats using subcellular fractionation methods 
(Galante et al., 1995). It was therefore surprising that there was no increase in GLUT4 and 
dystrophin colocalisation following 2 h of hyperglycaemia in NGT in the study presented 
here, despite elevated plasma glucose and insulin concentrations and increased rates of whole 
body glucose disposal above baseline. A possible explanation for this unexpected finding is 
provided in chapter 4 of this thesis, in which we observed increases in GLUT4 and dystrophin 
colocalisation 30 min after the start of an OGTT, which returned to overnight fasted basal 
levels at 60 and 90 minutes post glucose ingestion. Therefore it is possible that GLUT4 
translocation to the PM in the present study may have occurred at an earlier time point during 
the hyperglycaemic clamp. 
Glucose disposal (Rd) was lower in the final 30 min of hyperglycaemia in T2D 2 h compared 
to NGT 2 h. However there were no differences in GLUT4 and dystrophin colocalisation 
between NGT 2h and T2D 2h, indicating that skeletal muscle PM GLUT4 content is not the 
primary determinant of the lower rates of glucose disposal in T2D.  
GLUT4 and dystrophin colocalisation after 24 h hyperglycaemia in NGT. GLUT4 and 
dystrophin colocalisation was again unchanged following 24 h of hyperglycaemia despite the 
persistent and very large elevations in plasma insulin and the sustained high rates of glucose 
disposal. There was no difference in whole body glucose disposal in the final 30 min of 2 h 
and 24 h hyperglycaemia in NGT, though plasma insulin concentration was significantly 
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higher following 24 h hyperglycaemia compared to 2 h. Therefore, when correcting glucose 
disposal for plasma glucose and insulin concentrations, insulin sensitivity (Rd/[I][G]) in the 
final 30 min of 24 h hyperglycaemia in NGT was reduced to comparable levels to T2D 
following 2 h hyperglycaemia, indicating more insulin is required to achieve an equivalent 
glucose disposal response. However, as GLUT4 and dystrophin colocalisation is unchanged 
in NGT during elevated rates of glucose disposal, and is not different between NGT and T2D 
despite marked differences in glucose disposal rates, it appears unlikely to be the major 
determinant of elevated rates of glucose disposal or impaired insulin action following 24 h of 
hyperglycaemia.  
Alternative mechanisms that may contribute to the increased rates of whole body glucose 
disposal following hyperglycaemia in NGT. As GLUT4 PM content does not change 
following hyperglycaemia in NGT there must be alternative mechanisms that contribute to the 
elevated rates of whole body glucose disposal. 
As discussed above, during hyperglycaemia the mass action effect resulting from the steeper 
concentration gradient between arterial and intracellular glucose are highly likely to 
contribute to the high rates of glucose disposal in the present study (Yki-Jarvinen et al., 
1987a). In support of this, whole body glucose disposal is almost doubled as a result of 
doubling the plasma glucose concentration without increases in plasma insulin concentrations 
(Yki-Jarvinen et al., 1987b). Therefore baseline glucose transporter PM content in peripheral 
tissues may be sufficient to drive the increased whole body glucose disposal during 
hyperglycaemia in NGT via the mass action effect. 
GLUT4 localisation at the T-tubule membranes has not been analysed in the current study due 
to methodological difficulties in quantitation which are explained in chapter 2. However 
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chapter 2 of this thesis did demonstrate the presence of GLUT4 in the T tubule membranes of 
human skeletal muscle. Therefore, it is possible that increases in GLUT4 localisation may 
have been more prominent at the T-tubule membranes compared to the PM in the current 
study. This raises the possibility that GLUT4 in the T-tubule membranes may have 
contributed to skeletal muscle glucose uptake and the increased whole body glucose disposal 
observed during hyperglycaemia in NGT. However, further methodological advances are 
needed in order to examine this possibility in human muscle. 
An additional alternative mechanism that is likely to make significant contributions to 
increased whole body glucose disposal rates and skeletal muscle glucose uptake in particular 
during 2 h hyperglycaemia in NGT is increased skeletal muscle microvascular recruitment 
induced by the elevated plasma insulin concentrations. An increase in the capillary 
permeability surface area product and glucose delivery to the muscle fibre is known to be a 
key determinant of skeletal muscle glucose uptake in response to insulin (Steinberg et al., 
1994, Vincent et al., 2006, Gudbjornsdottir et al., 2003). 
Although skeletal muscle is generally considered the quantitatively most important tissue for 
glucose disposal, even during hyperglycaemia (Baron et al., 1988), it is also important to 
consider that tissues other than skeletal muscle, namely liver and adipose tissue, may 
contribute significantly to whole body glucose disposal in conditions of hyperglycaemia. 
Muscle, adipose tissue and liver may all contribute to the high rates of whole body glucose 
disposal measured in the current study. For example, intravenous glucose infusion to induce 
hyperglycaemic-hyperinsulinaemia resulted in a doubling of splanchnic (primarily liver, gut 
and pancreas) glucose uptake in comparison to euglycaemic-hyperinsulinaemia (Ferrannini et 
al., 1980, DeFronzo et al., 1978). Furthermore in animal models exhibiting reduced capillary 
density through muscle specific vascular endothelial growth factor (VEGF) knockout, whole 
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body glucose disposal did not change in comparison to wild type animals, however more 
glucose was deposited as glycogen in the liver during hyperinsulinaemic-euglycaemic clamp 
suggesting increased liver glucose uptake (Bonner et al., 2013). Therefore in the current study 
in which hyperglycaemia (24 h in particular) may have impaired microvascular recruitment 
(see subsequent section, Kim et al., 2005), high whole body glucose disposal rates may have 
been maintained in part through increased splanchic glucose uptake. In addition during 
hyperinsulinaemic-euglycaemic clamp in obese rats adipose tissue glucose utilisation was 
increased compared to lean rats (Penicaud et al., 1987). Therefore it is possible that increased 
rates of whole body glucose disposal were achieved in part at least through increased glucose 
uptake into other tissues than skeletal muscle during hyperglycaemia in NGT. 
Alternative mechanisms that may contribute to reduced rates of whole body glucose disposal 
in T2D. Obesity and T2D have been associated with reduced insulin-mediated NO production 
from vascular endothelial cells and reduced capillary density (Barrett et al., 2009, Barrett et 
al., 2011, Wagenmakers et al., 2006). The subsequent impairment in insulin-mediated skeletal 
muscle microvascular recruitment and lower glucose and insulin delivery to the muscle bed, 
has been shown to be reduced in obese compared to lean humans and has been suggested to 
significantly contribute to the development of skeletal muscle insulin resistance  (Clerk et al., 
2002, Clerk et al., 2006, Keske et al., 2009). Therefore, it is likely that reduced glucose 
delivery to the skeletal muscle contributes to the reduced skeletal muscle glucose uptake and 
therefore reduced whole body glucose disposal observed following 2 h hyperglycaemia in 
T2D compared to NGT.  
Alternative mechanisms that may contribute to reduced insulin sensitivity in NGT following 
24 h hyperglycaemia. In the current study high rates of whole body glucose disposal were 
maintained following 24 h hyperglycaemia in NGT, without changes in skeletal muscle PM 
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GLUT4 content. However insulin sensitivity (calculated by correcting glucose disposal for 
plasma glucose and insulin concentrations, (Rd/[I][G])) in the final 30 min of 24 h 
hyperglycaemia in NGT was reduced to comparable levels to T2D following 2 h 
hyperglycaemia. It has been shown previously that exposure of muscle cells to 
hyperglycaemic conditions in vitro induces defects in the insulin signalling pathway (Pillay et 
al., 1996). However, as there was no apparent change in GLUT4 localisation in the current 
study, it seems that mechanisms other than impaired GLUT4 translocation explain the 
reduction in insulin action following 24 h of hyperglycaemia in humans. 
A previous study showed that bovine aortic endothelial cells exposed to high glucose (25 
mM) for 24 h exhibit impaired insulin mediated activation of eNOS and production of NO 
(Kim et al., 2005). If such an effect were to occur in humans in vivo, then it would impair 
terminal arteriole dilation and microvascular recruitment in skeletal muscle and contribute to 
skeletal muscle insulin resistance (Kim et al., 2005, Steinberg et al., 1994, Vincent et al., 
2003). Therefore it is possible that in the current study 24 h hyperglycaemia in vivo in humans 
may induce insulin resistance through impaired eNOS activation and microvascular 
recruitment and this is an important area for future investigation.  
Conclusions. In conclusion, 2 h and 24 h of hyperglycaemia did not influence the 
colocalisation of GLUT4 with the PM marker dystrophin in NGT despite substantial 
elevations in plasma insulin concentrations and increased rates of whole body glucose 
disposal. According to this study, factors other than GLUT4 presence at the skeletal muscle 
PM, such as T-tubule membrane GLUT4 localisation, microvascular recruitment (Clark, 
2008), glucose uptake into other tissues (Ferrannini et al., 1980, DeFronzo et al., 1978), and 
the glucose mass action effect (Yki-Jarvinen et al., 1987a) may be responsible for the 
elevation in whole body glucose disposal rate in the final 30 min of 2 h hyperglycaemia in 
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NGT compared to baseline. In addition, neither the lower whole body glucose disposal rate 
that occurred in the final 30 min of 2 h hyperglycaemia in T2D nor the insulin resistance that 
developed after 24 h of hyperglycaemia coincided with a decrease in GLUT4 and dystrophin 
colocalisation. Impairments in insulin-stimulated activation of microvascular eNOS and 
skeletal muscle capillary recruitment are potential alternative mechanism by which prolonged 
hyperglycaemia reduces insulin sensitivity. 
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Excess calorific intake and reduced levels of physical activity are contributing to the 
increasing prevalence of obesity and type 2 diabetes (T2D) worldwide. Overt T2D is preceded 
by insulin resistance; a phenomenon whereby peripheral tissues do not respond adequately to 
insulin resulting in hyperglycaemia and related complications. The mechanisms that 
contribute to increased postprandial glucose uptake in healthy individuals need to be further 
investigated in order to identify the main targets for interventions to combat the increasing 
prevalence of T2D. Skeletal muscle is both the primary site of postprandial glucose uptake in 
insulin sensitive individuals (Katz et al., 1983, Ferrannini et al., 1985) and a major site of 
insulin resistance in obesity and T2D (DeFronzo et al., 1985). GLUT4 is the major glucose 
transporter isoform expressed in skeletal muscle (Mueckler, 1994). As such GLUT4 has a 
significant role to play in the successful, or unsuccessful, maintenance of glucose 
homeostasis. In the published literature membrane fractionation methods have been used to 
isolate the plasma membrane (PM) fraction of human skeletal muscle and estimate its GLUT4 
content. However these methods have been criticised as they have a number of 
methodological limitations. Firstly membrane fractionation requires very large muscle 
samples (~1g) which would be impractical to achieve using the Bergstrom percutaneous 
needle biopsy technique (Bergstrom, 1975). However of greater importance is the potential 
contamination of PM fractions with myofibrillar proteins and other GLUT4-containing 
membranes (Fazakerley et al., 2009b) and the inability to discriminate between GLUT4 just 
adjacent to the PM and GLUT4 fully incorporated into the PM and able to transport glucose 
(Schertzer et al., 2009). Both of these limitations may lead to overestimation of the GLUT4 
content of the PM. Therefore an overarching aim of this thesis was to develop an 
immunofluorescence microscopy method suitable for measurement of both the subcellular 
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distribution of GLUT4 in storage vesicles of various sizes and the colocalisation of GLUT4 
with the PM marker dystrophin in sections of human skeletal muscle (chapter 2). This method 
was then used in the subsequent chapters to compare the effect of 2 modes of exercise training 
(chapter 3), acute oral glucose ingestion, endurance exercise and the combination of the two 
(chapter 4), a hyperinsulinaemic-isoglycaemic clamp in lean and obese Zucker rats (chapter 5) 
and a hyperglycaemic clamp in human volunteers with normal glucose tolerance (NGT) and 
T2D (chapter 6) on size and distribution of the GLUT4 stores and colocalisation with the PM 
marker dystrophin. 
 
7.2. Novel findings of this thesis and relevance to the existing literature 
7.2.1. GLUT4 immunofluorescence microscopy method development 
An immunofluorescence microscopy method has been developed using a fully validated 
GLUT4 antibody to visualise the subcellular distribution of GLUT4 in human and rat skeletal 
muscle (chapter 2). This method has shown that GLUT4 in human vastus lateralis muscle in 
the overnight fasted state is present in large clusters (> 1 µm diameter) and in smaller clusters 
(< 1µm diameter), which are both dispersed throughout the cell interior. GLUT4 clusters of 
both sizes are also observed close to or colocalising with the PM marker dystrophin, in 
particular in perinuclear regions. This subcellular distribution is very similar to the 
distribution seen previously in the published literature in rodent skeletal muscle using 
confocal fluorescence and transmission electron microscopy with the majority of GLUT4 
localised to the fibre periphery and in large and small clusters (Ploug et al., 1998, Lauritzen et 
al., 2006). This similarity provides the first indication that the immunofluorescence 
microscopy method developed in this thesis is valid. A Pearson’s correlation coefficient of 
approximately 0.4 in the overnight fasted state indicated that substantial GLUT4 and 
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dystrophin colocalisation was already present in the overnight fasted state. In support of this 
observation studies in transgenic mouse muscle fibres using labelling of exofacially tagged 
GLUT4 demonstrate GLUT4 fusion with the PM in the basal state; with one study describing 
a small amount of exofacially-tagged GLUT4 labelling in the basal state (Lizunov et al., 
2012) and another reporting a more substantial amount with externalised myc labelling under 
basal conditions approximately 50 % of that after insulin stimulation (Schertzer et al., 2009). 
In addition the images in chapter 2 also show that GLUT4 colocalises with the T-tubule 
membrane marker DHPR in the overnight fasted state. These findings are in contrast to EM 
studies in rodent skeletal muscle using the immunogold labelling technique that report very 
little GLUT4 in the PM and T-tubule membranes in the basal state (Ploug et al., 1998, 
Rodnick et al., 1992). As explained, however, in chapter 1 there are some methodological 
issues with immunogold labelling of GLUT4 which may lead to an underestimation of the 
GLUT4 content of the PM in the basal state. The above immunofluorescence method was 
subsequently used to generate the novel results described in the following chapters of the 
thesis, which are summarised in the subsequent sections. 
7.2.2. Training induced changes in subcellular GLUT4 distribution and GLUT4 content 
In chapter 3 a comparison was made between the effect of 6 weeks sprint interval training 
(SIT, repeated Wingate sprints) and traditional endurance training (ET) on total GLUT4 
protein content and subcellular distribution in human vastus lateralis muscle of previously 
sedentary young men. This immunofluorescence microscopy technique confirmed equivalent 
increases in total muscle GLUT4 content seen previously using Western blot analysis 
following ET and SIT (Burgomaster et al., 2007, Little et al., 2010) and furthermore showed 
that the increases in total GLUT4 protein content were primarily due to an increase in number 
and area of the intracellular GLUT4 staining clusters. Large clusters (> 1 µm diameter) 
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increased predominantly in number, while the smaller clusters (< 1 µm diameter) increased in 
size, with no increase in number. Assuming that the increases in the intracellular GLUT4 
stores also increase the total amount of GLUT4 available for translocation, this may 
contribute to the improved glucose homeostasis that was seen both after ET and SIT 
interventions of 1 -12 weeks in duration (Hughes et al., 1993, Dela et al., 1996, Cox et al., 
1999, Babraj et al., 2009, Richards et al., 2010, Phillips et al., 1996, Daugaard et al., 2000, 
Burgomaster et al., 2007, Hood et al., 2011, Little et al., 2010). The colocalisation of GLUT4 
with the PM marker dystrophin in biopsies taken in the overnight fasted state did not change 
following training. However, a more detailed analysis of the GLUT4 stores in close proximity 
to the PM is required to further investigate the subcellular localisation of increases in GLUT4 
content. This will be discussed in section 7.5 of this chapter. Previous literature suggested that 
the increase in GLUT4 following training occurs in insulin responsive stores in particular, 
therefore, increasing the GLUT4 available for GLUT4 translocation in response to a given 
insulin stimulus (Ivy, 2004).  
7.2.3. Effect of acute exercise and oral glucose ingestion on GLUT4 localisation 
In chapter 4 immunofluorescence visualisation of GLUT4 using the method developed in 
chapter 2 has clearly shown an increase in GLUT4 staining around the PM following 30 min 
of cycling exercise at 65 % of VO2max in human skeletal muscle. GLUT4 exhibited a 
continuous PM signal following exercise and marked increases were seen in colocalisation of 
GLUT4 with dystrophin staining both visually and through quantitation using the Pearson’s 
correlation coefficient. Therefore, these results suggest that this newly developed 
immunofluorescence colocalisation method can be used to show exercise-induced increases in 
GLUT4 translocation to the PM in human skeletal muscle. The data presented in this thesis is 
in line with immunofluorescence data in rodent skeletal muscle in which just 5 min of 
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electrical stimulation induced an ~50 % increase in GLUT4 PM content, which was 
maintained during 30 min electrical stimulation (Ploug et al., 1998, Lauritzen et al., 2010). In 
addition chapter 4 showed that the redistribution of GLUT4 in response to exercise occurred 
without any changes in the content and distribution of SNAP23 in the PM, suggesting that 
there is enough SNAP23 present in the overnight fasted state to allow increased docking and 
fusion of GLUT4 in the PM in response to exercise. 
Colocalisation of GLUT4 with dystrophin has also been measured in chapter 4 to investigate 
the effect that an oral glucose tolerance test has on GLUT4 translocation in human skeletal 
muscle. Thirty minutes after glucose ingestion moderate continuous GLUT4 staining along 
the PM was observed with significant increases in Pearson’s correlation coefficient, though 
distinct GLUT4 clusters remained clearly visible. In contrast, the moderate continuous stain 
was not seen after 60 min and 90 min. Collectively these data suggest that GLUT4 
translocation to the PM in response to the physiological rises in plasma insulin following 
glucose feeding is transient. This observation is novel and is somewhat surprising given 
previous observations that rates of glucose disposal (Ferrannini et al., 1985, Breen et al., 
2011) and leg glucose uptake (Katz et al., 1983) are still elevated 90 min following glucose 
ingestion. In addition while Lauritzen et al. (2006) observed accumulation of GLUT4-GFP at 
the mouse muscle fibre border 10 min after injection of insulin into a tail vein, with maximum 
values reached after 20 min (Lauritzen et al., 2006), the accumulation of GLUT clusters in the 
PM region remained elevated for 150 min (Lauritzen et al., 2008). It should, however, be 
noted that the amount of insulin injected was very high in this study and that the plasma 
insulin concentrations reached were equally high (approximately 200 000 µIU.mL
-1
) 
(Lauritzen et al., 2008). For comparison, the hyperinsulinaemic-isoglycaemic clamp in 
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chapter 5 in the lean Zucker rats led to a mean plasma insulin concentration of ~ 320 µIU.mL
-
1. 
In addition the results of chapter 4 suggest that the magnitude of GLUT4 translocation in 
human skeletal muscle is greater following 30 min exercise at 65% VO2max than 30 min 
following glucose ingestion. In adipocytes two modes of insulin-mediated GLUT4 exocytosis 
have been proposed to occur whereby 1) the prevalence of distinct GLUT4 clusters in PM 
regions already present in the basal state increases and 2) GLUT4 molecules disperse into the 
PM (Stenkula et al., 2010). The GLUT4 translocation data in human skeletal muscle 
presented in this thesis may be of relevance to the work of Stenkula et al. (2010). Following 
exercise, the clusters of GLUT4 staining are absent and GLUT4 staining is instead continuous 
along the PM, indicative of GLUT4 dispersal in the PM. On the other hand, following glucose 
ingestion, GLUT4 clusters localised to the PM remain clearly visible despite the appearance 
of moderate continuous staining along the PM at 30 min following glucose ingestion. These 
observations that exercise appears to induce greater GLUT4 dispersal through the PM in 
comparison to glucose ingestion, in combination with the differing magnitude of the increase 
in Pearson’s correlation coefficient, led to the suggestion in chapter 4 that the magnitude of 
GLUT4 translocation in human skeletal muscle is greater following exercise at 65% VO2max 
than 30 min following glucose ingestion. This is consistent with skeletal muscle glucose 
uptake data which showed 3-fold increases in leg glucose uptake in the 4 h period following 
glucose feeding (Katz et al., 1983) and 15-fold increases in leg glucose uptake during exercise 





7.2.4. Effect of a hyperinsulinaemic-isoglycaemic clamp on GLUT4 localisation in Zucker 
rats 
Eighty minutes after the start of a hyperinsulinaemic-isoglycaemic clamp in lean (LZR) and 
obese (OZR) Zucker rats, there was no increase in the colocalisation of GLUT4 with 
dystrophin in skeletal muscle fibres in comparison to the post-absorptive state despite 
substantially elevated rates of glucose disposal (chapter 5). A potential explanation for the 
lack of increase in GLUT4 and dystrophin colocalisation during the hyperinsulinaemic-
isoglycaemic clamp is that the effect of the insulin stimulation, similar to the effect of the 
OGTT in chapter 4, is transient. Reinternalization of the fused GLUT4 molecules may then 
occur, in this case despite the continuously high insulin concentrations, with the insulin signal 
switched off at the later time points. This would imply that other mechanism take over at the 
later time points to explain the continuously high glucose disposal rates observed in this study 
and the continuously high muscle glucose uptake rates observed previously during a 2 h 
hyperinsulinaemic-isoglycaemic clamp in rats (Wallis et al., 2002). Unfortunately, as the 
study design was formulated based on the expectation that GLUT4 translocation would occur 
at 80 min muscle samples were not collected at earlier time points and, therefore, this 
explanation cannot be supported with hard evidence.  
There were also no differences in GLUT4 and dystrophin colocalisation between LZR and 
OZR in the overnight fasted and the insulin-stimulated states, despite previous studies 
reporting significant reductions in skeletal muscle glucose uptake during a 2 h 
hyperinsulinaemic-isoglycaemic clamp in OZR compared to LZR (Wallis et al., 2002). This 
implied that there are other mechanisms than impaired GLUT4 translocation behind the 
skeletal muscle insulin resistance in the OZR.  
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7.2.5. Effect of a hyperglycaemic glucose clamp 5.4 mM above the overnight fasted level in 
human volunteers with NGT and T2D 
A 2 h intravenous glucose infusion with the aim to create hyperglycaemic conditions, with the 
plasma glucose concentration elevated 5.4 mM above overnight fasted levels, was sufficient 
to raise plasma insulin concentrations markedly above baseline and elevate rates of whole 
body glucose disposal in NGT, therefore insulin sensitive, volunteers (chapter 6). However, 
the expected increase in colocalisation of GLUT4 with dystrophin following 2 h 
hyperglycaemia compared to the overnight fasted state did not occur. These data seem to 
suggest that after 2 h intravenous glucose infusion, GLUT4 PM content is not responsible for 
the elevated rates of whole body glucose disposal. It is possible that similar to the OGTT 
(chapter 4), intravenous glucose infusion also leads to transient increases in colocalisation 
between GLUT4 and dystrophin. These muscle samples were part of a research collaboration 
and no biopsy was taken at earlier timepoints to enable investigation of this possibility. There 
also were no increases compared to the overnight fasted state in the colocalisation of GLUT4 
with dystrophin in the patients with T2D. Pearson’s correlation coefficients in fact were the 
same for both groups both in the overnight fasted state and after 2 h of hyperglycaemia. This 
suggests that the insulin resistance of T2D does not lead to a reduction in the colocalisation of 
GLUT4 with the PM marker dystrophin either in the overnight fasted state or following 2 h 
intravenous glucose infusion. Following 24 h of hyperglycaemia in NGT, insulin sensitivity 
was reduced to values seen in T2D following 2 h hyperglycaemia, again with no changes in 
GLUT4 and dystrophin colocalisation. Similar to the observations made in chapter 5, the data 
resulting from intravenous glucose infusion suggests that changes in GLUT4 fusion with the 
skeletal muscle fibre PM are not responsible for decreases in whole body glucose disposal 
that occur in T2D individuals following 2 h hyperglycaemia compared to NGT and are also 
258 
 
not important in the development of insulin resistance following 24 h of hyperglycaemia in 
NGT. 
7.3. Comments on methodology in relation to the published literature 
The limitations of membrane fractionation methods in combination with Western blot 
analysis to investigate GLUT4 translocation in response to insulin and contraction are 
discussed in section 1.4.1 of the general introduction. These limitations provided the rationale 
for the development of a new method to investigate GLUT4 subcellular localisation and 
translocation to the PM in human skeletal muscle in this thesis. Confocal fluorescence 
microscopy studies published in the literature in rodent skeletal muscle and the data presented 
in chapter 4 of this thesis in human skeletal muscle have both shown insulin- and contraction-
mediated translocation of GLUT4 to the PM (Lauritzen et al., 2008, Lauritzen et al., 2006, 
Lauritzen et al., 2010). The method presented in this thesis is superior to that in the confocal 
fluorescence microscopy studies (Lauritzen et al., 2006, Lauritzen et al., 2008, Lauritzen et 
al., 2010) in the sense that it utilises the PM marker dystrophin to identify the PM and 
quantifies GLUT4 and dystrophin colocalisation rather than quantifying GLUT4 intensity in a 
peripheral region of interest assumed to be the PM. One technique that can be utilised in 
rodent muscle but not human muscle in vivo due to technological limitations is exofacial 
tagging of GLUT4 with GFP, haemaglutinnin (HA) or myc protein tags. GLUT4-GFP fusion 
protein has enabled highly elegant analysis of the temporal response of GLUT4 translocation 
to insulin and contraction in vivo in mouse muscle (Lauritzen et al., 2006, Lauritzen et al., 
2008, Lauritzen et al., 2010). HA and myc protein tags on the first extracellular loop of 
GLUT4, which becomes extracellular only when GLUT4 is inserted into the PM, has allowed 
confirmation of GLUT4 insertion into the PM in isolated muscle cells through detection of the 
externalised tag with an anti-myc (Schertzer et al., 2009) or anti-HA antibody (Fazakerley et 
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al., 2009a). However as specified neither method can be applied to human skeletal muscle in 
vivo. 
While confocal microscopy achieves superior resolution in comparison to widefield 
microscopy, all light microscopy methods have a resolution limit of approximately 200 nm. 
The significance of this resolution limit to the data presented in this thesis and the previously 
published literature became apparent towards the end of the PhD studies comprising this 
thesis. TIRF microscopy studies in mouse skeletal muscle that endogenously expressed a HA-
GLUT4-GFP protein, have shown that eighty percent of insulin-mediated GSV fusion events 
emanated from stationary vesicles that were within 100 nm of the PM and therefore likely 
pre-tethered at the PM prior to insulin stimulation (Lizunov et al., 2012). The small pool of 
mobile GSVs was not affected by insulin (Lizunov et al., 2012). This demonstrates the 
importance of pre-tethered GLUT4 localised within 100 nm of the PM (Lizunov et al., 2012). 
Therefore given the resolution limit of light microscopy it is not possible to distinguish 
between a vesicle that is fused at the PM, pre-tethered at the PM or simply in close proximity 
to the PM (Schertzer et al., 2009, Lauritzen and Schertzer, 2010). Therefore, it should be 
noted that the transition from tethered to fused GLUT4 may not have been detected in the 
current study, which potentially limits the sensitivity of measuring increases in GLUT4 and 
dystrophin colocalisation using this method. However it is important to emphasise that this is 
a limitation observed with all standard confocal microscopy methods and similarly with 
measurement of GLUT4 content in isolated membrane fractions (Schertzer et al., 2009). The 
TIRF microscopy method also relies on expression of GLUT4 tagged with a fluorescent 
protein which means the method is not suitable for replication in human skeletal muscle in 
vivo. Despite the resolution limit of confocal microscopy, the immunofluorescence 
microscopy method developed in this thesis has been able to generate novel information 
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regarding GLUT4 localisation and GLUT4 translocation in human skeletal muscle. Therefore 
considering the limitations of subcellular fractionation methods and the inability to use TIRF 
methodology in human skeletal muscle in vivo, the immunofluorescence microscopy method 
developed in this thesis is the best method currently available to generate novel information 
on GLUT4 localisation in human skeletal muscle. The results obtained in this thesis have 
shown that this method can be used to measure fibre type specific GLUT4 content, changes in 
the number and size of GLUT4 clusters induced by training interventions, and changes in the 
colocalisation of GLUT4 with the PM marker dystrophin induced by moderate intensity 
exercise and ingestion of a 75 g bolus of glucose. 
 
7.4. Mechanisms in addition to GLUT4 fusion with the skeletal muscle fibre PM that 
may contribute to increases in skeletal muscle glucose uptake 
The modest transient increase in GLUT4 and dystrophin colocalisation seen after glucose 
ingestion in chapter 4 does not seem to account for the 3-fold increase in skeletal muscle 
glucose uptake observed in the 4 h period following glucose feeding (Katz et al., 1983). The 
increase in Pearson’s correlation coefficient seen after 30 min of exercise also does not seem 
to explain the 15-fold increase in muscle glucose uptake that is seen during exercise at 50-
60% VO2max (Katz et al., 1986, Martin et al., 1995). In addition the absence of an increase in 
GLUT4 and dystrophin colocalisation 80 min into a hyperinsulinaemic-isoglycaemic clamp in 
LZR (chapter 5) does not explain the 5-fold increase in glucose infusion rate observed in 
chapter 5 or the 5-fold increase in hind-limb glucose uptake observed previously during a 2 h 
hyperinsulinaemic-isoglycaemic clamp in LZR (Wallis et al., 2002). This implies that in these 
conditions there must be additional parallel mechanisms or alternative mechanisms that lead 
to these marked increases in muscle glucose uptake.  
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In chapter 2 we observed colocalisation of GLUT4 with the dihydropyridine receptor (DHPR) 
which confirms GLUT4 is also present in the T-tubule membranes in human skeletal muscle 
similar to observations made before in rodent muscle. The T-tubule membrane system 
comprises invaginations of the muscle PM which extend deep into the muscle fibre and is 
well characterised as a site of insulin- and contraction-mediated GLUT4 translocation in 
rodent muscle (Ploug et al., 1998, Lauritzen et al., 2006, Lauritzen et al., 2010). The T-tubule 
membrane surface area has been suggested to be two- to three-fold larger than that of the PM 
(Lauritzen et al., 2006), with suggestions that it may even be nine times larger and may 
contribute as much as 94 % of the GLUT4-mediated glucose uptake in rodent skeletal muscle 
(Wang et al., 1996). Regretfully it was not possible to quantify GLUT4 translocation to the T-
tubule membranes due to methodological difficulties that have been discussed in chapter 2. 
Suggestions that may help to improve the quantitation of GLUT4 translocation to the T-tubule 
membranes in human skeletal muscle in future studies are given in section 7.5 of this chapter. 
It, however, remains possible that at the time points sampled in this study, increases in 
GLUT4 localisation may have been much more prominent at the T-tubule membranes 
compared to the PM. 
Insulin-mediated skeletal muscle microvascular vasodilation leading to increases in skeletal 
muscle capillary blood flow is a second mechanism that may lead to increases in the delivery 
of both glucose and insulin to the interstitial fluid that surrounds the muscle fibres and that, 
therefore, may increase skeletal muscle glucose uptake (Clark, 2008, Steinberg et al., 1994). 
Insulin-mediated skeletal muscle microvascular vasodilation begins 5-10 min into a 
hyperinsulinaemic-euglycaemic clamp in rats and precedes the activation of the insulin 
signalling cascade and increases in glucose uptake in skeletal muscle (Vincent and Barrett, 
2002, Vincent et al., 2004). Of relevance to the later time points in particular, Gudbjornsdottir 
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et al. (2003) have shown that there are marked increases in the capillary permeability surface 
area (PSA) product which are proportional to the increase in glucose uptake that has been 
observed 90-120 min after the start of an OGTT and even larger increases in that period 
during a hyperinsulinaemic-euglycaemic clamp using physiological insulin levels 
(Gudbjornsdottir et al., 2003). In addition increases in total leg and muscle blood flow that are 
beginning to occur approximately 2 h after the start of a hyperglycaemic-euglycaemic clamp 
(Laakso et al., 1990, Utriainen et al., 1995, Yki-Jarvinen and Utriainen, 1998) may also 
contribute to the high glucose disposal rate observed at later time-points in chapters 5 
(hyperinsulinaemic-isoglycaemic clamp in rats) and 6 (hyperglycaemic glucose clamp in 
individuals with NGT), conditions in which no increases in colocalisation of GLUT4 with 
dystrophin were observed. 
A number of studies have provided evidence that an increase in GLUT4 intrinsic activity may 
occur after GLUT4 has translocated to and fused with the PM and this is a third mechanism 
that may thus contribute to the increase in glucose uptake under insulin-stimulated conditions 
(Michelle Furtado et al., 2003). Potential mechanisms proposed for the increase in GLUT4 
intrinsic activity include phosphorylation and binding of enhancer or inhibitor proteins, the 
latter of which is suggested to change the activity of GLUT4 through changes in its 3D 
structure (Michelle Furtado et al., 2003). 
The final step in glucose uptake into the skeletal muscle is the irreversible phosphorylation of 
glucose to glucose 6-phosphate by the enzyme hexokinase (HKII), thereby trapping the 
glucose molecule inside the muscle cell (Wasserman et al., 2011). A negative feedback 
mechanism also exists whereby glucose 6-phosphate inhibits HKII activity (Wasserman et al., 
2011). Studies in transgenic mice that over-express HKII in skeletal muscle have shown 
increased muscle glucose uptake during hyperinsulinaemic-euglycaemic clamp in comparison 
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to wild type controls (Fueger et al., 2004). In addition transgenic mice in which HKII activity 
is impaired by approximately 50 % in heart, muscle and adipose tissue displayed reduced 
whole body insulin sensitivity assessed during a hyperinsulinaemic-euglycaemic clamp 
(Fueger et al., 2007). Mechanisms that lead to activation of HKII should, therefore, also be 
considered as a mechanism that may increase muscle glucose uptake, providing sufficient 
GLUT4 is available at the PM for glucose transport into the muscle cell (Wasserman et al., 
2011). In addition downstream processes such as increased glycogen synthesis may have a 
role to play in increasing rates of muscle glucose uptake. For example, increased glycogen 
synthesis will reduce intracellular glucose 6-phosphate concentration thereby increasing HKII 
activity and increasing phosphorylation of glucose. This in turn would decrease the free 
glucose concentration in the muscle and increase the concentration gradient between arterial 
blood, the interstitium and the muscle fibres, thereby leading to increased rates of GLUT4-
mediated glucose transport (Wasserman et al., 2011).  
In summary while chapter 4 clearly shows GLUT4 translocation occurs in human skeletal 
muscle 30 min following glucose ingestion and following 30 min cycling exercise at 65 % 
VO2max, there are additional mechanisms that may contribute to insulin- and contraction-
mediated increases in skeletal muscle glucose uptake which may predominate when the 
colocalisation of GLUT4 and dystrophin returns to the overnight fasted baseline values (at 60 
and 90 min into the OGTT) or does not increase above the overnight fasted baseline values 
(chapter 5 and 6). These mechanisms were beyond the scope of this thesis and, therefore, have 






7.5. Suggestions for future research 
7.5.1. Possibilities for improvement in the GLUT4 translocation assay in human skeletal 
muscle 
As mentioned in the previous section a major aspect of the role that GLUT4 translocation may 
play in increases in skeletal muscle glucose uptake that could not be evaluated in the studies 
contributing to this thesis is the translocation of GLUT4 to and fusion with the T-tubule 
membranes. Methodological issues associated with the quantitation of T-tubule GLUT4 
content (chapter 2) prevented its assessment in response to glucose ingestion, acute exercise, a 
hyperinsulinaemic-isoglycaemic clamp and a hyperglycaemic glucose clamp. The 
development of a method to quantify GLUT4 content in the T-tubule membranes remains an 
important target for future research. Immunofluorescence microscopy of single human muscle 
fibres might offer a solution as it allows elongation of the sarcomeres and, therefore, may 
allow clearer visualisation of GLUT4 in T-tubule membranes (Murphy et al., 2009). This 
muscle fibre preparation method should be combined with assessment of colocalisation of the 
GLUT4 stain with the T-tubule membrane marker DHPR and assessment of the intensity of 
the GLUT4 striations using line profiling techniques (Sylow et al., 2013). 
Further information on GLUT4 localisation changes in response to exercise training, glucose 
and insulin administration and acute exercise could be gained through more detailed analysis 
of the large and small intracellular GLUT4 clusters. One option to contribute towards this 
would be to use specific markers to label GSVs, endosomes and TGN associated membranes, 
such as VAMP2 (Foley et al., 2011), tranferrin receptor (TfR) (Ploug et al., 1998) and TGN38 
(Ploug et al., 1998), respectively. Assessment of colocalisation of GLUT4 with these markers 
using confocal immunofluorescence microscopy could generate further information on 
whether training increases GLUT4 content in a particular storage location and whether 
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glucose feeding and exercise recruit GLUT4 from a particular storage location in human 
skeletal muscle. Furthermore it could be helpful to measure the content of the GLUT4 clusters 
observed in this thesis in concentric layers extending into the fibre from the PM to determine 
1) whether training induces greater increases in GLUT4 stores in layers closer to the PM and 
2) whether insulin and contraction deplete GLUT4 to a greater extent from stores closer to the 
PM as observed in rodent muscle by (Lizunov et al., 2012). Such measurements would 
require additional software which is commercially available (MATLAB, v. 2012b, The 
MathWorks Inc., Natick, MA, 2012).  
The above methods to further investigate the identity of GLUT4 storage clusters in human 
skeletal muscle could all be carried out using standard confocal immunofluorescence 
microscopy methods; albeit with the consideration of the 200 nm resolution limit of light 
microscopy methods. However to fully confirm GLUT4 and the TGN, endosomal or GSV 
markers are localised to the same compartment rather than two compartments within 200 nm 
of one another higher resolution imaging methods are required. One option for this would be 
super resolution fluorescence microscopy, such as stimulated emission depletion (STED) 
microscopy, which can achieve a spatial resolution of 30-40 nm (Huang et al., 2009). This has 
the advantage of being able to use fluorescence markers for colocalisation analysis, which 
would enable easier quantitation, through colocalisation, of changes in the GLUT4 content of 
TGN, endosome membranes and GSVs following training, glucose administration or acute 
exercise. The alternative would be to use transmission electron microscopy (TEM), which can 
achieve a spatial resolution of 0.3-1 nm (Massover, 2011). In this case antibodies conjugated 
to colloidal gold particles of different diameters would be used to identify GLUT4 and TGN, 
endosomal or GSV markers (Hagiwara et al., 2010). These high resolution methods of course 
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require access to highly specialised equipment, which was not possible during the PhD studies 
presented in this thesis. 
7.5.2. Suggestions for future applications of the newly-developed GLUT4 translocation assay 
Future experiments need to investigate additional time points in studies similar to those 
presented in this thesis. Firstly, the early response to a hyperinsulinaemic-isoglycaemic clamp 
in LZR and to a hyperglycaemic glucose clamp in NGT should be investigated to determine 
whether, as suggested in this thesis, the GLUT4 translocation response is transient in these 
situations, similar to observations made during an OGTT in chapter 4 of this thesis. Secondly 
it would be worth investigating whether GLUT4 translocation can be detected in human 
skeletal muscle at 15 min following glucose feeding, as it is possible that the maximum 
GLUT4 translocation response occurs before the 30 min time point sampled in this thesis. 
Another important application of this GLUT4 translocation assay in humans will be to 
compare increases in GLUT4 and dystrophin colocalisation, and if the methodological 
problems can be solved increases in GLUT4 T-tubule membrane content, in insulin sensitive, 
insulin resistant and T2D human populations, over a time course following glucose ingestion 
and during exercise. The number of possible time points comprising a time course is limited 
in a human study due to the invasive nature of a percutaneous muscle biopsy. The optimum 
time points are difficult to establish however suggestions would be at baseline and 15, 30 and 
60 min following glucose feeding and in a separate cohort of matched participants at baseline 
and 15, 30 and 60 min into cycling exercise at 65 % VO2max. Plasma membrane fractionation 
studies have suggested that insulin- but not contraction-mediated GLUT4 translocation would 
be reduced in T2D individuals (Zierath et al., 1996, Garvey et al., 1998, Kennedy et al., 
1999). This now needs to be confirmed with the immunofluorescence microscopy method 
presented in this thesis. In an ideal scenario assessment of GLUT4 translocation would be 
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combined with assessment of leg glucose uptake and microvascular recruitment through the 
leg glucose balance technique (Baron et al., 1988) and contrast-enhanced ultrasound (CEU) 
(Clark, 2008, Sjoberg et al., 2011), respectively, to assess the contribution of the most 
important alternative mechanisms in the control of skeletal muscle glucose uptake. The CEU 
method to measure microvascular recruitment in response to insulin and exercise should be 
complemented with an immunofluorescence microscopy method used to measure eNOS Ser 
1177 phosphorylation in the microvasculature (Cocks et al., 2012) at all time points at which 
muscle biopsy samples are collected. Taken together these data would provide valuable 
information on the relative role played by increases in GLUT4 PM content and microvascular 
recruitment in the increases in insulin- and contraction-mediated skeletal muscle glucose 
uptake at different time points after glucose feeding and following the onset of exercise. 
Another area of interest to which a GLUT4 translocation assay could be applied is in the 
investigation of increases in insulin sensitivity that occur following an acute exercise bout. 
Once again membrane fractionation methods have suggested that insulin-mediated GLUT4 
translocation to the PM is increased following a prior exercise bout (Hansen et al., 1998), 
however this again ought to be tested with the immunofluorescence microscopy method 
developed in this thesis. Similarly this immunofluorescence microscopy method could be 
used to further investigate the mechanisms behind the exercise training-induced increases in 
insulin sensitivity (Hughes et al., 1993, Dela et al., 1996, Cox et al., 1999, Babraj et al., 2009, 
Richards et al., 2010, Phillips et al., 1996, Daugaard et al., 2000, Burgomaster et al., 2007, 
Hood et al., 2011, Little et al., 2010). Firstly it should be investigated whether training 
induces increases in insulin- and contraction-mediated GLUT4 translocation, in addition to 
the increases in total GLUT4 content in human skeletal muscle in chapter 3. This could be 
assessed by comparing the increase in Pearson’s correlation coefficient following glucose 
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feeding and exercise before and after a period of exercise training. Using the earlier 
suggestion to combine GLUT4 immunofluorescence staining with staining for TGN, 
endosomal and GSV markers for different pools of GLUT4, it may be possible to determine 
whether particular pools that increase their GLUT4 content following training are then 
preferentially depleted following glucose feeding or exercise to enhance the GLUT4 
translocation response. This could help to further elucidate the mechanism behind the 
training-induced improvements in insulin sensitivity.  
7.5.3. The importance of combining an assay for GLUT4 translocation with assessment of 
SNAP23 localisation 
Combined staining of GLUT4 and SNAP23 at the PM, as was attempted in chapter 2, would 
enable assessment of whether regions of GLUT4 and SNAP23 staining heterogeneity at the 
PM are localised to the same region. If this were confirmed to be the case it would support the 
idea that GSV fusion with the PM occurs at specific PM domains. Chamberlain and Gould 
(2002) observed that the majority of SNAP23 was present in PM lipid rafts in 3T3-L1 
adipocytes (Chamberlain and Gould, 2002). Lipid rafts are cholesterol and sphingolipid-
enriched regions of the PM (Owen et al., 2012). Therefore in future studies it should be 
explored whether SNAP23 is also localised to lipid rafts domains in human skeletal muscle, 
implying that the lipid rafts would be the sections of the PM where preferential docking and 
fusion of GLUT4 occurs prior to subsequent diffusion of GLUT4 along the PM leading to the 
heterogeneous distribution seen in chapter 4 30 min after glucose feeding and the onset of 
cycling exercise. The lipid content of lipid raft domains may be vital for the successful 
docking and fusion of GLUT4 at the PM and would also bring GLUT4 into close proximity 
with the insulin signalling proteins Cbl and TC10 which reside in lipid rafts (Baumann et al., 
2000, Chiang et al., 2001). Identification of individual lipid rafts through 
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immunofluorescence microscopy is challenging due to limitations in the markers available 
and the small size (10-200 nm) of the raft domains. However glycophosphatidylinositol 
(GPI)-anchored proteins have been used previously as lipid raft markers and super resolution 
microscopy methods discussed previously could be used to identify individual lipid raft 
domains and therefore assess colocalisation of GLUT4 and SNAP23 (Owen et al., 2012). In 
addition combination of GLUT4 and SNAP23 staining would allow further investigation of 
the SNARE highjacking hypothesis (Sollner, 2007) by determining whether increased skeletal 
muscle lipid content reduces SNAP23 content in the PM and inhibits the translocation of 
GLUT4 in the insulin stimulated state. This would add further to the limited evidence that 
reduced t-SNARE-PM abundance contributes to the impaired insulin action involved in the 
pathogenesis of T2D. 
 
7.6. Final conclusions 
The immunofluorescence method to assess GLUT4 localisation developed as part of this 
thesis has demonstrated that exercise training-induced increases in GLUT4 content are driven 
predominantly by increases in the number of large and area of small intracellular GLUT4 
storage clusters. Furthermore insulin- and contraction-mediated GLUT4 translocation have 
been successfully visualised and quantified in human skeletal muscle for the first time. The 
data presented in this thesis further suggest that insulin-mediated GLUT4 translocation is 
transient and occurs following a similar temporal pattern to the peak elevation in plasma 
insulin concentration. In addition the evidence indicates that GLUT4 PM content is not 
always the determining factor for glucose uptake and other factors such as microvascular 
recruitment, intrinsic GLUT4 activation and HKII activity may play a role as well. 
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Further experiments are required to confirm that increases in translocation also occur in the 
first 30 min of hyperinsulinaemic-isoglycaemic clamp in LZR and 30 min after the start of a 
hyperglycaemic clamp in humans as suggested in chapters 5 and 6 (NGT group only). In 
future studies these methods should then be used to assess the fundamental mechanisms 
behind insulin- and contraction mediated glucose uptake and investigate the mechanisms 
underlying the development of skeletal muscle insulin resistance and T2D. Beyond that these 
methods will enable investigation into whether lifestyle and pharmaceutical interventions are 
able to rescue GLUT4 translocation and normalise glycaemic control. This can in turn inform 
medical professionals as to the optimal interventions and metabolic targets to combat the 
increasing prevalence of insulin resistance, metabolic syndrome and T2D worldwide thereby 
reducing the associated financial burden and mortality implications. 
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